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ABSTRACT 
 
Bovine Digital Dermatitis (DD) is a leading cause of lameness in dairy cattle in the 
US with more than 70% of herds affected. Despite 40 years of research, the definitive 
etiologic agent(s) associated with the disease process is unknown. While clinical lesions have 
been well described, little is known about the macroscopic, microscopic, and bacterial 
changes associated with the early stages of lesion development from normal skin to clinical 
lesions. The goal of this dissertation was to describe the temporal changes associated with 
lesion development in Holstein dairy cattle, particularly early stage lesions, and develop a 
model for lesion induction. By following a cohort of Holstein dairy cows for a three year 
period, several important epidemiologic findings were recognized. In the absence of control 
measures, DD lesions developed at a rate of 4 lesions per 100 cow feet-months, with the 
average time for a lesion to develop being 133 days. From the recognition of the macroscopic 
changes that preceded clinical DD lesions, a novel scoring system was developed. While 
20% of the feet observations had clinical DD lesions, an additional 55% of observations had 
lesions that were indicative of early DD lesion development. Biopsies from these different 
stages of lesion development were submitted for metagenomic analysis using next generation 
sequencing. The bacterial microbiota of these biopsies was found to progress through a 
systematic series of changes that correlate with the macroscopic lesion scoring system with 
the microbiota of each stage being statistically different from other stages. As one of the 
major goals for these studies was to gain a better understanding of the etiology of disease, an 
experimental model was needed to test candidate pathogens. Four preliminary studies were 
conducted to optimize conditions and methodologies for induction of DD lesions that led to a 
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final consensus protocol that was able to induce DD lesions in 95% of Holstein calves within 
28 days. The results of these studies support the hypothesis that DD is a polybacterial disease 
process that undergoes systematic macroscopic, microscopic, and bacterial changes as lesions 
develop.
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CHAPTER 1: 
GENERAL INTRODUCTION 
 
Introduction 
 Lameness in dairy cattle affects approximately 11% of all bred heifers and 24% of cows 
in the US per year. Digital dermatitis (DD) accounts for 62% of the lameness in bred heifers and 
49% of the lameness in cows (1). The economic impact of DD in the US has been estimated at 
over $190 million per year in treatment costs, decreased reproductive performance, and lost milk 
production (2). The disease was first definitively reported in the US in 1980 as highly contagious 
foot lesions in New York (3) and quickly spread to multiple states across the US and to 
California by 1992 (4, 5). Since that time, the prevalence has been on the rise with an estimated 
17% of dairy cattle affected in 1996 to 28% of US dairy cattle affected by 2007 (1). The etiology 
of disease is still undetermined with the most wide accepted theory being that the disease process 
is poly-microbial that involves multiple species within the genus of Treponema. 
 Despite numerous studies evaluating DD lesions utilizing culture, molecular, and 
histologic techniques, the exact causative agent(s) as well as the course of development of the 
lesions remains unknown. This is likely due to the logistic challenges that accompany studying a 
disease process of the lower limbs that requires extensive restraint to properly evaluate, as well 
as the length of time it takes DD lesions to develop. While there are a plethora of studies that 
have reported the prevalence of DD lesions from single time-point evaluations of feet, foot 
trimmer records, and slaughterhouse examinations, there are only a few longitudinal studies that 
have evaluated feet over an extended period of time. Because of this reason, the literature is 
biased with studies that only evaluate the final stages of disease which may have taken weeks to 
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months to develop and not lesions at the onset of disease. The research presented in this 
dissertation was based on identifying DD lesions at the onset of development to evaluate the 
macroscopic, microscopic, and bacterial changes that occur as lesions develop. As this 
longitudinal study encompassed several years, additional insights on the epidemiology of disease 
were also evaluated. 
 As one of the major goals for these studies was to gain a better understanding of the 
etiology of disease, a method to experimentally test potential pathogens was needed to fulfill 
Koch’s postulates. The only published DD induction model was deemed too complicated and 
labor intensive to apply to large scale studies (6). Several pilot trials along with five large scale 
experimental trials were conducted to improve our ability to induce DD lesions in 
immunologically naïve Holstein calves. Knowledge obtained from analysis of naturally 
occurring DD lesions from our longitudinal study was utilized to identify candidate pathogens 
for testing with our refined induction protocols. 
 
Dissertation Organization 
 This dissertation is organized in five chapters. The first chapter includes a literature 
review of pertinent peer reviewed studies related to the epidemiology and etiology of DD. 
Chapter 2 describes the epidemiologic observations and analysis of the longitudinal study. This 
includes data on incidence rate, morphologic and microscopic analysis of various lesion stages, 
and treatment outcomes. Chapter 3 expands on the longitudinal study with a focus on culture-
independent methods to evaluate the etiology of DD. This chapter also includes a description of a 
novel scoring system developed during this study and the microbiota changes associated with 
lesions as they develop from normal skin to clinical DD lesions. The fourth chapter describes the 
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five experiments conducted to improve our techniques to induce DD lesions in calves. The final 
chapter is a summary of the research conducted and the conclusions drawn from the research. It 
also includes recommendation for future research related to the findings of this dissertation. 
 
Literature Review 
Prevalence and economic impact of Digital Dermatitis 
Bovine Digital Dermatitis (DD) is a leading cause of lameness in dairy cattle in the 
United States (1) but has also been reported at various levels in beef cattle (7-9). In the most 
recent National Animal Health Monitoring System survey of US dairy farms, DD accounted for 
61.8% of the lameness in bred heifers and 49.1% of the lameness in cows (1). DD was 
determined to be the most costly of all foot disorders ($95 per case) in a stochastic simulation 
model when an estimated prevalence of 20% for clinical DD was employed (10). When milk 
production losses associated with treatment, decreased reproductive performance, and treatment 
were incorporated, the losses were estimated at $126 - $133 for every clinical case of DD (11, 
12). The total economic loss to the dairy industry has been calculated at $190 million per year in 
the US (2). The estimated economic impact in the US was based on the 17% prevalence from 
1996 NAHMS report. The 2007 NAHMS report estimates the current prevalence at 28% (1) 
which would suggest the $190 million per year estimate vastly underestimates the economic 
impact in the US. Digital dermatitis was also found to have the greatest impact on welfare of all 
bovine lameness disorders due to the high incidence and long duration (13). Additionally, lame 
cows have proven to be difficult to identify and vastly underestimated by producers (14). The use 
of lameness as an estimate for digital dermatitis prevalence has also been shown to be unreliable 
with only 39% of cows with severe DD lesions showing signs of lameness (15). Estimates of 
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prevalence have been published across multiple countries (8, 16-24) and range from 1.4% in 14 
Norwegian herds to 39% 5 Danish herds. The large range of prevalence reported from these 
studies was highly variable based on location, management system, and prevention measures 
employed. For herds in free-stall barns, most estimates suggest a prevalence of 20-25% of 
animals affected. These estimates are based on the prevalence of clinical DD lesions that have 
been described as characteristically circumscribed, erosive to papillomatous, surrounded by a 
ridge of hyperkeratotic skin and hypertrophied hairs (25). 
Several longitudinal studies have attempted to report the rate at which DD lesions 
develop. These studies employed a large range in length of time cows were observed, 
observation frequency, and types of DD prevention measures over time, however, none of these 
studies observed natural lesion development in a controlled environment without any 
intervention strategies for an extended period of time. This is partly due to the prolonged period 
required for lesion development which necessitates these types of studies to encompass several 
years. It is also difficult to accurately assess and document lesions over that period of time 
without exposing the lower limbs and interdigital space for examination by utilizing some type 
of hoof trimming chute. Because these studies did not report incidence in a consistent manner, to 
compare across studies, an analysis in which data from each study was converted to new active 
lesions per 100 cow feet-months was performed for the purposes of this literature review. 
Hedges et al. (26) found the rate of new cases to be 4.2 cases per 100 cow feet-months from 5 
herds in the UK when followed over 18 months while evaluating the effects of feeding biotin on 
the rates of lameness. Relun et al. (27) found the rate of new cases to be 4 cases per 100 cow 
feet-months from 52 herds in France when followed for 11 months while conducting a controlled 
clinical trial on different treatment regimens for naturally occurring DD lesions. Nielsen et al. 
5 
 
(28) evaluated the rate of lesion development on three Danish herds while enrolled in a clinical 
trial involving an automatic hoof washing machine. The rate of development on these herds was 
8.6 cases per 100 cow feet-months. Holzhauer et al. (29) evaluated the rate of DD development 
in an endemically infected herd in the Netherlands when all preventative measures were 
removed. This herd was followed for only three weeks, but developed DD lesions at a 
dramatically higher rate than previous reports (16 cases per 100 cow feet-months). While the 
incidence rate of DD development is influenced by a large number of factors, the first three trials 
mentioned above embody a number of different herds from different geographical areas and 
management systems, and would be representative of most dairy herds. The incidence rate of 16 
lesions per 100 cow feet-months would represent a worst-case scenario in which an endemically 
infected dairy herd removes all preventative measures. 
 
Digital Dermatitis morphology – macroscopic and microscopic 
The first manuscript to describe the macroscopic appearance of a large number of DD 
lesions was done on 10 California dairies by Read and Walker in 1998 (25). The majority of the 
lesions were circumscribed, erosive to papillomatous and surrounded by a ridge of 
hyperkeratotic skin bearing hypertrophied hairs. The lesions were typically circular to oval in 
shape, raised above the surrounding skin, and 2-6 cm in diameter. Lesions were more likely to 
involve the rear legs (82%) and the majority (83%) were located on the proximal border of the 
interdigital space. The macroscopic differences in DD lesion morphology have been described 
with several novel scoring systems primarily used in research settings (30-32). Dopfer et al. 
described four stages of lesion development with stage M1 being the formation of a small 
ulcerative area, stage M2 being a mature papillomatous or ulcerative lesion, stage M3 being a 
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healing lesion, and stage M4 being a chronic recurrent lesion (32). Britt et al. (33) used a five-
point scoring system that was based on the evaluation of active lesions by color, stage, associated 
pain, and size. Manske (30) utilized a 6 point scoring system that accounted for the stage and 
severity of DD lesions. It has also been shown that there can be dynamic macroscopic changes 
between active and chronic stages in as little as seven days (28, 34). The system designed by 
Dopfer et al. is the only scoring system meant to describe the different stages of lesion 
development as they transition between normal skin and clinical DD lesions and is the most 
widely used system in literature today. 
The histopathologic changes associated with DD have been described in numerous 
publications (3, 8, 24, 32, 35-42); several of these studies summarize the histopathologic changes 
associated with a large set of DD lesions (8, 32). Dopfer et al. (32) described the microscopic 
changes associated with each of the lesions stage in the “M” scoring system. Ml lesions were 
described as having rete ridge formation, partial loss of epithelium and parakeratosis, ballooning 
degeneration, and papillary projections towards the skin surface ending in micro-abscesses and 
hemorrhages. M2 lesions were described as having a complete loss of stratum corneum, 
pronounced hemorrhage at the lesion border, horny columns, ballooning degeneration and 
acanthosis. M4 lesions were described as having a highly proliferative epidermis, pronounced 
rete ridge formation, hyperplastic stratum corneum, and acanthotic stratum spinosum. No 
description of M3 lesions was given. Brown et al. (8) described the microscopic changes from 
active versus resolving lesions. Active lesions were described as having zones of acute 
degeneration, necrosis, and focal thinning of the stratum corneum with inflammatory cell 
infiltration. Resolving lesions were described as acanthotic, marked thickening of the epidermis, 
with additional layers of stratum spinosum and stratum, with a decreased thickness of the stratum 
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granulosum in most quiescent lesions. Both studies found a consistent microscopic observation 
of spirochetes within the lesions through the use of silver staining. Additionally spirochetes have 
been observed with the use of immunohistochemistry (43, 44), electron microscopy (44-46), and 
fluorescence in situ hybridization (FISH) (22, 35, 47-53).  
 
Etiology of Digital Dermatitis 
Bovine DD was first morphologically described in 1974 at the 8th International Meeting 
on Diseases of Cattle in Milan, Italy (54), but despite over 40 years of research, the fulfillment of 
Koch’s postulates in identification of an etiological agent(s) has yet to be achieved. The first 
reports of a possible etiologic cause of the disease were reported in 1992 (4), which was soon 
followed by a report describing the isolation and identification of an anaerobic spirochete, 
believed to be a Treponema spp., in the lesions (55). Since that time, a number of additional 
papers have been published demonstrating the association of the lesions with additional bacteria. 
An analysis of published literature describing the evidence for each of these bacterial agents and 
their role in DD will be described. 
 
The evidence for Treponema spp. 
The first report of a spirochete-like, filamentous organism within DD lesions was 
described by Blowey and Sharp in 1988 (41). It was soon found that these organisms belong to 
the species Treponema and with that became the first bacterial species cultivated and implicated 
in the etiology of bovine DD (55). Even from the original report, which described two unique 
bacterial morphologies that belonged to the Treponema species, the identification of multiple 
Treponema spp. through visual, biochemical, immunological, and molecular techniques has been 
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a consistent finding. The first paper to describe the different Treponema spp. based on molecular 
techniques was done by Choi et al. (49) in which five unique species were identified utilizing 
16S rRNA sequencing. Three of the five species were closely related to isolates from human 
periodontal disease (T. phagedenis, T. vincetii, and T. denticola) and the remaining two were not 
closely related to any cultivable Treponema spp. Choi et al. also used fluorescence in situ 
hybridization (FISH) to demonstrate the spacial distribution of the various Treponema spp. 
within DD lesions and found the majority of the Treponema spp. within active lesions were that 
of T. denticola-like. 
Utilizing the sequences reported in these earlier studies, several Treponema spp. specific 
PCR tests were developed to amplify Treponema spp. 16S rRNA sequences in order to further 
characterize the Treponema spp. from DD lesions (56, 57). These Treponema spp. specific PCR 
primers were used in one of the first studies to compare the prevalence of Treponema spp. in DD 
lesions versus normal feet (43). This study by Demirkan et al. showed a clear association 
between DD lesions and Treponema spp. with 82% of DD lesions containing Treponema spp. 
DNA and 0% of normal feet containing Treponema spp. DNA. In addition, several studies (58, 
59) found a significant humoral response to Treponema spp. antigens in cattle with DD, in 
comparison to cattle without DD lesions. To investigate if additional uncultivable Treponema 
species could play a role in DD, Moter et al. (50) used FISH and oligonucleotide probes directed 
at non-cultivated strains of Treponema from human periodontal disease as well as probes from 
previously described DD associated Treponema spp. It was found that the previously reported 
Treponema denticola-like organisms only resided on the surface of the epidermis while deeper 
tissues contained higher levels of un-cultivated Treponema spp. A continued effort to cultivate 
these organisms from DD lesions using complex media resulted in the cultivation of several new 
9 
 
Treponema species (51, 60, 61). These included a species similar to Treponema maltophilum (a 
human oral spirochete), designated Treponema brennaborense (51), and six unique species of 
Treponema closely related to Treponema phagedenis from DD lesions from Iowa cattle (61).  
Dhawi et al. (62) attempted to characterize the immune responses of cattle in the UK to 
various Treponema spp. antigens, and similar to other immunologic studies (58, 59), cattle 
without DD lesions were less likely to have an immune response to DD antigens. However, the 
study indicated that cattle with DD lesions did not have a consistent immune response to any 
specific Treponema spp. antigen, as specific farms had unique immune responses to different 
Treponema antigens. The initial explanation for this was that different species of Treponema 
were capable of producing DD lesions at different farms across the UK. However, despite the 
presence of an immunological response to Treponema spp. in animals with DD lesions, an 
investigation into the protective effects of a vaccine targeted against Treponema spp. was found 
to have minimal success (63). Another study was undertaken to investigate the virulence and 
antigenic relatedness of four previously isolated Treponema phagedenis-like spirochetes isolated 
from DD lesions in a murine mouse model (64). It was found that these Treponema phagedenis-
like spirochetes isolated from DD lesions have differential virulence and antigenic traits from 
those seen with the nonpathogenic human T. phagedenis strain in vivo. These same Treponema 
phagedenis-like spirochetes were found to impair the innate immunity and wound repair 
functions of bovine macrophages when exposed to their cellular constituents, possibly enabling 
the bacteria to resist clearance and induce lesion formation (65).  
In 2008, three unique phylogroups were identified from 23 Treponema spp. isolates from 
30 DD lesions (66). Sequencing of the isolates put them into three phylogroup clusters which 
were categorized as Group 1 (Treponema medium / Treponema vincentii-like), Group 2 
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(Treponema phagedenis-like), and Group 3 (Treponema denticola / Treponema putidum-like). 
These phylogroups groups showed a large genotypic and phenotypic diversity between 
phylogroups which also differed from any named Treponema spp. at that time. With the 
development of a PCR for each of these phylogroups, the prevalence of each phylogroup was 
evaluated against 51 DD lesions. The Treponema medium / Treponema vincentii-like, 
Treponema phagedenis-like, and Treponema denticola / Treponema putidum-like phylogroups 
were present in 96.1%, 98%, and 76.5% of DD lesions, respectively (44). At the same time, 
another study utilized FISH to determine if any of 12 phylogroups of DD associated Treponema 
spp. were more or less associated with DD lesions (52). This study found that four of the twelve 
phylogroups were associated with 71% of the DD lesions. The probes for these four phylogroups 
were targeted to Treponema spp. identified from human periodontal disease which included T. 
vincentii, T. denticola, T. maltophilum and T. phagedenis. 
To this point, the phylogroups identified in the studies mentioned were not standardized 
and each researcher used their own nomenclature. Klitgaard et al. (47) in 2008 standardized 
much of the phylotypes nomenclature by sequencing a 600bp 16S rRNA fragment from 237 
Treponema spp. clones. Similar to techniques in human periodontitis, “phylotype” was defined 
as clusters of cloned sequences that differed from known species by approximately 2% and were 
99% similar to members of their cluster (67). The sequences were grouped into nine phylogroups 
based on 98% sequence similarity and designated as PT1 – PT9. Five of the nine phylogroups 
were nearly identical to the five phylogroups described by Choi et al. (49) in 1997. Several of 
these phylogroups also showed similarity to the T. vincentii, T. phagedenis, and T. denticola 
phylogroups also described in previous studies (56, 57, 66). The FISH analysis in this same study 
also showed a large difference between the spatial distribution and density of various phylotypes 
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with PT1 and PT6 being the most prevalent and most invasive phylotypes. Additional 16S rRNA 
identification of candidate pathogens from five DD lesions in comparison to four healthy feet 
was undertaken by Yano et al. (68) in 2010 with the creation of 1525 clones. The DD lesions 
were obtained from a slaughterhouse with no known history and were identified as chronic 
lesions showing a hyperkeratotic papillomatous lesion. Sequence analysis showed T. denticola-
like and T. phagedenis-like spirochetes were predominant in DD lesions and a minimal number 
of spirochete sequences (PT3) were found in normal feet.  
Additional work was conducted in 2011 to further characterize the different DD 
associated Treponema spp. Brandt et al. (69) utilized a broad panel of Treponema spp. specific 
PCRs and Sanger sequencing to evaluate the relative proportions of Treponema spp. in DD 
lesions obtained from cows from four Austria farms. This study found that 93% of DD lesions 
were positive for one of the Treponema spp. and 13% of DD lesions contained more than one 
Treponema spp. It was also found that T. pedis-like spirochetes were found in 51% of DD 
lesions, T. medium-like spirochetes were found in 38% of DD lesions, T. phagedenis-like 
spirochetes were found in 4% of DD lesions, and T. brennaborense was not detected in any of 
the samples. Six DD samples contained spirochetes of the type IV oral Treponema spp. strains 
and six others contained unpublished Treponema spp. sequences. 
In addition to the Treponema phylotypes classification of PT1-PT9 proposed by 
Klitgaard et al. in 2008 (47), PT10-PT17 phylotypes were added in 2012 by Rasmussen et al. 
following the cloning of 103 clones from 15 DD biopsies (48). PT10 incorporated the 
Treponema brennaborense cultivated previously by Schrank et al. (51) and PT11 incorporated 
the Treponema pedis cultivated by Evans et al. (70). The PT12-PT17 were identified as unique 
uncultured phylotypes being most similar to Treponema refringens. These 17 phylotypes were 
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then utilized to produce oligonucleotide probes that could be used for a FISH analysis of DD 
lesions. The study found that DD lesions contained, on average, seven different phylotypes of 
Treponema spp. with some lesions having upwards of 15 unique phylotypes. In comparison, only 
three of the 21 normal skin biopsies contained any Treponema spp. phylotypes and the 
phylotypes present were different than those found in DD lesions. The most common phylotypes 
identified from DD lesions included PT6, PT17, PT4, and PT7, whereas the normal feet 
contained PT3 as well as sequences not identified within the 17 phylotypes. This study was able 
to construct a phylogenic tree (adapted in Table 1) based on the reported 16S rRNA sequences. 
Five main clusters have been identified from DD lesion Treponema spp. that were consistently 
identified in multiple studies. Additionally, Table 1 represents the nomenclatures used from 
various studies and how they overlap with each other and fit into the clusters proposed by 
Rasmussen et al. 
As a follow-up to the previous manuscript by Rasmussen et al, this same group utilized 
high-throughput sequencing and Treponema spp. specific 16S rRNA V3-V4 primers to evaluate 
the relative proportions of Treponema phylotypes present in DD lesions from 36 cows (71). Of 
the 51,635 sequences that matched a known reference from NCBI blast or the RDP database, 20 
unique OTUs were present from the DD lesions. From the 17 previously described Treponema 
spp. phylotypes (PT1-PT17), 14 of those were detected in this study. Furthermore, five 
additional un-cultured Treponema spp. phylotypes were detected that had not been previously 
reported in DD lesions. A novel Treponema spp. phylotype was also identified that was 
dissimilar to all other Treponema spp. 16S rRNA sequences. This phylotype underwent nearly 
full-length 16S rRNA sequencing by cloning and sequencing using vector primers. This novel 
phylotype was classified as PT18. The phylotypes found in this study were again assembled in a 
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phylogenic tree (Table 1) and six main clusters were identified. They were identified as Cluster 1 
(T. denticola/T. pedis-like), Cluster 2 (T. phagedenis-like), Cluster 3 (T. refringens-like), Cluster 
4 (T. medium/T. vincentii-like), Cluster 5 (Treponema maltophilum-like), and Cluster 6 
(Spirochaeta zuelzerae-like). Unlike the study by Rasmussen et al. (48) Treponema 
brennaborense was not detected and therefore omitted from the phylogenic tree and not included 
in any of these clusters. For all of the DD lesions, the majority of the OTUs were from Clusters 
1-4 with PT5, PT6, PT7, and PT9 found in greater than 80% of the biopsies. 20 of the 36 
biopsies had greater than 50% of the phylotypes present within lesions were identified as being 
from the T. denticola/T. pedis-like cluster. Table 1 shows the nomenclature across studies and 
where each of these phylotypes fell into each cluster. The FISH analysis from this paper was 
highly correlated with the sequencing with T. phagedenis being the most prevalent species and, 
when present, T. pedis being the most highly abundant species. 
With the majority of the literature pointing to Treponema spp. as the most likely 
pathogen in DD, an attempt to induce DD in cattle using Treponema spp. was conducted by 
Gomez et al. (6) in four Holstein yearlings. Of the four animals in this induction trial, four feet 
total were utilized for attempting to induce with Treponema spp. Of these four feet, only one was 
considered a successful induction with the lesion described histologically as being similar to a 
DD lesion, but with a “sparse bacterial mat, light invasion of spirochetes, minimal inflammation, 
and no ulceration”. This study was conducted in the same environment as cattle induced with DD 
tissue homogenate and minimal controls, subsequently the effect of cross-contamination with 
live organisms was difficult to assess. 
In conclusion, the evidence for Treponema spp. as a causative agent(s) in DD include the 
association of Treponema spp. in DD lesions identified by cultivation, FISH, PCR, and 
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metagenomics. The nomenclature for the different types of Treponema spp. has been constantly 
undergoing changes based on the fact that many of the phylotypes have yet to be cultivated. At 
this point, there are four clusters (Cluster 1 (T. denticola/T. pedis-like), Cluster 2 (T. phagedenis-
like), Cluster 3 (T. refringens-like), Cluster 4 (T. medium/T. vincentii-like)) that have been 
reported in the majority of the literature as having clinical relevance to DD. Studies of the DD 
associated Treponema spp. have also identified them as having the ability to cause disease by 
impairing the innate immune and wound repair functions of bovine macrophages. Multiple 
immunologic studies have also found an increase in antibodies to Treponema spp. in herds and 
individual cows with DD. The most glaring evidence lacking for Treponema spp. as the 
causative agent for DD is the fact that Koch’s postulates have yet to be fulfilled. Attempts to 
induce DD lesions with cultures of Treponema spp. have failed to induce disease. Additionally, 
vaccinations against DD associated Treponema spp. have also failed to decrease the incidence or 
severity of disease. To this point, all studies have focused on clinical DD lesions and not DD 
lesions at the onset of disease. Therefore, there is not enough evidence currently available to 
differentiate Treponema spp. from a causative organism or merely an organism associated with 
clinical DD lesions. 
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Table 1: Various nomenclatures used in multiple studies evaluating Treponema species in DD 
lesions 
Rasmussen et al. 
2012
Klitgaard et 
al. 2008
Klitgaard et 
al. 2013
Choi et al. 
1997
Evans et al. 
2008
Species (*closest match)
PT7 T. denticola
PT8 DDKL-3 Group 3*** *T. denticola
PT11 T. pedis
Clone 517 *T. pedis
Clone 9T-42 *T. denticola
PT16** *T. denticola
PT18 *T. denticola or *T. pedis
PT6 DDKL-4 Group 2*** T. phagedenis
PT14** *T. phagedenis
PT13 *T. refringens
PT1 *T. refringens
PT2 *T. refringens
PT3 DDKL-20 *T. refringens
PT4 DDKL-12 *T. refringens
PT12 *T. refringens
PT15 *T. refringens
PT17 T. refringens
PT5 DDKL-13 Group 1*** T. medium
Clone 198 *T. vincentii
PT9 *T. vincentii
Cluster 5 PT10** *T. brennaborense
T. malt. -like Clone 356 *T. maltophilum
T. zuel. -like Clone 2.82 *T. zuelzerae
***Group 1: Treponema medium/Treponema vincentii -like; Group 2: Treponema phagedenis -like; 
Group 3: Treponema denticola/Treponema putidum -like
Cluster 4: T. 
medium/T. 
vincentii -like
Cluster 1: 
T.denticola / T. 
pedis -like
Cluster 2: T. 
phagedenis -like
Cluster 3: T. 
refringens -like
**extrapolated from Rasmussen-12 as sequences were not found in Klitgaard-13
 
 
The evidence for Dichelobacter nodosus 
 The first report of Dichelobacter nodosus associated with foot pathology in cattle was 
published in 1978 when an association of D. nodosus from interdigital dermatitis in cattle was 
reported (72). Several early reports on the virulence of these isolates found that all isolates from 
cattle were deemed non-virulent with the use of the gelatin gel test (73, 74).The first manuscript 
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to investigate the role D. nodosus may play in the etiology of DD was published in 2012 by 
Rasmussen et al. (48). This study utilized FISH to evaluate the presence of D. nodosus in 90 DD 
lesion and 24 normal bovine skin samples. The results found that 51% of the DD lesions were 
colonized by D. nodosus whereas only 13% of the healthy feet were positive for the organism. In 
a similar study by Capion et al. (35), they found that 27% of M1, M2, M3, and M4 lesions had 
colonization by D. nodosus when evaluated by FISH. This study only reported the total percent 
of lesions positive for D. nodosus and did not report the differences between the four lesion 
scores or evaluate any normal bovine skin as controls. In 2012, Rogdo et al. (75) evaluated the 
presence and serogroups present in D. nodosus isolates from cattle co-grazed with sheep. The 
results showed that 98% of cattle were PCR positive for D. nodosus with all 10 serogroups 
present and a large diversity of serogroups represented on each farm. Serogroup A was found in 
a higher proportion in cattle co-grazed with sheep that had a high incidence of severe ovine 
footrot. As no virulence testing was done, it was still undetermined if these D. nodosus present in 
cattle were virulent. In a similar study by Knappe-Poindecker et al. (76) with co-grazing of cattle 
and sheep, PFGE was used to determine if cross-infection of virulent D. nodosus was capable. 
This study did isolate several virulent strains of D. nodosus in cattle found to be genetically 
indistinguishable from sheep strains following co-grazing with sheep that had a history of 
footrot, although the presence of virulent D. nodosus in cattle was associated with a decreased 
rate of interdigital dermatitis. In 2013, Knappe-Poindecker et al. (22) set out to not only evaluate 
the presence of D. nodosus, but to determine the serotypes present and evaluate the virulence of 
D. nodosus from DD lesions. DD lesions were obtained from 14 different farms with varying 
levels of DD problems and PCR and culture methods were utilized to evaluate the presence of D. 
nodosus. D. nodosus was detected by PCR in 100% of DD lesions and 60% of normal skin. 
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Cultivation of D. nodosus was successful in 75% of DD lesions and 12% of normal skin. Of the 
10 serogroups of D. nodosus, all but groups F and M were detected and all isolates cultured were 
considered non-virulent with the use of the gelatin gel test. The finding of all cattle strains being 
non-virulent is supported by Gilhuis et al. (77) in 58 isolates from Norway as well. In the only 
study in beef cattle, Sullivan et al. (9) found 71% of DD lesions were PCR positive for D. 
nodosus, whereas 26% of healthy feet were PCR positive for D. nodosus. 
 In conclusion, there is still minimal evidence linking D. nodosus to bovine DD. There is a 
high association of bovine feet with the presence of D. nodosus which is increased in interdigital 
and digital dermatitis, but most of the strains that have been cultivated from a number of studies 
from a large geographical range have been determined to be non-virulent strains. Although 
virulent strains of D. nodosus cause a more severe form of footrot in sheep, the strains deemed 
non-virulent are still capable of causing a less severe form of disease entailed benign footrot 
(78). The importance of strain virulence in cattle has not been clinically evaluated, although there 
was an association with decreased severity of dermatitis when virulent strains of D. nodosus 
were isolated from cattle (22). To date, there have also not been any attempts to fulfill Koch’s 
postulates by attempting to induce bovine DD with pure cultures of D. nodosus. 
 
The evidence for Bacteroides spp. and Porphyromonas spp. 
 The literature on Bacteroides spp. and Porphyromonas spp. is intermingled as the 
Porphyromonas genus used to be classified as Bacteroides. The first report of bacteria of the 
Bacteroides genus cultivated from DD lesions was by Blowey and Sharp in 1988 (41). 
Koniarova et al. reported the cultivation of Bacteroides spp. in 25% of the feet from swabs of the 
corium in diseased cattle in 1993 (79). In 1995, Collighan et al. (57) used culture independent 
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16S sequencing to investigate organisms associated with DD. Of the 20 clones sequenced from 
two DD lesions, 5 of the 20 sequences were closely related to Bacteroides levii (now called 
Porphyromonas levii). None of these first three studies utilized control feet to compare the 
prevalence of Bacteroides in healthy bovine skin. In 2010, Yano et al. (68) used culture-
independent 16S sequencing to identify candidate pathogens from DD lesions. This was the first 
study to include healthy bovine skin as a comparison to DD lesions. Of the 1525 clones produced 
from 5 DD lesions, 13.4% of the OTUs closely matched an uncultivated Bacteroides species. 
This was the second most predominant bacterium identified from DD lesion, (only to Treponema 
spp.) and was not found at all in normal healthy feet. Several OTUs closely related to other 
Bacteroides and Porphyromonas species were also identified, although none found to be a higher 
proportion than 2% of the OTUs. Santos et al. (80) in 2012 utilized very similar methodologies 
as the previous study, with the exception of dividing biopsies into superficial, intermediate, and 
deep. This study found the bacterial family Bacteroidetes present, but in less than 8% of the total 
OTUs from all layers of DD lesions. The OTU found most abundant in deep aspects of DD 
lesions matched the sequence from the uncultivated Bacteroides spp. identified by Yano et al. 
The OTU found most abundant in superficial aspects of DD lesions matched a sequence closely 
related to Porphyromonas levii. In healthy feet, no OTUs were identified as belonging to the 
Bacteroidetes family. 
Several studies have also looked at immune responses to Bacteroides and 
Porphyromonas in cows and herds with and without DD. In 2003, Trott et al. (61) investigated 
the immune response to Bacteroides vulgaris in cattle with and without DD lesions from a single 
herd with a history of DD. This study found that cattle with erosive DD lesions produced 
significant cellular responses to Bacteroides vulgaris. In 2010, Moe et al. (81) evaluated the 
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immune response to Porphyromonas levii in cows with and without DD lesions as well as cows 
from herds with or without a history of DD. This study found significant higher levels of 
antibodies directed at Bacteroides and Porphyromonas in herds with a history of DD, but did not 
find a difference between cows with or without DD lesions within herds with a history of DD. 
The evidence for Bacteroides and Porphyromonas species as causative agents for DD is 
still inconclusive. As a percent of total bacteria present in DD lesions, neither Bacteroides spp. 
nor Porphyromonas have been found to constitute more than 25% of the total bacterial 
population. Conversely, when DD lesions were compared to healthy feet, neither Bacteroides 
spp. nor Porphyromonas spp. were detected. Similarly, cows within herds with DD were more 
likely to have an immune response to Bacteroides spp. and Porphyromonas spp. The question 
still remains as to the importance of these organisms as either contributors to the disease process 
or merely opportunistic secondary pathogens. 
 
The evidence for other bacterial species 
 Fusobacterium necrophorum has been implicated in several studies as a potential 
contributor to DD. Isolation of F. necrophorum from DD lesions was observed in several studies 
between 1988 and 1994 (42, 79, 82). In 2005, Cruz et al. (83) examined DD lesions 
immunohistochemically using polyclonal rabbit antisera to F. necrophorum to determine the 
presence of F. necrophorum in DD lesions. This study found 42% of lesions to be positive for F. 
necrophorum with none of the four controls positive. In 2010, Moe et al. (81) evaluated the 
immune response of cattle and herds with and with a history of DD to F. necrophorum. There 
was no statistical difference in reactive antibodies between cows or across herd with or without a 
history of DD. In 2012, Rasmussen et al. (48) utilized FISH to quantify F. necrophorum in DD 
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lesions. The study found minimal invasion of F. necrophorum in any of the DD tissues 
evaluated. In a similar study by Knappe-Poindecker in 2014, 0 of the 94 tissues evaluated with 
FISH were positive for colonization with F. necrophorum. In 2015, a study in beef cattle using 
species-specific PCR found F. necrophorum in 44% of DD lesions, but also found that 32% of 
healthy feet were positive for F. necrophorum (9). Although F. necrophorum has been isolated 
from DD lesions, the lack of evidence for deeper colonization using FISH and a similar 
prevalence in normal and diseased feet provides minimal evidence for the role of F. 
necrophorum in the etiology of DD. 
 Campylobacter spp. were first hypothesized as possibly having a role in the etiology of 
DD at the 4th International Symposium on Disorders of the Ruminant Digit in 1982 (84). In 
1997, Dopfer et al.(32) reported the presence of C. faecalis in DD lesions through the use of an 
immunofluorescence test, although no details were given as to percent of lesions positive. In 
1999, Ohya et al. (85) was able to cultivate C. faecalis and C. sputorum from DD lesions. The 
rate of cultivation was 67% for C. faecalis and 71% for C. sputorum with 43% of lesions having 
both Campylobacter species. In the only study to include control feet for comparison, Cruz et al. 
(83) examined DD lesions immunohistochemically using polyclonal rabbit antisera to 
Campylobacter jejuni to determine the presence of Campylobacter spp. in DD lesions. This 
study found 47% of lesions to be positive for Campylobacter spp. with none of the four controls 
positive. Additionally, the use of culture independent 16S metagenomic profiling by Yano et al. 
(68) in 2010 found no OTUs matching any Campylobacter spp. of the 1525 clones produced. 
The evidence for Campylobacter spp. as a causative agent for DD is still lacking. While 
Campylobacter spp. have been isolated from DD lesions and viewed within DD lesions, they 
appear to in a very low percentage of the total bacteria. With greater than 70% of dairy cattle 
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harboring Campylobacter spp. in their feces (86), the pathogenic role of the Campylobacter spp. 
identified in DD lesions remains questionable. 
 Several other organisms have been implicated in the pathogenesis of DD. Borrelia 
burgdorferi was proposed as a possible pathogen in 1994 (87), but was later found that the 
evidence for B. burgdorferi was cross-reactivity to Treponema spp. (43, 59, 88). Guggenheimella 
bovis was identified as a possible pathogen involved in the pathogenesis of DD in 2005 (89), but 
the lack of consistency in identifying the bacteria from DD lesions has made it unlikely to be a 
contributor in the disease process (53, 90). Viral etiologies, such as Bovine Papillomavirus have 
been proposed as a potential pathogen, but several studies have found no evidence of viral 
involvement (3, 69).  
 
Summary of etiologic agents 
While there is a consistent presence of multiple Treponema species in DD lesions (41, 44, 
47-49, 52, 56, 57, 66, 68, 69, 71, 91), attempts to induce disease by skin inoculation with pure 
cultures of these microorganisms have largely failed to result in significant disease in a majority 
of the animals inoculated (6). Additionally, the clinical use of vaccines focused against 
spirochetes provides limited protection against the disease process (63). While the consistent 
clinical response to antibiotic therapy suggests a bacterial agent(s) involved in the etiology of the 
DD (36, 37, 92-103), the fulfilment of Koch’s postulates in identifying the key bacterial 
constituent necessary to produce disease has yet to be proven. The association of DD lesions 
with a variety of bacterial agents, the response of the lesions to antibiotics, and the failure to 
induce or protect from the disease using monovalent vaccines strongly suggests that DD is a 
polymicrobial disease process (63, 104, 105). There is evidence to support the claim for poly-
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bacterial in human periodontitis (106). Treponema denticola and Porphyromonas gingivalis have 
been co-localized in subgingival plaque and exhibit metabolic symbiosis in vitro and synergistic 
virulence in animal models (107). This conclusion is further supported by two recent studies that 
utilized the culture independent method of sequencing clones of 16S rRNA genes (rDNA) by 
Sanger technology to classify a subset of bacteria derived from biopsies of both lesions and 
healthy feet (47, 68). While these studies demonstrate that there are mixed microbial populations 
present in DD lesions that differ from that of normal skin, the lack of information regarding stage 
and chronicity of the biopsies, combined with the relatively low number of 16S rRNA sequences 
limits the confidence in the overall conclusions. Attempts to induce DD lesions with cultures of 
any of the other bacteria identified from DD lesions have not been attempted, and until this has 
been done, we cannot differentiate association from causation for many of the bacteria identified 
from DD lesions. 
 
Treatment of Digital Dermatitis 
The treatment of individual animal DD lesions has typically consisted of topical therapy 
with tetracycline (30, 41, 93, 95, 100) or lincomycin (36, 96, 108). Although less commonly 
used, reports on topical treatment with copper, zinc, disinfectants, and various proprietary 
compounds have also been described with various levels of success (30, 98, 109-111). Several 
studies have also reported various levels of success with systemic antibiotics including 
oxytetracycline, penicillin, ceftiofur, erythromycin, and cefquinome (25, 97, 103). In the only 
study that compared topical to systemic therapy with the same antibiotic (tetracycline), Louriero 
et al. (97) found topical treatments to be superior to systemic antibiotic therapy. While topical 
treatment for DD is the most widely used reported treatment by producers for cost and ease of 
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application, 20% of producers surveyed were also using systemic antibiotics either alone or in 
conjunction with topical treatment (112). The treatment success rate reported in the literature is 
widely variable and largely based on definition of treatment success. In studies that assessed 
complete healing of the lesion to normal skin, success rates ranged from 14-39% (98, 100), 
whereas studies that defined treatment success as a decreased lesion size or decreased pain the 
success ranged from 47-73% (37, 93). Additionally, the effectiveness of topical treatments in the 
majority of studies is based on a follow up period of less than 30 days post treatment. Although 
the majority of lameness and sensitivity from DD lesions is improved following treatment (93), 
the long-term success at completely treating individual DD lesions has rarely been measured. 
Berry et al. followed cattle for 341 days following topical lincomycin treatment (36) and found 
that 54% of all treated lesions required re-treatment before the end of the study. Read et al. (25) 
also showed 48% of lesions needed to be retreated with 12 weeks following initial treatment with 
various treatments. In conclusion, DD lesions are responsive to numerous topical and systemic 
therapies that decrease the size and sensitivity of lesions, but long-term controlled studies on the 
effectiveness of complete healing of DD lesions is lacking. 
 
Prevention of Digital Dermatitis 
The primary method for control and prevention of DD is through the use of a medicated 
footbath. Approximately 40% of producers regularly used a footbath for the prevention of DD, 
with the most commonly used products being copper sulfate and formaldehyde (1). Numerous 
studies have been published on footbath design, products, and implementation protocols (111, 
113-122). While clinically important to the overall control of DD in dairy operations, an in depth 
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review of the literature will not be presented as the focus of this dissertation was on individual 
animal treatment. 
 
Significance of the Research 
 This dissertation represents significant and timely studies that are aimed to start to close 
the knowledge gap regarding the etiology of digital dermatitis. The descriptions of lesions at the 
onset of disease will aid our understanding of how lesions develop from normal skin to clinical 
lesions. The creation of a reliable and consistent induction model will benefit multiple studies 
regarding treatment and prevention strategies. 
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Abstract 
Bovine digital dermatitis (DD) is a leading cause of lameness in dairy cattle in the United 
States with prevalence estimates as high as 30%. While clinical lesions have been well described, 
little is known about the morphologic changes that are associated with the early stages of lesion 
development from normal skin to clinical lesions. This study utilized the Iowa DD scoring 
system to evaluate the epidemiology of natural lesion development by digitally photographing 
the rear legs of a cohort of dairy cows over a three year period. Sixty-one adult Holstein dairy 
cows were monitored for 1,032 cow foot-months. The incidence rate of lesion development was 
4 lesions per 100 cow foot-months, with the average time for a lesion to develop being 133 days. 
While 20% of the 1,678 foot observations exhibiting clinical DD lesions, an additional 55% of 
all observations exhibited preclinical Stage 1 and 2 lesions that were indicative of DD lesion 
development. Utilizing the dichotomous categorization of preclinical lesions in the Iowa DD 
scoring system, it was found that 1
st
 lactation heifers had a higher rate of the thickened and 
crusted “B” type lesions, whereas the ulcerative “A” type lesions were more likely to be 
identified in multiparous animals. For clinical DD lesions that received topical treatment, scoring 
of the post-treatment lesions using the Iowa DD scoring system was found to be useful in 
prognosticating both the risk of recrudescence and the time until recrudescence.  Systemic 
disease, systemic antibiotic therapy, and periparturient stress were not associated with an 
increase or decrease in DD lesion scores. Treatment with a single topical tetracycline wrap was 
associated with a significant (p<.001) decrease (-1.17) in DD lesion score. The results of this 
study demonstrate that the complex morphologic changes associated with digital dermatitis can 
be readily classified using the Iowa DD scoring system and the scores can be utilized to predict 
and monitor the effects of treatment and prevention measures. 
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Introduction 
Bovine digital dermatitis (DD) is a leading cause of lameness among dairy cattle in the 
United States (1) and appears to be increasing in prevalence among beef cattle (2). It is estimated 
that each case of DD costs the farmer between $95-133 in lost production, treatments and 
discarded milk (3-6) In the most recent National Animal Health Monitoring System (NAHMS) 
survey of US dairy farms, DD accounted for 61.8% of the lameness in bred heifers and 49.1% of 
the lameness in cows. Estimates of within-herd prevalence have been published across multiple 
countries (7-15) and range from 1.4% in 14 Norwegian herds to 39% in 5 Danish herds. For 
herds in free-stall barns, most of the estimates for prevalence are in the range of 20-25% (11). 
However, these estimates are typically based on the prevalence of clinically mature DD lesions 
that have been described as characteristically circumscribed, erosive to papillomatous, 
surrounded by a ridge of hyperkeratotic skin and with hypertrophied hairs (16). This shortcoming 
(i.e., only considering mature lesions) has resulted in uncertainty regarding the epidemiology of 
early stage lesions in US dairies. Several authors have published scoring systems designed to 
describe the progression of DD lesion morphology during the course of lesion development from 
normal skin to clinical lesions (17-19). Dopfer et al. described four stages of lesion development 
with immature DD lesions being lumped into a single stage M1 charecterized by the formation of 
a small ulcerative area in the skin. These lesions progress with stage M2 lesions being a mature 
papillomatous or ulcerative lesion, stage M3 being a healing lesion, and stage M4 being a 
chronic recurrent lesion (19). Other scoring systems have been developed to differentiate the 
variations among active lesions; thus, they are not useful for describing the early stages of 
lesions (17, 20). To better differentiate the development of early stage lesions, both 
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morphologically and etiologically, our group (18) recently described the Iowa DD scoring 
system. In order to refine our understanding of lesion development, the Iowa DD scoring system 
describes four distinct morphologies of preclinical lesions that are observed prior to development 
of clinical lesions.  Each of these preclinical lesion stages, as well as all mature lesion stages, 
have been shown to contain a unique community of bacteria specific to that lesion stage, thus 
validating that the morphologic stages can be used as a proxy for the bacterial profile present in 
the lesion (18).  The true prevalence for all of these types of DD lesion morphologies in 
comparison to clinical DD prevalence has yet to be determined. 
The treatment of individual animal DD lesions that are causing acute lameness in cattle is 
important for the clinical management of DD on dairy farms and has typically consisted of 
topical therapy with tetracycline (17, 21-24) or lincomycin (25-27). Most prospective studies 
designed to evaluate the effectiveness of topical treatments have followed cows for less than 30 
days post treatment. However, clinical experience suggests that treatment success requires long-
term follow up of individual animals to observe for lesion regression or recrudescence. While the 
majority of DD associated lameness and sensitivity to touch is improved following topical 
treatment (23), the long-term success of topical treatment resulting in complete healing of the 
skin on an individual lesion basis has rarely been measured.  Berry et al. followed cattle for 341 
days following topical lincomycin treatment (25) and found that 54% of all treated lesions 
required re-treatment before the end of the study. Similarly, Read and Walker (16) showed that 
48% of lesions needed to be retreated within 12 weeks following initial treatment. Unfortunately, 
at present there is no way to determine which lesions are most likely to heal and which are most 
likely to recrudesce (and hence require retreatment).  
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Few studies have observed the natural DD lesion development in a controlled 
environment with the absence of DD prevention strategies (i.e. footbaths). This is largely due to 
the prolonged period of lesion development, requiring these studies to last for several years, 
combined with the risk of not utilizing preventative measures. Adding to the complexity of these 
studies is the difficultly of accurately assessing and documenting lesions over that period of time 
without closely examining feet by routinely using a hoof trimming chute. There is an urgent need 
to better understand the natural epidemiology of lesion development from the earliest stages of 
lesion formation in order to better understand the potential role of management practices in DD 
control and prevention. The goal of this study was to follow a group of Holstein cows across 
several years, including multiple lactations, in the absence of any prevention strategies in order 
to better understand the natural development and progression of digital dermatitis lesions. 
 
Materials and Methods: 
Sixty one adult Holstein dairy cows were enrolled in three cohorts over a three year 
timeframe for this study. The study was conducted at the Iowa State University Dairy Farm. At 
the time of the study, the farm was milking approximately 350 cows and the lactating barn 
consisted of 12 pens with free stalls, mattress liners, and composted manure solids bedding. 
Cows enrolled during the dry period were housed in a single pen with free stalls and sand 
bedding. The first cohort of 40 cows consisted of first, second, and third lactation animals that 
were enrolled as they calved in the summer of 2010. These animals were randomly selected from 
the herd and enrolled solely based on their calving due date and not being enrolled in any other 
research trial at the time.  This initial cohort of cows was not evaluated for DD status prior to 
enrollment and no history of DD lesions was available at the time of enrollment. The second 
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cohort of 13 cows was enrolled in the spring of 2011 and consisted of first lactation animals that 
were expected to calve during March and April. These animals were again randomly selected as 
a convenience sample of animals that were not enrolled in any other research project at that time. 
In contrast to Cohort 1, this group was screened prior to enrollment for the presence of DD 
lesions and any animal with evidence of classic end-stage DD lesions was excluded from the 
study. The third cohort of 8 cows was enrolled in the summer of 2012 and consisted only of first 
lactation animals that were due during May and June. As with the two previous groups these 
animals were randomly selected as a convenience sample of animals that were not enrolled in 
any other research project at that time. This third group was screened prior to enrollment for the 
presence of DD lesions and any animal with evidence of either developing or clinical DD lesions 
was excluded from the study. 
 Throughout the study, all enrolled cows were excluded from any of the standard DD 
treatment and prevention procedures utilized by the ISU dairy. All cows were equipped with 
RFID tags which diverted enrolled cows away from the dairy farm’s footbath on days in which 
the rest of the herd was treated. Additionally all trial cows were marked with unique leg bands to 
avoid topical parlor treatments and to avoid cows being presented for routine treatments by farm 
staff and/or the foot trimmer. Routine foot trimming and treatment of non-DD foot lesions were 
provided by study personnel in order to allow for a complete recording of lesion history.  Cows 
were assigned to one of the 12 lactating pens based on their lactation number and stage of 
lactation following the farms standard procedures. As the study was three years in length, cows 
were allowed to be removed from the study if the farm selected them for culling for any reason. 
The most common historical reasons for culling from the herd of cows enrolled in this study 
included reproductive performance and coliform mastitis.  
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 At the time of enrollment, each of the enrolled study cows was lifted on a tilt table for 
detailed examination of each foot to determine and record evidence of DD lesions. The feet were 
lightly washed with tap water and each foot was scored using the Iowa DD lesion scoring system 
(described below) as well as being digitally photographed to allow for blinded lesion scoring 
using pictures. All cattle enrolled in this study were examined in the same manner every three to 
four weeks throughout the study period. All observations were made by a single observer (AK) 
to assure consistency. In addition full thickness skin biopsies were collected for each lesion when 
it was observed to change Iowa DD lesion score between observation periods. Biopsies were 
collected utilizing a regional limb block with 2% Lidocaine and with punch biopsies ranging in 
size from 3 mm to 6 mm. The feet were lightly washed with tap water to remove all organic 
debris, but were not scrubbed with any disinfectant such as to minimize the disruption of the 
natural progression of disease. These biopsies were evaluated by bacterial metagenomics as 
described in a separate manuscript (18). All animal procedures and biopsy methods were 
approved prior to the initiation of the study by the Institutional Animal Care and Use Committee 
of Iowa State University. 
 Lesion scoring was done utilizing the Iowa DD lesion scoring system as described 
previously (18).  Briefly, this scoring system classifies lesions as either normal skin (Stage 0), 
initial onset lesions (Stage 1), developing lesions (Stage 2), or lesions associated with clinical 
disease in the acute hyperemic ulcerative form (Stage 3) or the chronic hyperkeratotic form 
(Stage 4). Additionally, Stages 1 and 2 are subdivided into two subtypes with “A” type lesions 
being exclusively located in the plantar interdigital cleft and having a more ulcerated appearance, 
with “B” type lesions having a thickened, crusted appearance diffusely spread across the heel. 
Digital photographs were transferred to a local computer hard drive where they were labeled 
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with the cow, foot and date metadata for each photograph. Photographs each were presented 
randomly to the observer and DD lesions were subsequently scored blindly with no identification 
present in any image. 
Routine locomotion scoring was also performed throughout the study to monitor for 
evidence and severity of lameness. Any animal that reached a locomotion score of 4 on the 5 
point lameness scale (28), or any animal noted by caretakers as being lame, was promptly 
examined by the study personnel. If lameness was associated with DD lesions, and no other 
cause of lameness was observed, treatment with a topical tetracycline wrap was initiated. In this 
study, we categorized animals into four possible groups based on the observed outcome 
following a single treatment of a clinical DD lesion (Stage 3 or 4) with a tetracycline wrap. 
These groups were classified as: 1) a lesion that did not respond to treatment (i.e. a lesion of 
Stage 3 or 4 did not drop below a Stage 3 following treatment),  2) a lesion that responded to 
treatment (regression to Stage 2 or less) but subsequently returned to a Stage 3 or 4 lesion within 
the time of observation, 3) a lesion that responded to treatment (regression to Stage 2 or less) and 
remained as a Stage 1 or 2 lesion without returning to normal skin or returning to a clinical lesion 
and 4) a lesion that responded to treatment and returned to normal skin. These four outcomes 
were deemed as “non-responsive to treatment”, “lesion recrudescence”, “lesion regression”, and 
“treatment success”, respectively. A “treatment failure” collectively included all of the first three 
categories that did not result in a lesion reverting to normal skin. 
 Throughout the study, metadata regarding systemic treatment, illness and other medical 
interventions was collected using the farm’s Dairy Comp® computerized record management 
system. These metadata were used to analyze the association of these events with an increased or 
decreased incidence or progression of DD. The events that were analyzed included: 1) systemic 
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diseases such as metritis, ketosis, pneumonia, and peritonitis that could potentially lead to 
immunosuppression, 2) systemic administration of an antibiotic, 3) topical treatments of a DD 
lesion due to severe lameness and 4) periparturient stress associated with calving. These events 
were compared statistically using regression and ANOVA methods assuming continuously coded 
outcome measures and normally distributed residuals. 
 Statistics analyses of associations of risk factors with DD lesion scores were analyzed 
utilizing a regression analysis. To examine if differences existed between groups of cows and 
their lowest DD lesion score and recrudescence rates following treatment, a one-way ANOVA 
was conducted. To evaluate the differences between each of these groups, post-hoc t-tests were 
conducted assuming equal variances. The differences between lactations and the percent of “B” 
lesions were evaluated using a two-sided student’s t-test. 
 
Results 
 As the study was focused on the progression and regression of natural DD lesions, six 
cows were selectively removed from the study since they had no evidence of DD lesions on any 
foot for an extended period of time. Animals were also selected for removal if they had DD 
lesions that progressed to end stage lesions on multiple feet and no changes were noted for an 
extended period of time as well. Thirteen cows were selectively removed before the end of the 
study following severe illness or severe lameness resulting from non-DD foot pathology. All 
animals that were removed from the study were examined and treated with a topical tetracycline 
wrap at the time of removal if any evidence of DD lesions were present. 
Of the 61 cows enrolled on this study, the average observation length was 515 days with 
a minimum of 132 and a maximum of 978 days. The cows enrolled on the study were examined 
41 
 
on a tilt-table a total of 918 occasions. Each examination consisted of both rear feet being 
digitally photographed throughout the study with some cows having each foot observed up to 28 
different times in multiple lactations. The morphologic scoring system developed during this 
study demonstrated that DD lesions progressed systematically with lesion scores highly 
correlated (either one stage greater or one stage less) to previous lesion scores (R2=0.7913; 
p<0.0001). The majority of the feet observed (105/122, 86%) had evidence of DD development 
on at least one observation while enrolled in the study. Of those 105 feet observed with 
developing DD lesions, 45 developed to clinical DD lesions (Stage 3 or 4) while on the study. 
This yielded a mean incidence rate of 4 cases for every 100 foot-months at risk. For new lesions 
that developed while on the trial, the average time for a lesion to progress from the first 
morphologic changes associated with a Stage 1 lesion to a clinical Stage 3 lesion was 133 days 
(range: 38 – 315 days, median: 105 days). A significant (R2=.2072; p<.001) correlation was 
observed between the lesion statuses of the rear legs with 78% of the rear legs having a matching 
lesion status (i.e. lesion or no lesion). When present, lesions on both rear legs tended to progress 
or regress in a similar manner. When a lesion on one leg increased or decreased by a single 
lesion score the opposite leg was likely to increase or decrease in the same direction by a lesion 
score of 0.21 (p<.001). Figure 1 demonstrates this co-dependence on an example subset of cows 
by plotting their LR and RR lesion scores (y axis: 1-4) over a period of time. 
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Figure 1: Individual Cow Rear Leg Morphologic Lesion Scores. Four representative charts (A-
D) of individual cow’s rear leg scores over the period of sequential observations for that cow. 
Chart A represents a cow that was enrolled in its 2nd lactation and followed for 596 days, also 
including the cow’s 3rd and 4th lactations. Chart B represents a cow that was enrolled in its 1st 
lactation and followed for 196 days. Chart C represents a cow that was enrolled in its 1st 
lactation and followed for 385 days. Chart D represents a cow that was enrolled in its 1st 
lactation and followed for 627 days. The charts illustrate that the lesions present on both hind 
feet will tend to increase or decrease in the same direction of lesion severity over time. 
 
Over the course of the three years, 1,678 individual foot observations were scored blindly 
from digital photographs using the Iowa DD Scoring System. From these observations, 75% of 
all foot observations were scored as having either developing lesions (Stage 1 and 2) or clinical 
lesions (Stage 3 and 4). Clinical lesions comprised only 20% of all foot observations; in effect, 
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this meant that in 55% of all observations cows had lesions that would not classically be defined 
as digital dermatitis. Lameness from digital dermatitis (defined as a locomotion score of 4 or 
greater) was exclusively associated with clinical lesions (Stages 3 and 4). The average time from 
clinical lesion development (Stage 3) to lameness was 161 days (range 0-330 days). Moreover, 
many cows maintained clinical lesions for prolonged periods of time without developing 
lameness. One cow in the study was enrolled with a Stage 4 lesion and maintained that lesion for 
869 days until the conclusion of the study without ever developing lameness as defined as a 
locomotion score of greater than 3 on a 5 point scale (28). The Iowa DD Scoring System 
differentiates Stage 1 and Stage 2 lesions into two distinct types of morphologic categories. 
These have been combined in many of the analyses as a means to calculate an increase or 
decrease in lesion score; however, there are definite differences in the epidemiology of the two 
morphologies. Figure 2 shows the percentage of feet that had a “B” type lesion by lactation. 
Stages B1 and B2 are much more common in 1st lactation heifers than in all other lactations 
combined (41% versus an average of 14%; p<.001). Additionally, Table 1 shows a summary of 
the types of lesions present on each individual cow as well as the length of enrollment and 
lactations represented during the entirety of the study. 
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Figure 2: The percentage of the feet that had a “B” type by lactation. The percentage is based on 
the number of feet that had “B” lesion in cows undergoing lesion development. Stages B1 and 
B2 are statistically more common in 1st lactation heifers compared to all other lactations (41% 
vs average of 14%, p<.001). “B” type lesions differ from “A” type lesions in that they develop 
more diffusely across the heel and have a thickened, crusted appearance, whereas “A” type 
lesions initiate on the plantar interdigital cleft and have a more ulcerated appearance. 
 
Table 1: Lesion summary data for all cows on study. 
Cow 
ID 
Group 
Lact
1 
Lact
2 
Lact
3 
Lact
4 
Days on 
Trial 
# Feet with 
Preclinical 
Lesions 
# Feet 
With 
Clinical 
Lesions 
# Feet 
Treated 
Type 
"A" 
Type 
"B" 
1 A 
  
X X 624 2 0 0 0 
2 A 
  
X 
 
298 2 0 0 0 
3 A 
  
X X 551 2 0 2 1 
4 A 
  
X 
 
316 0 0 1 1 
5 A 
  
X 
 
426 0 0 0 0 
6 A 
  
X X 762 1 0 2 2 
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Table 1 continued 
7 A 
 
X X 
 
662 1 1 1 1 
8 A 
  
X 
 
259 1 0 0 0 
9 A 
 
X 
  
305 2 0 0 0 
10 A 
 
X 
  
430 0 0 0 0 
11 A 
 
X 
  
370 2 0 0 0 
12 A 
 
X X 
 
639 1 1 0 0 
13 A 
 
X 
  
633 2 0 1 1 
14 A 
 
X 
  
295 2 0 0 0 
15 A 
 
X X 
 
648 1 1 1 1 
16 A 
 
X X 
 
510 2 0 1 1 
17 A 
 
X X 
 
615 2 0 0 0 
18 A 
 
X X X 952 1 1 1 1 
19 A 
 
X X X 885 2 2 2 2 
20 A 
 
X 
  
255 2 0 1 1 
21 A 
 
X X 
 
644 0 1 0 0 
22 A 
 
X X 
 
860 2 0 2 2 
23 A 
 
X 
  
289 0 1 0 0 
24 A 
 
X X 
 
904 2 0 0 0 
25 A 
 
X 
  
339 2 0 0 0 
26 A 
 
X X 
 
642 2 0 0 0 
27 A X 
   
477 1 2 2 2 
28 A X X 
  
351 2 2 2 2 
29 A X X X 
 
978 2 0 1 1 
30 A X 
   
401 2 0 0 0 
31 A X 
   
470 2 0 1 1 
32 A X X 
  
627 1 1 0 0 
33 A X 
   
621 2 0 1 1 
34 A X X X 
 
971 2 0 2 1 
35 A X X 
  
743 2 0 1 1 
36 A X X X 
 
801 2 0 1 1 
37 A X 
   
285 0 1 2 0 
38 A X X X 
 
957 2 1 2 2 
39 A X 
   
362 2 0 0 0 
40 A X 
   
299 2 0 1 1 
41 B X 
   
332 0 0 0 0 
42 B X 
   
243 2 0 0 0 
43 B X X 
  
622 2 0 1 1 
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Table 1 continued 
44 B X X X 
 
668 2 0 0 0 
45 B X 
   
684 2 2 1 1 
46 B X X 
  
660 1 0 0 0 
47 B X 
   
370 2 2 0 0 
48 B X X 
  
684 2 1 1 1 
49 B X X 
  
328 0 0 0 0 
50 B X 
   
642 1 2 1 1 
51 B X X 
  
647 0 2 1 1 
52 B X X 
  
439 1 0 2 2 
53 B X X 
  
655 0 2 2 2 
54 C X 
   
261 0 0 0 0 
55 C X 
   
290 0 1 1 1 
56 C X 
   
255 0 2 1 1 
57 C X 
   
273 0 2 0 0 
58 C X X 
  
299 0 0 0 0 
59 C X 
   
283 2 0 1 1 
60 C X X 
  
132 0 1 0 0 
61 C X X 
  
247 2 0 2 1 
Table 1: Lesion summary data for all cows on study. Group A consisted of first, second, and 
third lactation animals that were enrolled as they calved in 2010. They were not evaluated for 
DD status prior to enrollment and no history of DD lesions was available at the time of 
enrollment. Group B was enrolled in 2011 and consisted of first lactation animals that were 
screened prior to enrollment for the presence of DD lesions and any animal with evidence of 
classic end-stage DD lesions was excluded from the study. Group C was enrolled in 2012 and 
consisted only of first lactation animals that were screened prior to enrollment for the presence of 
DD lesions and any animal with evidence of either developing or clinical DD lesions was 
excluded from the study. Each lactation checked indicates that foot observations were made 
during that lactation. The number of preclinical (Stages 1 and 2) and clinical (Stages 3 and 4) 
lesions indicates the number of rear feet that developed to that stage at some point while on 
study. 
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For demonstrative purposes several representative examples of digital dermatitis lesions 
progressing through the various stages of development are shown in Figure 3. This figure shows 
the lesion stages at each of our observations with several representative photos of the different 
lesion stages. Cow A was enrolled in the trial at the beginning of her 2nd lactation with an 
existing A1 lesion. Over the first 50 days of the trial the A1 lesion progressed to an A2 lesion 
strictly based on the size of the lesion. On the day 78 observation an ulcerative clinical Stage 3 
lesion was observed and on day 138 the hyperkeratotic characteristics of a chronic Stage 4 lesion 
were now observed. On day 272 the lesion was treated and rapidly regressed back to a Stage A2 
lesion where it remained for the remainder of the time on the trial (428 days). Cow B was 
enrolled in the study at the beginning of her 1st lactation. She began the trial with a B1 lesion 
that increased in size to a B2 lesion within the first few weeks on the trial. This lesion remained a 
B2 lesion for over 200 days until a Stage 3 lesion was observed on day 242. A digital photograph 
is shown in Figure 2 for day 251 that shows the transition from a B2 lesion to a Stage 3 lesion. 
The criterion for a Stage 3 lesion is ulceration and a small area of ulceration was noted when the 
crusts of a B2 lesion were lost. This small area quickly progressed to a more obvious Stage 3 
lesion at the Day 290 observation. On Day 290, the lesion was treated and over the next several 
months the lesion regressed back through several of the preclinical lesion stages. This lesion is 
typical of many of our 1st calf heifers that originally developed a DD lesion through “B” lesions; 
following treatment, these regressed back to “A” type lesions. 
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Figure 3A:     Figure 3B: 
 
Figure 3: Examples of DD Lesion Changes on Individual Feet over Time. A list of lesion scores 
over a period of time are listed for two different cow rear feet. A subset of lesion morphologies 
are shown that are most representative of each DD lesion score. Both of these feet progressed 
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systematically through the Iowa DD scoring system, with Cow A progressing with “A” type 
lesions and Cow B progressing with “B” type lesions. Both feet were treated during their 
observation period with Cow A being treated on day 272 and Cow B being treated on day 290.  
See text for additional details. 
 
A total of 52 topical tetracycline wraps were applied to Stage 3 and 4 lesions over the 
course of the study, either due to lameness associated with a DD lesion or a lesion treated at the 
time a cow was removed from the study. As some of the feet were observed for an extended 
period of time, many of the feet that developed end stage lesions were treated and redeveloped 
lesions at a later time. These treated lesions were monitored and subsequently scored during 
routine tilt-table observations. Of the 52 lesions treated with topical tetracycline, 43 of them were 
monitored for a minimum of 50 days to evaluate the effect of treatment and lesion recrudescence. 
Of these 43 lesions, 40 of them regressed to a lower lesion stage following treatment. Table 2 
shows a summary of the subsequent observations and the lowest lesion stage reached following 
treatment. Despite the fact that topical tetracycline was effective in reducing lesion scores, it was 
highly ineffective (9%) at returning DD lesions back to normal skin. Significant differences 
(p<.05) were observed between the lowest lesion score observed following treatment and the rate 
of recrudescence of disease. Lesions that regressed to Stage 2 following treatment had the 
highest rate of recrudescence (59%) and the lowest number of days (120) for these lesions to 
return to clinical lesions (Stage 3 or 4). The lesions that regressed to Stage 1 following treatment 
were less likely (p<.05) to return (29%) and the days required for these lesions to return was 
longer (224) than those that only regressed to Stage 2. Of the four lesions that completely healed 
(Stage 0), none of them developed clinical lesions again during their observation period, which 
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averaged 420 days following treatment for these four animals. There was no statistical difference 
(p=.12) between recrudescence rates between those that regressed to Stage 0 versus Stage 1, but 
there was a highly significant difference (p<.01) in recrudescence rates between those that 
regressed to Stage 0 versus Stage 2. There was no difference (p=.11) between the recrudescence 
rates of lesion classified as Stage 3 or Stage 4 at the time of treatment. 
 
Table 2: DD Lesion Treatment and Recrudescence 
Lowest DD 
Score* 
# 
Lesions 
# Recur %
 
days to recur days monitored 
3 3 3 100% 0 298 (265-323) 
2 22 13 59%
a,b 
120 (85-431) 289 (52-603) 
1 14 4 29%
a 
224 (52-306) 265 (56-679) 
0 4 0 0%
b 
N/A 420 (252-567) 
Table 2: The lowest DD score refers to the lowest DD lesion score that lesions regressed to 
following a single treatment with topical tetracycline. All DD lesions treated in this analysis 
were initially classified as either Stage 3 or 4 clinical lesions at the time of treatment. The “# 
Recur” refers to the number of lesions that return to a DD lesion score of 3 or 4 during the time 
period observed. The amount of time each lesion was observed is shown in the last column, and 
also shown is the mean time observed following treatment and the range of time for individual 
lesions. The “days to recur” indicates the time from treatment to the time in which the lesions 
returned to a Stage 3 or 4. In cases in which lesions did not regress any lower than Stage 3, these 
would be considered treatment failures and thus do not have a time to recur. A superscript of the 
same letter indicates statistical significance between recurrence rates. 
*DD lesion scores were based on the Iowa DD Lesion Scoring System 
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Over the three years of the study a total of 369 events were recorded in the metadata 
categories listed in Table 3. In order to evaluate the effect these events had on DD lesion 
development, we arbitrarily required that the pre-event score had to be recorded within 14 days 
(either side) of the event, and the outcome score of the event was evaluated as the average lesion 
score between days 14 and 60 following the event. The 14 day window was based on the 
observation that lesion scores rarely changed lesions scores naturally in less than 14 days. Even 
following topical treatment, which would likely have the most rapid effect on a DD lesion, 
lesions typically did not change morphologic appearance for approximately 14 days. The 
exception to the 14 day window was for evaluation of the dry period which was based on lesion 
scores at dry-off (between 55 and 80 days pre-calving) and the event outcome was the score 
recorded during the first 14 days after calving. This deviation was due to the dry pen location 
being distant to the tilt-chute and therefore the inability to evaluate lesion development during 
this time period.  Post-parturient stress was evaluated by using day 14 post calving as the “event 
date” and the results were again the average lesion score between days 14 and 60 following the 
event. Of the 369 events, 177 had lesion scores recorded during both the pre-event window and 
the window for evaluation following the event. As many events occurred simultaneously with 
other events (for example, systemic disease often occurred along with systemic antibiotic 
therapy) a separate analysis is shown in Table 3 (third column) that lists events that occurred 
independently of anything else for that animal. Two events were considered simultaneous if they 
occurred within 14 days of each other for the same reasons discussed above. The elimination of 
simultaneous events lowered the number of events that qualified for analysis to 121. Of the five 
types of events recorded, the only event that significantly altered the development of DD lesions 
was topical tetracycline therapy which decreased lesion scores by more than one score on 
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average. When compared to systemic antibiotics, there was a significant difference (p<.001) in 
the effects that topical tetracycline had on the DD lesion scores. 
 
Table 3: The Effect of Various Events of DD Lesion Stage 
 
Simultaneous 
Events 
Independent 
Events 
  
Event n 
DD Score 
Change 
n 
DD Score 
Change 
Criteria for 
Event Score 
Criteria for Event 
Result 
Systemic 
Disease 
42 -0.01 19 0.13 
+/- 14 days of 
event 
+14 to 60 days after 
event 
Systemic 
Antibiotics 
26 -0.24 7 -0.07 
+/- 14 days of 
event 
+14 to 60 days after 
event 
Topical DD 
Therapy 
27 -1.08 21 -1.17 
+/- 14 days of 
event 
+14 to 60 days after 
event 
Dry Period 26 -0.10 26 -0.10 
-80 days of 
calving 
+14 days after 
calving 
Post-parturient 
Period 
46 0.11 39 0.03 
Days 0-28 post 
calving 
+14 to 60 days after 
event (day 14) 
Table 3: The effect of selected events on DD lesion scores are listed above. Systemic disease 
included coliform mastitis, ketosis, metritis, pneumonia, LDA, and peritonitis. The systemic 
antibiotics were not given to treat digital dermatitis, but the effect on DD lesions was measured 
when systemic antibiotics were given to treat a number of other conditions. Topical DD therapy 
was a single topical wrap with tetracycline. For these events, the DD lesion score at the time of 
event was the average lesion score when measured within 14 days of an event. Due to some 
events occurring more than 14 days from an examination, those events were excluded from 
analysis. The event result for these events was the average lesion score from observations made 
between 14 and 60 days after event. The effect of dry period was slightly modified as cows were 
not available for observations during the dry period. The event score for this analysis was the 
final examination score prior to dryoff that was less than 80 days from calving. The event result 
for the dry period was the first lesion score following calving that was less than 14 days from 
53 
 
calving. The effects of periparturient period were evaluated by using day 14 following calving as 
the event and the result was measured 14 to 60 days following event. The column indicating 
independent event outcome included only events in which no other events happened within 14 
days of the event. The simultaneous event column included these events. 
  
Discussion: 
 This study clearly demonstrates that the Iowa DD Scoring System utilized for the 
analysis of DD lesion development serves as an effective method to study lesion progression and 
regression. It has been previously shown that DD lesions differ morphologically over time, and 
several scoring systems have been devised (19) in an attempt to categorize the progression of 
lesion development. We believe that the Iowa DD scoring system has several significant 
advantages over previously described scoring systems. First, it allows for a more detailed 
evaluation of the development of early stage lesions by providing 4 distinct classifications 
instead of incorporating all developing lesions into one category.  Second, we demonstrate in this 
manuscript that the lesion score following therapy provides useful prognostic data regarding the 
likelihood of recrudescence and the period of time until recrudescence.  We are not aware of any 
other scoring system that has been demonstrated to provide this prognostic information. Finally, 
the Iowa DD scoring system is the only scoring system that has also been statistically validated 
to have a unique microbiota associated with each of the specific morphologic lesions (18). Based 
on these observations we believe that the Iowa DD scoring system could also be a useful tool for 
herd level surveillance during routine trimming and footcare. In comparison to other scoring 
systems, the greater emphasis placed on classifying the earliest lesion stages and their associated 
prognostic outcomes provides for an evidence based approach to managing DD prevention 
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measures on farms. The earlier recognition of lesions provided by the scoring system allows for 
earlier intervention and prognostication which in turn allows for better decision-making 
regarding the necessity for retreatment of lesions.  
 There were a number of other important observations noted over the course of the three 
years that have implications as to how we view the incidence of digital dermatitis. The fact that 
75% of observations had lesion scores greater than zero suggests that when cows are not exposed 
to any DD prevention measures, the majority of feet in farms with endemic DD could develop 
some level of digital dermatitis. With only 26% of those lesions being clinical lesions that would 
be recognized by hoof trimmers and practitioners as classic DD lesions, estimates of incidence 
rates and prevalence are likely greatly underestimated in the literature. We did not directly 
measure prevalence as this was an entry restricted cohort study and not a single time point 
analysis of prevalence across all animals in the herd. To compare our data to the other literature 
on prevalence, we used our incidence rate of 4.36 DD lesions per 100 feet-months and an 
average DD lesion lasting 5.26 months in our study to calculate a prevalence of 22.9% (29). 
Although we did not directly measure prevalence, our calculation of prevalence was in line with 
other studies estimates of 20-26% in free stall barns (11). Importantly, the use of lameness in 
herds as a proxy for the prevalence of DD would underestimate the number of cows affected 
with DD as we observe that the majority of clinical lesions fail to induce lameness. The use of 
locomotion score as a way to identify cows with DD was shown to be very inconsistent with 
many cows maintaining clinical lesions for months to years without ever reaching a Stage 4 or 5 
locomotion score. This is consistent with data from Frankena et al. (30) in which only 39% of 
cows with severe DD lesions ever showed any of lameness. 
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The finding of “B” lesions being more frequently observed in 1st lactation animals is 
interesting. Given their age and the relatively low incidence of DD in heifers on this farm this 
finding might suggest that DD naïve animals are more likely to develop this subtype of lesion 
during the first disease exposure. Likewise, the “A” lesions may represent a natural progression 
of lesions in animals with prior exposure. As some of the cows enrolled were already in their 2nd 
and 3rd lactation and their history of DD lesions was unknown upon enrollment, we were unable 
to determine if the lesions in these cows were proceeded by other lesions that had healed at the 
time of enrollment. Therefore, additional work regarding the difference in the natural history and 
epidemiology between type A and B lesions is warranted and may provide a better understanding 
of the initiation and host response to this disease process. 
Figure 3 is a graphical working hypothesis of lesion development and regression over 
time representative of what was commonly observed. Digital dermatitis lesions progress from 
normal skin through either “A” lesions or “B” lesions to the final end stage lesions (Stage 3 and 
4). A full description of the Iowa DD scoring system is provided by Krull et al. (18) with A2 and 
B2 lesions being larger in size than A1 and B1 lesions. All clinical lesions observed in this study 
progressed through these stages prior to becoming Stage 3 lesions. Likewise, the ulcerative and 
hyperemic lesions, characteristic of Stage 3 lesions, always preceded the more chronic Stage 4 
lesions that are proliferative and hyperkeratotic. Following treatment of Stage 3 or 4 lesions, 
there is a period of time (usually less than 10 days from a single point treatment) in which the 
outside layer of the epidermis becomes black and necrotic. Until this necrotic tissue sloughs, it is 
difficult to determine the amount of lesion regression and which lesion stage the treated lesion 
will become. As shown in Table 1, rarely does a single point treatment yield the result of a lesion 
returning to normal skin (Stage 0). The majority of time the lesion will regress to the preclinical 
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category (Stage 1 or 2). As demonstrated in this study the amount of lesion regression is highly 
correlated with the likelihood of recrudescence and the time to recrudescence. 
 
Figure 3: A Schematic of Digital Dermatitis Progression and Regression 
 
Figure 3: Digital dermatitis lesion development model is shown in the above schematic. DD 
lesions always begin with a change from normal skin to either A1 or B1 lesions. These lesions 
can remain in this preclinical lesion stage for an indefinite period of time transitioning between 
the various lesion categories. At some point, an area of these preclinical lesions begins to 
ulcerate and become hyperemic indicative of a Stage 3 lesion. If left untreated, these Stage 3 
lesions will eventually hypertrophy and exhibit the classic “hairy heel wart” appearance. 
Following treatment of the active or clinical lesions, there is a period of time in which much of 
the tissue becomes necrotic and eventually sloughs. During this time, it is difficult to accurately 
stage the DD lesion. Once the necrotic tissue is gone, unless there is a treatment failure, the 
lesions can again be classified in the preclinical lesion category.  
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The natural history and epidemiology of DD lesion development observed in this study 
yielded similar results to Relun et al. (31) in a long-term follow-up of over 4,000 cows from 
French dairy farms. That study found the median time for the occurrence of a new DD lesion to 
be 146 days whereas our average time for a lesion to develop was 133 days. The incidence rate 
from both studies was 4 new cases per 100 cow foot-months. The increased risk for an animal to 
have a lesion on the contralateral foot when a lesion was observed on a single rear foot in the 
present study was consistent with the findings of the French study. The major difference is that 
our study was conducted on a single farm in the United States with a single breed (Holstein) 
whereas the Relun et al. study was done across multiple farms in France with multiple breeds 
and management systems very different to that of the U.S. production system. Like our study, 
they conducted all examinations on a tilt-table instead of using parlor evaluations. The fact that 
the results were very similar despite the location and study population differences suggests that 
digital dermatitis development is likely to be consistent world-wide and across breeds. 
The high rate of lesion recrudescence following a single topical treatment has been 
repeatedly shown in multiple studies (23, 25, 32). The majority of papers reporting the treatment 
success and recrudescence only followed treated lesions for 30 days or less. Only the study by 
Berry et al. (25) followed any of the treatments past 30 days to evaluate treatment success when 
re-examined at 341 days. The results of this present study indicate a high rate of DD lesion 
recrudescence following a single tetracycline treatment (44%) when followed for an extended 
period of time (as long as 679 days). The average time required for these lesions to recrudesce 
was also much longer than most of the studies had reported as follow-up time after treatment. 
Additionally, none of 17 lesions that initially responded to treatment and later re-developed DD 
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lesions did so in less than 50 days. This calls into question the outcomes of treatment studies that 
assess lesion recrudescence at 30 days, as is commonly reported in the literature. This short 30 
day follow-up period makes it difficult to determine if the lesions are treatment failures or lesion 
recrudescence. Our data shows that a single topical treatment of tetracycline had a treatment 
success rate of 9% which is lower than previous reports.  This discrepancy is partly due to the 
definition of treatment success, which in our study requires the skin returning to normal. In 
studies that assessed complete healing of the lesion to normal skin, success rates ranged from 14-
39% (24, 33), whereas studies that defined treatment success as a decreased lesion size or 
decreased pain the success ranged from 47-73% (23, 34). There is also a large discrepancy in the 
duration of follow-up between these studies which may have also contributed to the differences. 
Importantly, we were able to use the Iowa DD scoring system to evaluate lesion morphology 
following treatment and also have validated its use as a prognostic tool for lesion recrudescence. 
The collection of metadata during the course of the study was done in an attempt to 
identify the effect of various management factors and interventions on DD lesion development. 
We recorded every event that happened to the cows on trial including mastitis, ketosis, displaced 
abomasum, metritis, pneumonia, etc. that occurred over these three years. As we examined our 
data, there were not enough instances from each of these events separately to derive any 
conclusions about their effects on DD lesions. Therefore, we combined all of these events to 
determine if systemic illness of any kind had any effect on lesion development. As we were also 
looking at the effects of systemic antibiotics and the periparturient period, it was difficult to 
assess many of these things independently of each other. Many times a case of metritis was 
obviously associated with the periparturient period as well as systemic antibiotics used to treat 
the condition. The data shown in Table 2 summarizes these effects with and without these 
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confounders included. There was no effect on lesion score from events that would be expected to 
be associated with immunosuppression, including systemic disease, dry period, or periparturient 
period; although this should be interpreted with caution as this was not the primary focus of the 
study. 
Although no antibiotics are labeled by regulatory agencies to treat digital dermatitis in 
cattle in the United States, we were interested to see if antibiotics given for different disease 
would affect DD lesion development. Although systemic tetracycline has been shown to have 
limited success (35), systemic cefquinome (not an approved product in the U.S.) has been shown 
to reduce DD lesion size in the UK (36). In the few cases of the present study where systemic 
antibiotics were given for non-systemic disease (typically footrot cases), systemic antibiotics did 
not have a significant (p>.05) effect on lesion score. For all of the events measured, the only 
event that was statistically significant (p<.05) was topical tetracycline therapy. This was not 
surprising considering the many papers documenting treatment success using tetracycline (23, 
24, 34, 35), however the fact that the Iowa DD scoring system was able to be used to document 
this in a statistical manner was encouraging for its use in future treatment trials. 
 The observations from this study provide important insights into how DD lesions 
progress from normal skin to the readily identifiable clinical disease. The Iowa DD lesion 
scoring system was shown to be a valuable tool in describing these changes as well as serving as 
a way to measure the outcome of DD intervention strategies. Future research into whether more 
aggressive treatment as a means to return DD lesions back to normal skin would be beneficial in 
lowering the recrudescence rate is warranted. Additionally, further studies evaluating the 
economics of treating the more prevalent preclinical lesions prior to developing into clinical DD 
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lesions should be looked at to reduce lameness and production losses associated with clinical 
lesions. 
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Abstract 
Bovine Digital Dermatitis (DD) is a leading cause of lameness in dairy cattle throughout 
the world. Despite 35 years of research, the definitive etiologic agent associated with the disease 
process is still unknown. Previous studies have demonstrated that multiple bacterial species are 
associated with lesions, with spirochetes being the most reliably identified organism. This study 
details the deep sequencing based metagenomic evaluation of 48 staged DD biopsies collected 
during a 3 year longitudinal study of disease progression. Over 175 million sequences were 
evaluated utilizing both shotgun and 16S metagenomic techniques. Based on the shotgun 
sequencing results there was no evidence of a fungal or DNA viral etiology. The bacterial 
microbiota of biopsies progress through a systematic series of changes that correlate with the 
novel morphologic lesion scoring system developed as part of this project. This scoring system 
was validated as the microbiota of each stage was statistically different from those of other 
stages (p<0.001). The microbiota of control biopsies were the most diverse and became less 
diverse as lesions developed. Although Treponema spp. predominate the advanced lesions they 
are in relatively low abundance in the newly described early lesions that are associated with the 
initiation of the disease process. The consortia of Treponema spp. identified at the onset of 
disease changes considerably as the lesions progress through the morphologic stages identified. 
Results of this study support the hypothesis that DD is a polybacterial disease process and 
provide unique insights into the temporal changes in bacterial populations throughout lesion 
development. 
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Background 
According to the most recent National Animal Health Monitoring System survey of US 
dairy farms (1), lameness is the second most common health problem identified in dairy cattle. 
Digital dermatitis (DD) was found to be the primary cause for lameness within the study herds, 
accounting for 61.8% of the lameness in bred heifers and 49.1% of the lameness in cows. Bovine 
DD was first described in 1974, but despite over 35 years of research, the etiological agent(s) 
associated with this disease have yet to be definitively identified. The first morphologic 
description of DD as an ulcerative disease of the bovine coronary band occurred at the 8th 
International Meeting on Diseases of Cattle in Milan, Italy (2). The first etiologic descriptions of 
the disease were published in 1994, which was soon followed by a report describing the isolation 
and identification of an anaerobic spirochete, believed to be a Treponema spp., in the lesions (3, 
4). Since that time, a number of additional papers have been published demonstrating the 
association of the lesions with additional bacteria including Bacteroides spp. (now called 
Porphyromonas spp. (5), Campylobacter spp. (6, 7), Borrelia spp. (8), as well as viral etiologies 
(9, 10). While there is a consistent presence of several Treponema phylotypes in DD lesions (9, 
11-15), attempts to induce disease by skin inoculation with pure cultures of these 
microorganisms have largely failed to result in significant disease in a majority of the animals 
inoculated (7, 16). Furthermore, there is evidence to suggest that the clinical use of vaccines 
focused against spirochetes provides limited protection against the disease process (17). The 
consistent clinical response to topical or systemic antibiotics suggests a bacterial agent as the true 
etiology of the disease (18-22). The association of DD lesions with a variety of bacterial agents, 
the response of the lesions to antibiotics, and the failure to induce or protect from the disease 
using monovalent vaccines strongly suggests that DD is a polymicrobial disease process (9, 23-
66 
 
25). This conclusion is further supported by two recent studies that utilized the culture 
independent method of sequencing clones of 16S rRNA genes (rDNA) by Sanger technology to 
classify a subset of bacteria derived from biopsies of both lesions and healthy feet (15, 26). 
While these studies demonstrate that there are mixed microbial populations present in DD 
lesions that differ from that of normal skin, the lack of information regarding stage and 
chronicity of the biopsies, combined with the relatively low number of 16S rDNA sequences 
limits the confidence in the overall conclusions. 
The fact that DD develops through a systematic series of morphological stages was first 
described by Dopfer et al. in 1997 (7). The authors describe four stages of lesion development 
with stage M1 (“M” in honor of Mortellaro’s initial description of the lesions) being the 
formation of a small ulcerative area, stage M2 being a mature papillomatous or ulcerative lesion, 
stage M3 being a healing lesion, and stage M4 being a chronic recurrent lesion. The 
histopathologic changes associated with the development of DD have been described (7, 27-29). 
Briefly, DD lesions have been described histologically to include acute, suppurative 
inflammation of the epidermis with superficial necrosis and hyperkeratosis (10), along with 
perivascular aggregations of lymphocytes and plasma cells (30). A consistent microscopic 
observation of spirochetes within lesions has been demonstrated by multiple researchers through 
the use of Hematoxylin and Eosin staining, Warthin–Starry silver staining (31), 
immunohistochemistry (13, 28), electron microscopy (13, 32), and fluorescence in situ 
hybridization (FISH) (11, 12, 26, 29, 33-37). 
The objective of this project was to use deep DNA sequencing to analyze changes in the 
microbiota of DD lesions as they progressed through the temporal development of disease. The 
hypothesis was that the development of DD is polybacterial in nature, and consistent and 
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predictable changes to the bacterial microbiota of the bovine foot could be identified as lesions 
systematically progress through multiple distinct morphologic stages. Following the onset of 
clinical disease, an evaluation of the lesion microbiota following conventional topical treatment 
with tetracycline was desired to determine the effect of treatment on the microbial community. 
For this component, it was hypothesized that specific bacterial species associated with DD 
lesions would be displaced by nine days after treatment. 
 
Materials and Methods 
Lesion staging and biopsy collection 
DD biopsies were collected from adult Holstein dairy cattle housed at the Iowa State 
University Dairy Farm. Cattle on the trial were diverted away from the farm’s footbath through 
the use of radiofrequency ID tags and sort gates. No additional preventative measures were used 
to control DD in these cows, allowing for observation of the lesion development in the absence 
of intervention. Cattle on this study were examined every three to four weeks throughout the 
study and biopsies were taken from rear feet each time an individual foot changed lesion stage. 
Additionally, digital images of all feet were taken at each observation to allow for retrospective 
evaluation of lesion morphology and blinded staging of lesions. All observations were made by a 
single observer (AK) to assure consistency. All animal procedures and biopsy methods were 
approved by the Institutional Animal Care and Use Committee of Iowa State University. 
Lesions were identified as part of a three-year observational longitudinal study and 
classified using a novel scoring system (Figure 1) developed as part of this study. The Iowa DD 
scoring system was developed after initial efforts to utilize the previously described “M” scoring 
system proved to be problematic due to the recognition of two distinct previously unrecognized 
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morphologic appearances of early stage lesions. The study’s three-year duration allowed for 
lesion monitoring over an extended period of time and demonstration that both new morphologic 
forms ultimately led to the development of classic DD lesions. The morphologic differences of 
these subtypes suggested that different bacterial species might be involved and it was thus 
important for the study to be able to differentiate these early lesion subtypes. Instead of 
modifying the existing “M” scoring system, it was elected to develop an independent scoring 
system. The Iowa DD scoring system differentiates lesions progressing from normal skin (stage 
0) to initial onset (stage 1), developing lesions (stage 2), classic DD lesions in acute form (stage 
3), and chronic form (stage 4) of disease. Furthermore, stages 1 and 2 are subdivided into two 
morphological subtypes. The “A” type lesions initiate in the interdigital space and have a more 
ulcerated appearance in comparison to the “B” type lesions that develop more diffusely across 
the heel and have a thickened, crusted appearance. Both subtypes progress to the same 
morphologic stage 3 and 4 lesions. In some cases in this manuscript, the subtypes of stages 1 and 
2 will be combined for data analysis in order to simplify the presentation of the temporal 
development of disease. However, the subtypes were evaluated independently for assessment of 
biomarkers of disease for each stage. A separate category (termed stage 5 in this manuscript) is 
used to represent a distinct subset of biopsies that were taken exactly nine days post topical 
treatment of stage 3 or stage 4 lesions. A more complete description of the Iowa DD scoring 
system and the epidemiology of disease development will be reported in a separate manuscript. 
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Figure 1: An illustration of the lesion stages identified throughout the 3-year study. Images 
presented are that of lesions biopsied and utilized in this study. Stage 0 represents normal bovine 
skin, the A1/A2 and B1/B2 lesions represent morphological variations of developing DD lesions, 
and Stage 3 and 4 represent the clinical forms of disease responsible for lameness. A subset of 
biopsies treated and biopsied 9 days post-treatment are represented as Stage 5 in this manuscript. 
 
Biopsy collection was performed under local anesthesia provided by a regional limb 
perfusion with 20 mL of 1% lidocaine. DD lesions were gently rinsed with water to remove 
gross organic debris; no antibacterial products or surgical scrubs were used prior to performing 
biopsies. Two separate 3 mm biopsies were collected utilizing a biopsy punch to collect 
epidermis from a representative area of the lesion. Biopsies intended for metagenomic analysis 
were placed into 1.5 mL microcentrifuge tubes containing 0.5 mm stainless steel beads and 
transferred to the laboratory within six hours for DNA extraction. Biopsies intended for 
histopathologic analysis were immediately placed in 10% neutral buffered formalin. Biopsies 
were processed for DNA extraction by adding Buffer ATL and Proteinase K (QIAgen DNeasy 
Blood and Tissue Kit), homogenized using a Next Advance Bullet Blender, and incubated 
overnight at 56°C. Following overnight incubation, biopsies were processed as directed by 
manufacturer’s recommendations (QIAgen DNeasy Blood and Tissue Kit) and sample DNA was 
eluted and stored in AE buffer. Total DNA yield was quantified with the Qubit fluorometer (Life 
Technologies, Grand Island, NY) and DNA was stored at -80°C prior to downstream processing. 
Biopsies utilized for histologic examination were stained with hematoxylin and eosin (H&E) 
using the Gemini Autostainer with the H&E based staining protocol. Warthin-Starry staining was 
conducted using the Iowa State Veterinary Diagnostic laboratory standard operating procedure. 
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Shotgun sequencing 
Three samples were chosen from each of the seven morphologic stages for analysis using 
shotgun metagenomic sequencing. Along with these 21 samples, three additional samples were 
chosen from stage 4 lesions that had been treated with topical tetracycline nine days prior to 
biopsying (identified as stage 5 for simplicity). Table 2 provides details regarding the biopsies 
included in the project. An aliquot of all 24 samples was normalized to 2.5 ng/µl for use in the 
Nextera DNA Sample Prep Kit (Epicentre Biotechnologies, Madison, WI). Tagmentation of the 
samples was done using 50 ng of template, as directed by manufacturer. Following tagmentation, 
each sample was purified with the QIAgen MinElute PCR Purification Kit and eluted with 25 µl 
of Nextera Resuspension Buffer. PCR amplification was done per manufacturer’s instructions 
using a unique combination of indexing primers for each of the 24 samples to allow for 
multiplexing of samples. Following amplification, each DNA library had short DNA fragments 
(<150-bp) removed using AMPure XP bead purification. DNA concentration and library 
fragment sizes were analyzed using a Qubit fluorometer and Agilent High Sensitivity Chip. 
Sample library concentrations were normalized, pooled, and diluted to 2 nM for sequencing on 
the Illumina HiSeq platform. Libraries were run on a single flow cell lane of 100-bp paired-end 
sequences at the Iowa State University DNA Facility. 
 
16S sequencing 
Forty-eight samples were chosen for metagenomic analysis using amplification of the 
V3-V4 hypervariable region of the bacterial 16S rRNA gene (Table 1). This included the 24 
samples sequenced in the shotgun sequencing experiment plus an additional 24 samples 
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representative of each of the scoring system stages. All samples were processed using a universal 
16S forward primer (515F) and 48 unique Golay barcoded reverse primers (806R) as described 
by Caporaso et al. (38). Following 35 cycles of PCR amplification, the PCR product was 
confirmed by visualization of an approximately 300-bp band on agarose gel (0.8%). A negative 
control for every sample and primer combination was also processed in an identical manner and 
the absence of amplification was verified on agarose gel. Sample library DNA concentrations 
were quantified using a Qubit fluorometer and samples were pooled with equal amounts of 
DNA. The pooled libraries were cleaned up with the MO-BIO UltraClean PCR Clean-Up Kit 
and the concentration was then diluted to 2 nM. Due to the potentially low diversity of our 
libraries, Illumina PhiX Control v3 was added at a proportion of 20% prior to loading on the 
MiSeq platform. A single flow cell lane of 300-bp paired end sequences was run on the Illumina 
MiSeq at the Iowa State University DNA Facility. 
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Table 1: Metadata for each individual biopsy sample collected for this study 
Cow ID* Foot SubClass Stage 16S Shotgun 
Days Obs 
Prior 
Days 
Obs Post 
Total 
Days Obs 
Cow #1 RR - 0 X X 353 19 372 
Cow #15 LR - 0 X X 123 200 323 
Cow #19 LR - 0 X X 202 121 323 
Cow #21 LR - 0 X 
 
195 441 636 
Cow #24 RR - 0 X 
 
63 204 267 
Cow #26 LR - 0 X 
 
0 225 225 
Cow #4 LR A 1 X X 406 200 606 
Cow #5 RR A 1 X X 491 99 590 
Cow #7 RR A 1 X X 319 528 847 
Cow #2 LR B 1 X 
 
470 190 660 
Cow #14 RR B 1 X 
 
260 560 820 
Cow #16 LR B 1 X X 74 580 654 
Cow #17 RR B 1 X X 151 219 370 
Cow #20 RR B 1 X 
 
103 533 636 
Cow #21 LR B 1 X X 77 559 636 
Cow #23 LR B 1 X 
 
83 565 648 
Cow #25 LR B 1 X 
 
0 225 225 
Cow #3 LR A 2 X X 174 85 259 
Cow #9 RR A 2 X X 385 524 909 
Cow #16 LR A 2 X X 222 432 654 
Cow #22 LR A 2 X 
 
90 341 431 
Cow #2 LR B 2 X 
 
491 169 660 
Cow #8 LR B 2 X X 223 249 472 
Cow #14 RR B 2 X 
 
280 540 820 
Cow #20 RR B 2 X 
 
195 441 636 
Cow #21 LR B 2 X X 223 413 636 
Cow #23 RR B 2 X X 83 565 648 
Cow #23 LR B 2 X 
 
202 446 648 
Cow #2 LR - 3 X 
 
597 63 660 
Cow #8 LR - 3 X X 338 134 472 
Cow #13 RR - 3 X X 88 570 658 
Cow #14 RR - 3 X 
 
506 314 820 
Cow #20 RR - 3 X 
 
315 321 636 
Cow #22 LR - 3 X X 222 209 431 
Cow #23 LR - 3 X 
 
322 326 648 
Cow #24 RR - 3 X 
 
156 111 267 
Cow #25 LR - 3 X 
 
114 111 225 
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Table 1 continued 
Cow #26 LR - 3 X 
 
114 111 225 
Cow #11 LR - 4 X X 385 536 921 
Cow #12 LR - 4 X X 393 203 596 
Cow #14 RR - 4 X 
 
596 224 820 
Cow #18 LR - 4 X X 89 566 655 
Cow #20 RR - 4 X 
 
418 218 636 
Cow #21 LR - 4 X 
 
315 321 636 
Cow #22 LR - 4 X 
 
328 103 431 
Cow #6 RR - 5 X X 357 389 746 
Cow #10 LR - 5 X X 399 162 561 
Cow #18 LR - 5 X X 119 536 655 
     
Average: 252.3 316.7 569.0 
*Certain cows have several sequential biopsies taken and the ID corresponds to an individual 
cow. 
 
Metagenomic data analysis 
Shotgun data 
Raw data files were de-multiplexed and converted to .fastq using Casava v.1.8.2 
(Illumina, Inc, San Diego CA). Fastq files were concatenated and uploaded to the MG-RAST 
(39) server for analysis. The server was set to query for the organism information for all biopsy 
bins. A “best hit” analysis was performed using the M5NR database (40) as the source database. 
The MG-RAST graphical user interface was used to provide rarefaction curves and relative 
species abundance data. The data was then exported in biom format for further analysis in 
QIIME (38, 41). Bray-Curtis beta diversity plots (42) and Procrustes analysis (43) was 
performed using published QIIME scripts. 
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16S metagenomic data:  
Forward and reverse reads from the paired end sequencing were first merged using the 
fastq.join script. De-multiplexing and quality filtering were then performed using the 
split_libraries_fastq.py script. The pick_reference_otus_through_otu_table.py script was used for 
operational taxonomic unit (OTU) calling and taxonomic assignment based on the greengenes 
database (44) was performed. Jackknifed (45) (10,000 iterations) Bray-Curtis beta diversities for 
the samples were plotted by stage using the jackknifed_beta_diversity.py script and compared 
using a nonparametric Analysis of Similarity (ANOSIM) analysis with 1000 permutations. In 
order to test for biomarker taxa associated with each stage of lesion development, the Galaxy 
analysis tool (46, 47) was utilized to analyze LDA effect size (LEfSe). 
 
Results 
Shotgun sequencing 
Samples from shotgun sequencing varied in the number of 100-bp reads from 837,084 to 
22,799,300, with an average of 6,518,062 reads per sample and a total of 156,433,474 sequences. 
Of these reads, a total of 48,530,678 passed initial quality control presets of the MG-RAST 
software, with an average Duplicate Read Inferred Sequencing Error Estimation (DRISEE) (48) 
of 6.32%. With the M5NR database utilized as the annotation source, 661,098 reads matched a 
reference sequence with an e-value cutoff of 1e-5, 60% minimum identity, and a minimum 15-bp 
alignment. The percentage of eukaryotic reads was highest in controls (88.0%), decreased as 
lesions progressed to stage 1 and 2 lesions (40.9%, 6.9%) and was lowest in classic stage 3 and 4 
DD lesions (1.7%, 2.3%). Conversely, the percentage of bacterial reads increased as lesions 
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progressed from 2.1% in controls, 55.1% and 88.6% in stage 1 and 2 lesions, and 94.8% and 
97.2% in stage 3 and 4 lesions. Analysis showed that almost no sequences (less than ten total 
sequences) were associated with fungal DNA and less than 0.5% of all sequences were 
associated with viral elements, consisting primarily of phage DNA. 
To determine if quantitative differences existed between the normal cow skin control 
biopsies and different stages of lesions, an ANOSIM analysis was used to compare whether the 
Bray-Curtis distances within the same category of the samples is significantly different from 
those among different categories of the samples. The results of these analyses demonstrated that 
statistically significant differences do exist between the stages (p<0.001) at both the genus and 
species level. This allows for pair-wise comparisons of the different stages to be performed 
where significant differences exist between all comparisons (p<0.025), except the comparison of 
the control and post-treatment biopsies. 
A plot of taxonomic hits from each stage of disease development is plotted in Figure 2A, 
showing all bacterial families that have a relative abundance of at least 5% of the bacterial flora 
for any given stage. The morphological stages of A1 and B1 as well as A2 and B2 have been 
combined as stage 1 and stage 2 respectively to better demonstrate the temporal development of 
the disease process. Eleven families were identified that met these criteria. Families that did not 
reach the 5% threshold have been combined into “other” to give a representation of the total 
bacterial population dynamics of each stage. The family with the largest increase in abundance 
as lesions develop is from the Spirochaetaceae family systematically increasing from 0.0% in 
control feet to 94.3% in chronic (stage 4) lesions. In contrast, several families, including 
Staphylococcaceae, Streptococcaceae, Bacteroidaceae, Corynebacteriaceae, and 
Pasteurellaceae were overrepresented in controls and replaced with other bacterial families as 
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lesions progressed. Families that had lower abundance in controls and increased in early stage 
development included Spirochaetaceae, Mycoplasmataceae, Moraxellaceae, and 
Porphyromonadaceae. As lesions progressed to the classic DD morphologic appearance, the 
diversity of the bacterial microbiota greatly decreased. Spirochaetaceae became the predominant 
family in the stage 3 and 4 lesions (69.7% and 94.3%). The only other family to make up a 
substantial (>10.0%) constituent of stage 3 lesions was Mycoplasmataceae. Following treatment, 
there was a considerable shift in the bacterial population with Spirochaetaceae and 
Mycoplasmataceae being considerably reduced whereas Corynebacteriaceae, Moraxellaceae, 
and Porphyromonadaceae noticeably increased. 
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Figure 2A: 
 
Figure 2B 
 
Figure 2: Relative abundance, by stage, of bacterial families that represent at least 5% of the 
bacterial reads acquired. For simplicity the colors of individual families are the same in both 
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graphs. A: Relative abundance as derived from 24 biopsies sequenced using shotgun 
metagenomics, and B: Relative abundance derived from 48 biopsies sequenced using 16S based 
metagenomics. 
 
16S sequencing 
A total of 20,042,461 paired end sequencing reads were returned from the MiSeq. Using 
a fastq-join script, 17,003,839 overlapping forward and reverse sequences were aligned and 
joined. QIIME (38, 41) was then used to de-multiplex and quality filter using the default quality 
filter settings. The total number of reads that passed quality filtering was 15,792,486 with a 
maximum reads per sample of 644,571 and a minimum of 40,584. The greengenes (44) 16S 
rRNA gene database was used to designate OTUs in QIIME. The total number of unique OTUs 
identified from the dataset was 6001. The mean number of total OTUs per sample was 198,222 
with a maximum of 340,971 and a minimum of 38,563 OTUs. 
Alpha diversity (42) of each sample was calculated using rarefactions ranging from 10 to 
100,000 with ten iterations of each calculation. The alpha rarefaction plot (Figure 3) 
demonstrates the average estimated number of species identified based on the number of 
sequences sampled for each of the six lesion stages. The endpoint of this plot is 100,000 
sequences based on the fact that 45 of 48 samples had greater than 100,000 reads. As most of the 
data sets have reached an asymptote on the chart, depth of sequencing was demonstrated to be 
adequate and relatively few unique species would be identified with additional sequencing. This 
plot also demonstrates that the diversity of samples greatly decreases as the lesions progress from 
normal skin (stage 0) to early lesions (stages 1 and 2) to the end stage lesions (stages 3 and 4). 
Biopsies with the most diversity were those samples nine days post treatment (stage 5).
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Figure 3: Alpha rarefaction plot of the number of species observed when the OTU table derived 
from 16S based metagenomics was rarified in 10,000 increments from 10 to 100,000 reads. For 
each rarefaction ten (10) iterations were performed and the number plotted represents the 
average number of OTUs identified. 
 
Figure 2B is a plot of taxonomic hits from each stage of disease development in a similar 
plot to Figure 2A, although 2B only represents 16S data and is independent from the shotgun 
data presented in 2A. Bacterial families that represent at least 5% of the bacterial flora for any 
given stage are shown. Eleven families were identified as composing at least 5% of the flora at 
each stage, of which six were the same as those identified in the shotgun data. Similar to the 
shotgun data, the Spirochaetaceae family again increases dramatically from only 1.3% in control 
feet and to 69.7% in stage 3 lesions. The increase in Spirochaetaceae was not as linear and 
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systematic as the increase in the shotgun data with the peak in abundance occurring in stage 3 
lesions. In contrast to the shotgun data, there was a continued rise in abundance of 
Spirochaetaceae into stage 4 lesions. The only other bacterial family to be in sizable abundance 
in stage 3 and 4 lesions was again the Mycoplasmataceae family. Families that were 
overrepresented in control feet included Moraxellaceae, Corynebacteriaceae, Lachnospiraceae, 
and Ruminococcaceae. As lesions developed to stage 1 and stage 2, an increase in the 
Spirochaetaceae, Mycoplasmataceae, Porphyromonadaceae, Campylobacteraceae, 
Aerococcaceae, and Tissierellaceae families was noted. Following treatment, a rapid decline in 
Spirochaetaceae and Mycoplasmataceae occurred, concurrent with a rise in Moraxellaceae, 
Porphyromonadaceae, Bacteroidaceae, Corynebacteriaceae, Aerococcaceae, and 
Tissierellaceae, leading to a population that closely resembles that of control feet. 
As the 16S dataset provided 254-bp of overlapping sequences of the highly variable V3-
V4 region of the bacterial 16S region, a deeper analysis of the genus and species was done on the 
Spirochaetaceae family to identify potential key species. All of the species identified in the 
Spirochaetaceae family belonged to the Treponema genus with 45 unique species being 
identified from the greengenes database. Figure 4 shows Treponema spp. that make up 5% or 
more of the total Treponema population at any given stage. To identify the Treponema spp. that 
were associated with each individual OTU call, the greengenes reference 16S sequence was 
blasted in the Ribosomal Database Project (RDP) (49). Each Treponema spp. listed is the 
bacterial isolate that had the highest RDP score that was also greater than 0.95. Any BLAST 
comparison that did not return an isolate with an RDP score greater than 0.95 was listed with a 
unique Treponema spp. number. Twelve unique Treponema spp. were identified as contributing 
to at least 5% of the Treponema population for any given lesion stage. The remaining 32 
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Treponema spp. have all been combined to represent the other Treponema category in Figure 4. 
The results of this analysis show that constituents of the Treponema population undergo dramatic 
shifts as the lesions develop. While the Treponema spp. in the control feet are primarily 
Treponema sp33 along with a mixture of other Treponema spp., as lesions developed to stage 1 
and stage 2, there was a shift in the population with five species making up the majority of the 
bacterial community. These include three Treponema spp. previously identified by Klitgaard et 
al. (26) and designated PT1, PT2 and PT3. The other two abundant species identified in these 
lesions are Treponema phagedenis and Treponema sp44. Of these five species, Treponema PT2 
and Treponema sp44 make up the primary constituents of stage 1 lesions encompassing 77.4% of 
the Treponema population, whereas Treponema PT1, Treponema PT3, and Treponema 
phagedenis make up 82.6% of the stage 2 Treponema population. The morphologic shift from 
developing lesions to classic DD lesions is accompanied by a substantial increase in four 
Treponema spp. that were previously in very low numbers in developing lesions. These included 
Treponema PT8, Treponema denticola, Treponema pedis, and Treponema medium. These four 
species went from comprising only 0.1% and 2.6% of the population in stage 1 and stage 2 
lesions, respectively, to comprising 68.1% and 69.3% of the Treponema population in stage 3 
and stage 4 lesions, respectively. Accompanying this increase in the population of these four 
species was a rapid decline in four of the five highly abundant Treponema spp. identified in stage 
1 and stage 2 lesions. Only Treponema phagedenis remained at a substantial level (24.9% and 
23.4%) during this shift, as the other four species comprised less than 1% of the Treponema 
population in stage 3 and 4 lesions. Following treatment (stage 5), the diversity of Treponema 
spp. increased with all 12 contributing to at least 1% of the population, whereas all other lesion 
stages only had five to seven species contributing at that level. Across all lesion stages, only 
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Treponema phagedenis contributed to more than 0.1% of the population at every stage and 
ranged from 3.8% to 48.8% of the population throughout lesion development. 
 
Figure 4: The percentage (of total Treponema hits) of each Treponema spp. associated OTU 
plotted by stage of lesion. For each of the most abundant OTUs the “best-hit” RDP database 
match for the OTU sequence is provided in order to allow for comparison to other studies. These 
“best-hit” matches are derived from 254-bp sequences aligned to the RDP database in the V3-V4 
region that is known to be highly diverse in Treponema spp. 
 
A principle component analysis (PCoA) plot (50)was constructed using QIIME to 
analyze the beta diversity (42) between lesion stages. A 3-dimensional jackknifed (45) PCoA 
plot (Figure 5) was assembled using Bray-Curtis distances using 100 repetitions, each sampling 
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10,000 sequences, from each sample to analyze the variation from one replicate to the next. The 
chart contains confidence ellipsoids around each sample to visualize the variation between 
sample replicates. The same highly abundant 11 taxon that were plotted in Figure 2B were also 
plotted on the PCoA plot where the coordinates of each taxon is plotted as the weighted average 
of the coordinates of all samples. The size of the ellipsoid around each taxon is proportional to 
the mean relative abundance of the taxon across all samples. This plot groups the individual 
biopsies relatively well based on the Iowa DD scoring system with the control feet grouping high 
on the PC1 and PC2 axes, early stage lesions grouping along the entire PC1 axis and low on the 
PC2 axis, and end stage lesions grouping very low on the PC1 axis and high on the PC2 axis. 
Following treatment, the biopsies revert back towards the high end of the PC1 axis grouping in 
the same area as control feet and early lesions. The main taxa responsible for the shift from the 
high to the low end of the PC2 axis on the PCoA plot were Mycoplasmataceae, 
Campylobacteraceae, Porphyromonadaceae, and Tissierellaceae, whereas the single biggest 
driver of the shift from the high to the low end of the PC1 axis was Spirochaetaceae. The taxa 
most closely associated with normal skin or very early lesion development include 
Ruminococcaceae, Aerococcaceae, Corynebacteriaceae, and Moraxellaceae. In order to test for 
statistical differences between the groups, a nonparametric ANOSIM analysis with 1000 
iterations was performed. This resulted in a p-value of <0.001 indicating statistical differences 
between groups, and an R2 of 0.544 suggesting that roughly 54% of the differences between 
samples could be ascribed to their lesion stage. 
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Figure 5: A 3-dimensional jackknifed (45) replicate PCoA plot of Bray-Curtis distances. 
Jackknifing analysis utilized 100 iterations of 10,000 sequences each. The chart contains 
confidence ellipsoids around each sample to estimate the variation between stage replicates. The 
same highly abundant 11 taxon that were plotted in Figure 1B were also plotted on the PCoA 
plot where the coordinates of each taxon is plotted as the weighted average of the coordinates of 
all samples. The size of the ellipsoid around each taxon is proportional to the mean relative 
abundance of the taxon across all samples. 
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In order to determine the statistically and biologically significant organisms involved in 
the development of DD, the 16S data was analyzed using the web based genome analysis tool 
Galaxy (46, 47), accessible from the Huttenhower lab 
(http://huttenhower.sph.harvard.edu/galaxy/). This analysis first uses a nonparametric factorial 
Kruskal-Wallis sum-rank test (51) to detect significant differential abundance between samples 
at the p<0.05 level. Taxa that met this criterion underwent a linear discriminant analysis (LDA) 
to generate an LDA score to evaluate the effect size of each significant biomarker. This LEfSe 
(LDA effect size) analysis provides an output of all statistical and biologically significant taxa 
with an associated LDA score that is indicative of its relevance. For this data set, 412 taxa passed 
the KW p<0.05 and LDA scores ranged from approximately 2.58 to 5.51. A chart of all of the 
significant taxa and their LDA scores is provided in Appendix A. Figure 6 shows a cladogram of 
the 47 taxa that had an LDA score greater than 4.5. The greengenes database does not provide 
many of the species level designations, therefore all significant OTUs identified at the species 
level have been given a unique species number to represent potentially different species. The 4.5 
level was used as an arbitrary cut-point to represent approximately the top 10% most biologically 
significant taxa. When using lower cut points, the number of significant taxa in stage 0 biopsies 
greatly increased from 4.25% to 67.4% due to the larger diversity (albeit lower individual taxa 
significance) of the normal skin microbiota (alpha diversity shown in Figure 3). The 
morphological subclassifications of A and B were included in this analysis in an attempt to 
identify unique taxa associated with each lesion stage. All of the highly abundant families shown 
in Figure 2B are also represented in the cladogram as being statistically and biologically 
significant. The only highly abundant family that did not have an LDA score greater than 4.5 was 
the Lachnospiraceae family that had an LDA of 4.42. 
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Figure 6: Cladogram of the 47 taxa that had a Kruskal-Wallis p-value <.05 and an LDA score 
greater than 4.5 following analysis by LEfSe. The center of the cladogram represents the Phylum 
bacteria and each sequential ring represents the next taxonomic level down to the species level at 
the outer most ring. All non-significant and taxa with LDA scores <4.5 are represented in yellow, 
whereas significant taxonomic hits with LDA scores >4.5 are colored to match the stage at which 
they were significantly overrepresented. The actual LDA score for each taxa shown on the 
cladogram is shown on the bar charts of the legend. For each significant OTU at the species 
level, a unique species number is shown along with corresponding genus. 
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Based on the LEfSe analysis, there are distinct differences in the bacterial populations 
between A and B lesions. The only significant taxa identified in A1 lesions are Treponema PT2 
and Treponema sp44, while the A2 lesions were associated with Treponema phagedenis as well 
as Campylobacter ureolyticus. In contrast, there were no Treponema species significantly 
identified as biomarkers in B lesions. The significant biomarkers for B lesions were all included 
in the Firmicutes and Actinobacteria phyla. The Corynebacteriaceae and Tissierellaceae family 
were significant for B1 lesions and the Aerococcaceae family was significant for B2 lesions. The 
biomarkers associated with stage 3 and 4 lesions were primarily from the Treponema genera. 
Stage 3 lesions were associated with Treponema denticola, Treponema medium, and Treponema 
PT8, and stage 4 lesions were associated with Treponema pedis. The only other genera 
associated with classic DD lesions was Mycoplasma in stage 3 lesions. Following treatment 
(stage 5), several biomarkers from the Bacteroidia and Gammaproteobacteria classes were 
significantly associated with this stage. 
To compare the datasets between the shotgun and 16S data, a Procrustes analysis was 
performed using the Bray-Curtis distances and 10,000 iterations of a Monte Carlo simulation 
between the 24 samples included in both datasets. The PCoA plots from both datasets have been 
combined in Figure 7 to visualize the individual sample differences. Each biopsy run on both 
platforms is connected with a line between the 16S and shotgun data point. The points are also 
colored to correspond to the lesion stage represented. Monte Carlo simulations (52) resulted in a 
p-value of <0.001, which indicates that regardless of the method used, both pipelines gave very 
similar results as to the microbial community involved in the development of DD. 
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Figure 7: Procrustes analysis performed using the Bray-Curtis distances and 10,000 iterations of 
a Monte Carlo simulation between the 24 samples included in both the shotgun and 16S 
metagenomic datasets. Monte Carlo simulations resulted in a p-value of <0.001. 
 
Histopathology 
One hundred ninety-three biopsies were collected over the timeframe of this project and 
evaluated histologically by a pathologist who was blinded to the gross lesion stage. Biopsies 
were stained with H&E and examined for pathological changes as well as stained with Warthin–
Starry silver staining for evidence of spirochetes. A majority of the biopsies (174/193) were 
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categorized into one of three pathologic descriptions (Grades 1, 2, 3). The remaining 19 biopsies 
were described as having a unique pathologic description and are grouped in the “other” 
category. The grade 1 category encompassed all biopsies identified as normal bovine skin. Grade 
2 lesions were described as hyperkeratotic, acanthotic with surface hemorrhage and erythrocytic 
crusts. This histologic description was found to be more prevalent in the early stages of DD 
development with 48% of the early lesions categorized this way. Grade 3 lesions were described 
as segmental localized necrotizing to necrosuppurative epidermitis with individual cell necrosis, 
ballooning degeneration of epithelial cells, necrotizing vasculitis, intralesional bacteria 
consisting of delicate spirochetes, bacilli, and coccobacilli. This histologic description was of 
increasing prevalence in developing lesions (Figure 8) and the most prevalent in end stage 
lesions (70%). The biopsies taken nine days post treatment primarily fell into the grade 3 
category as well, despite the metagenomic data indicating a large shift in the microbiota at this 
time. A summary of the W/S staining for spirochetes is summarized in Figure 9 whereas a biopsy 
was classified as positive if there was any evidence of spirochetes within or on the surface of the 
skin regardless of the quantity of spirochetes present. Despite the chart plotting presence versus 
abundance (as in the metagenomic plots), the trend towards an increase in spirochetes as lesions 
develop is consistent with the microbiota shift in the metagenomic analysis. 
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Figure 8: Percentage of each stage of lesion classified by histologic score following blinded 
assessment by pathologist. 
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Figure 9: Percentage of Spirochete positive biopsies identified on histopathology for each stage 
of lesion development. Identification was based on silver stain applied to the biopsy and 
evaluated by pathologist as present or absent. 
 
Discussion 
From the results presented here, we conclude that the bacterial communities associated 
with DD biopsies change significantly as the lesions develop and that these bacterial 
communities are closely tied to the morphologic stage of lesion development. Each morphologic 
stage has been statistically validated as containing a unique microbiota different from the prior or 
subsequent lesions stages. This conclusion is based on an extensive evaluation of more than 175 
million sequences, evaluated with two different sequencing pipelines, encompassing 48 biopsies 
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from seven well-defined lesion stages as well as normal skin collected over a three year 
observational period. 
Several key findings include a dramatic increase in Treponema sequences as lesions 
progress, a shift in the Treponema spp. between lesion stages, and a nearly complete absence of 
viral or fungal DNA. There also appears to be specific phylogenic lineages that serve as 
biomarkers for each of the lesion stages. Overall, this data provides strong evidence to support 
the view that DD is a polybacterial disease with significant changes in Treponema spp. type and 
relative abundance as lesions develop through various morphologic stages. 
This evaluation of the temporal changes to the bovine foot metagenome throughout the 
early development of DD using culture-independent methods is the most in depth published to 
date. Several researchers (15, 53) have used 16S-based cloning to evaluate the DD microbiome 
by classic Sanger sequencing, creating at most 1525 clones from nine bovine feet. Klitgaard et al. 
(54) utilized high throughput 16S based 454 sequencing to create 212,827 sequences from 40 
cows, however instead of using universal 16S primers, they utilized a custom Treponema spp. 
specific primer to explore the diversity of this bacterial genus in each biopsy (54). Consequently, 
the relative abundance of the Treponema spp. was not provided in context with the overall 
bacterial community and it is not possible to ascertain if all Treponema spp. were indeed 
detected using the custom primer. In contrast, this study utilized biopsies from 48 different feet 
with seven well-defined stages of development as well as normal control feet. Furthermore, the 
biopsies were derived from cows with known lesion history (monitoring prior to and subsequent 
to sampling) as well as utilization of two separate metagenomic methods for analyzing the entire 
microbiome. The total number of sequences evaluated from these 48 biopsies (156,433,474 and 
20,042,461) also yielded much more depth than any previous study. 
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The results of the two separate sequencing techniques generated microbial communities 
with no significant differences when evaluated using a Procrustes analysis, further verifying the 
validity of the conclusions. The use of shotgun metagenomic methods allowed for verification of 
previous findings (9) that bovine papillomavirus does not play a role in disease, nor is it likely 
that any other DNA based viruses play a role based on the very minimal amount of viral 
sequences identified. The shotgun data also allowed ruled out the potential involvement of any 
fungal pathogens with the very minimal amount of fungal DNA present. 
Through the use of sequencing and histopathology, several key observations can be 
drawn from this project. In both 16S and shotgun sequencing, the amount of Treponema DNA 
isolated from each of the stage of development increased as the lesion score increased. This 
matched the histology results, where the percentage of biopsies that had spirochetes identified 
with W/S staining increased as the lesion scores increased. This population of Treponema spp. 
also appears to have different constituents at each of the various stages of development, which 
may help explain the variability noted in the Treponema spp. visualized from previous 
fluorescent in situ hybridization studies (33, 34, 54). The significance of these changes in 
Treponema spp. type and relative abundance in relation to the possible role of Treponema spp. in 
the etiology of DD remains unclear at the present time and warrants further investigation. It is 
clear that advanced lesions have a high percentage of Treponema spp. in relationship to other 
bacterial species, but it is still unclear if this is strictly an association or a true causation. 
The Iowa DD staging system developed throughout the course of the three years of this 
study was validated by the statistically significant microbiota changes that occurred within each 
of the stages. While there is some overlap of the M scoring system (7), it did not describe all of 
the morphological changes that were observed to take place throughout the course of lesion 
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development. The Iowa DD scoring system was especially better at describing the morphologic 
variability of the early stage lesions. These stages were of particular interest due to the evidence 
that various bacterial complexes can lead to the same end stage disease such as the complexes 
involved in human gingivitis (55-58). It is also felt that the numerical scoring system better 
corresponded to the temporal development of disease and provided an easier method for 
evaluating feet as they progressed from one stage to the next. Although this manuscript is using a 
“stage 5” to represent lesions that had been treated and are regressing, this was done for 
convenience of graphical representation and it should be emphasized that post-treatment, 
morphologically these lesions regress to earlier stages of development (stages 1 and 2) or back to 
normal skin. A manuscript describing the epidemiology of DD development is currently in 
preparation that describes the timeframe in which lesions progress and regress through these 
stages. The results of our ANOSIM calculations in both the shotgun and 16S data verified that 
the microbial communities of each individual stage were statistically different from all other 
stages. Therefore, it is believed that is important to continue to utilize this more detailed scoring 
system when evaluating the progression of DD from normal skin to the diseased state. 
The results of the previous DD 16S sequencing projects by Yano et al. (15) and Santos et 
al. (53) yielded similar results in their evaluation of normal healthy skin in comparison to DD 
lesions. Both papers found Proteobacteria to be abundant in healthy feet and Yano et al. found 
Actinobacteria to be abundant in healthy feet. They also both demonstrated a large increase in 
Treponema spp. in DD lesions as well as some increase in the Tenericutes. \These findings 
match the data sets reported here relatively well. Santos et al. only found Tenericutes at a 
significant level in the deep biopsies while this data shows a peak of Tenericutes in the acute 
(stage 3) lesions suggesting that they may play a role in the transition from early lesions to end 
96 
 
stage lesions. Both of the previous papers revealed a large number of Firmicutes in both healthy 
and diseased feet. In contrast, this data shows Firmicutes at a high level in healthy and early 
stage lesions and much less in end stage lesions, suggesting a non-pathogenic role for this 
bacterial family. While both of these culture-independent papers had similar conclusions, the 
depth at which this study explored lesion development using high throughput sequencing gives a 
closer look at the microbiota changes throughout the entire time-course of disease development. 
The Treponema spp. identified in stage 3 and 4 lesions are very similar to those identified 
by 454 pyrosequecing (54) from classic DD lesions. Klitgaard et al. identified four major 
Treponema clusters from DD lesions, which included T. denticola/T. pedis-like, T. phagedenis-
like, T. refringens-like, and T. medium/T. vincentii-like. The biopsies used in that study were 
from classically described DD lesions, which would include the stage 3 and 4 lesions from the 
Iowa DD scoring system presented herein. The most abundant Treponema OTU sequences 
“closest-matches” from stage 3 and 4 lesions included T. medium, T. pedis, T. denticola, T. 
phagedenis, and T. PT8. Interestingly, of these five species, only T. phagedenis made up more 
than 2% of the Treponema population in early stage lesions. In our analysis, the majority of the 
Treponema population in these early stage lesions were classified as PT1, PT2, PT3, and an 
unclassified Treponema spp. most closely related to T. refringens (RDP score = 0.750). In 
another paper by Klitgaard et al. (26), an abnormal DD presentation (biopsy specimen #40) was 
described as “showing circumscribed, focal, moist plaque with increased thickness of 
epidermis.” The lesion photographed was found to be 100% colonized by Treponema PT3 and 
would be classified as a B1 lesion in the Iowa DD scoring system. The finding that this early 
lesion did not contain any of the Treponema species identified in classic lesions is consistent 
with the results of the current study. This further documents the importance in understanding the 
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progression of the disease and indicates that many of the Treponema spp. identified from the 
chronic “end stage” of disease may not be important at the initial onset of disease. 
The identification of microbiota changes in the early stages of lesion development gives 
new insight into the microbial consortia required to initiate the onset of disease. The idea that 
various species of Treponema are important is not a novel concept (59-61), but the role that each 
of these species play throughout the course of development has been expanded. There is a group 
of Treponema spp. that made up the majority of the Treponema population at the onset of disease 
development, whereas a completely different group of Treponema spp. was prevalent at the end 
stage of the disease process. Although the greengenes database only identified one Treponema 
OTU at the species level (Treponema phagedenis), 47 unique OTUs were identified in the data 
set. Of these 47 OTUs, 11 of them comprise the majority of the Treponema population of these 
lesions. When comparing each of these sequences to the Ribosomal database, many of them have 
been identified as potential causative agents of DD. Klitgaard et al. (26) identified 10 unique 
Treponema isolates using 16S amplification and cloning of Treponema spp. from DD lesions. 
Three of the Treponema spp. that made up a majority of the population of early lesions are 
closely related to PT1, PT2, and PT3. Although this study may not be able to identify the various 
Treponema OTUs to the species level, there is a definite reproducible trend in the groups of 
Treponema spp. identified at the various stages of lesion development. Further work focused on 
identifying these specific Treponema OTUs at the species level is warranted to determine if 
certain Treponema spp. are important in initiation of disease while other later colonizing 
Treponema spp. may simply colonize a niche setup by the early colonizing bacteria. 
Despite the overabundance of Treponema spp. in end stage lesions, there appears to be a 
number of other bacterial families that play a role in this polymicrobial disease process. The “B 
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type” morphological lesions appear to have an association of Corynebacteriaceae and 
Aerococcaceae with the superficial acanthosis and crusting that distinguishes this stage of 
development. The “A type” lesions, which develop within the interdigital fold, appear to be 
colonized by several unique Treponema spp. as well as bacteria from the Campylobacter genera. 
This finding may be due to the unique, potentially microaerophilic, area of the lesions located in 
the interdigital fold. Campylobacter spp. are known to grow best in vitro at an oxygen content of 
5% (62, 63) and Treponema phagedenis has been found to grow at best in the author’s laboratory 
at approximately 2% oxygen (A. Krull and P. Plummer, unpublished data). While these bacteria 
may not be the cause of DD, they certainly could play a role in deteriorating skin integrity and 
setting up an ideal environment for more pathogenic bacteria to thrive. While stage 3 and 4 
lesions are obviously dominated by Treponema spp., it appears that Mycoplasma spp. may be of 
potential importance in the transition from an early lesion to an active lesion as well. 
Although a number of papers have suggested that Bacteroides spp. and Porphyromonas 
spp. play a role in the polymicrobial nature of the disease, this data would suggest that they may 
be opportunistic bacteria colonizing bovine feet in the absence of other bacteria as they are seen 
becoming statistically significant nine days post treatment. Another genus that has been proposed 
as potentially contributing to the disease process is Dichelobacter (29, 33, 34). Despite not being 
statistically significant in any particular stage of development, Dichelobacter did contribute to 
1.73% of the bacteria in stage 1 and 2 lesions, but less than 0.15% in all other lesion stages. This 
lack of statistical significance to any particular stage is most likely due to its presence in all four 
of the early lesion stages and further investigation into Dichelobacter’s role in the initiation of 
disease is warranted. It is also important to realize that the lower relative abundance of this 
organism does not preclude a critical role for it in the development of DD (64-68). 
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Regardless of the particular species identified in both the 16S and shotgun data, there is 
clear evidence that the bacterial diversity of the sample decreases as the lesions progress. The 
largest diversity of species was identified in control feet and post-treatment lesions, followed by 
early stage lesions, and finally the lowest number of species was identified in end stage lesions. 
Although on a different scale, the alpha rarefaction plot published by Santos et al. (53) showed a 
similar outcome with a much more diverse population in the healthy control feet than that 
observed in DD lesions. Due to only sequencing 700 clones, the alpha rarefaction plots from the 
Santos et al. paper have not come close to the asymptote. In this study, the alpha rarefaction 
curves are very close to plateauing, indicating that additional sequencing would not reveal many 
more species. 
While two deep sequencing approaches were used, the shotgun method had the advantage 
of giving insight into the relative abundance of bacteria, viruses, fungi in comparison the 
eukaryotic host DNA. This method led to the conclusion that there is relatively small percentage 
of bacteria associated with control feet, compared to upwards of 97% of the sequenced DNA 
associated with stage 3 and 4 lesions being bacterial DNA. It also verified that there was very 
little viral or fungal DNA present at any stage of lesion development. The limitation of this 
method was that with the relatively short reads of DNA from the entire genome of a wide range 
of bacterial species, there may have been a bias to identify more reads to those bacteria that have 
had their entire genome sequenced. Therefore, it was felt that this data was better utilized to 
analyze from a family level and to not analyze OTU calls at the genus and species level to 
attempt to mitigate this bias. Despite the fact that there were a high number of reads that did not 
match any known sequence, high throughput sequencing did provide a significant amount of 
usable data. The use of 16S rRNA gene-based sequencing on the MiSeq platform enabled the use 
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of overlapping 300-bp sequences to more confidently identify bacteria down to the genus and 
species level since the V3-V4 region is well-established for bacterial taxonomic classification 
(38, 69-71). 
From these results, we conclude that the DD disease process is polybacterial in nature 
with no significant viral or fungal component. In addition, DD manifests itself through consistent 
and predictable changes in the bacterial microbiota of the bovine foot as lesions systematically 
progress through multiple distinct stages. The identification of the early stage lesions and the 
phylogenic biomarkers associated with each lesion stage will be instrumental in identifying the 
essential microbial consortia required to initiate the onset of disease. Further work towards 
identifying the role each of these bacteria play in the progression of disease is needed in order to 
create novel prevention strategies targeted towards specific pathogens. 
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Appendix A: Statistically Significant OTUs from LEfSe Analysis 
Taxa: Stage: LDA 
Score: 
KW p 
value: 
Bacteria.Spirochaetes.Spirochaetes 4 5.51 0.0000 
Bacteria.Spirochaetes 4 5.51 0.0000 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae 4 5.51 0.0000 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema 
4 5.51 0.0000 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales 4 5.51 0.0000 
Bacteria.Firmicutes B2 5.27 0.0050 
Bacteria.Bacteroidetes 5 5.15 0.0183 
Bacteria.Bacteroidetes.Bacteroidia 5 5.14 0.0322 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales 5 5.10 0.0322 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5611 
A1 5.05 0.0008 
Bacteria.Firmicutes.Bacilli B2 5.04 0.0001 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.phagedenis 
A2 5.03 0.0001 
Bacteria.Firmicutes.Bacilli.Lactobacillales B2 5.02 0.0002 
Bacteria.Actinobacteria B1 5.02 0.0001 
Bacteria.Actinobacteria.Actinobacteria B1 5.02 0.0001 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales B1 5.01 0.0001 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae B2 5.01 0.0002 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae B1 5.00 0.0077 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium 
B1 4.99 0.0002 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae 
B1 4.98 0.0002 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5703 
4 4.91 0.0004 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5720 
3 4.91 0.0001 
Bacteria.Proteobacteria 0 4.90 0.0056 
Bacteria.Tenericutes.Mollicutes.Mycoplasmatales.Mycoplasmatace
ae.Mycoplasma 
3 4.90 0.0137 
Bacteria.Tenericutes.Mollicutes.Mycoplasmatales.Mycoplasmatace
ae 
3 4.90 0.0145 
Bacteria.Tenericutes.Mollicutes.Mycoplasmatales 3 4.90 0.0145 
Bacteria.Tenericutes 3 4.89 0.0226 
Bacteria.Tenericutes.Mollicutes 3 4.89 0.0223 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac 5 4.89 0.0134 
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eae 
Bacteria.Proteobacteria.Gammaproteobacteria 5 4.89 0.0003 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas 
5 4.88 0.0087 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas.species5031 
5 4.87 0.0248 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.M
oraxellaceae 
5 4.83 0.0002 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales 5 4.83 0.0001 
Bacteria.Tenericutes.Mollicutes.Mycoplasmatales.Mycoplasmatace
ae.Mycoplasma.species4792 
3 4.81 0.0004 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5723 
3 4.78 0.0001 
Bacteria.Proteobacteria.Epsilonproteobacteria.Campylobacterales.C
ampylobacteraceae.Campylobacter 
A2 4.78 0.0059 
Bacteria.Proteobacteria.Epsilonproteobacteria.Campylobacterales.C
ampylobacteraceae 
A2 4.76 0.0083 
Bacteria.Proteobacteria.Epsilonproteobacteria.Campylobacterales A2 4.76 0.0083 
Bacteria.Proteobacteria.Epsilonproteobacteria A2 4.75 0.0083 
Bacteria.Proteobacteria.Epsilonproteobacteria.Campylobacterales.C
ampylobacteraceae.Campylobacter.ureolyticus 
A2 4.74 0.0001 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae 0 4.73 0.0013 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5612 
A1 4.72 0.0065 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Bacteroidaceae 5 4.71 0.0020 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Bacteroidaceae.Ba
cteroides 
5 4.70 0.0048 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia 
B1 4.68 0.0002 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5690 
3 4.58 0.0000 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.M
oraxellaceae.Acinetobacter 
0 4.48 0.0002 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.GW_34 B1 4.46 0.0012 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Alloioco
ccus 
B1 4.44 0.0003 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Alloioco
ccus.species3599 
B1 4.44 0.0003 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae 0 4.42 0.0379 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus10
87 
B2 4.34 0.0009 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus10
87.species1087 
B2 4.34 0.0009 
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Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.pilosum 
B1 4.34 0.0012 
Bacteria.Firmicutes.Bacilli.Bacillales 0 4.34 0.0001 
Bacteria 4 4.34 0.0002 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5719 
A2 4.33 0.0027 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4440 
B1 4.31 0.0006 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas.species5035 
A1 4.31 0.0128 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Peptoni
philus 
B2 4.30 0.0027 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1836.species1836 
4 4.29 0.0002 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1836 
4 4.29 0.0002 
Bacteria.Tenericutes.Mollicutes.Mycoplasmatales.Mycoplasmatace
ae.Mycoplasma.species4785 
A2 4.27 0.0003 
Bacteria.Fusobacteria.Fusobacteriia.Fusobacteriales.Fusobacteriace
ae.Fusobacterium.species4475 
5 4.26 0.0208 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.GW_34.
species4518 
B1 4.25 0.0024 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4197 
B1 4.25 0.0033 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Aerococ
cus 
5 4.25 0.0004 
Bacteria.Fusobacteria.Fusobacteriia.Fusobacteriales.Fusobacteriace
ae.Fusobacterium 
5 4.24 0.0043 
Bacteria.Proteobacteria.Betaproteobacteria 0 4.24 0.0002 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Anaeroc
occus 
B1 4.24 0.0041 
Bacteria.Fusobacteria.Fusobacteriia.Fusobacteriales.Fusobacteriace
ae 
5 4.24 0.0043 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Aerococ
cus.species3552 
5 4.22 0.0004 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4200 
0 4.22 0.0001 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.1_68.sp
ecies3419 
B2 4.21 0.0037 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.1_68 B2 4.21 0.0037 
Bacteria.Firmicutes.Bacilli.Bacillales.Staphylococcaceae 0 4.20 0.0000 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.M
oraxellaceae.Acinetobacter.species3478 
5 4.19 0.0237 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Anaeroc B1 4.18 0.0046 
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occus.species3620 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Helcoco
ccus 
5 4.17 0.0019 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5699 
4 4.17 0.0000 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas.species5037 
A1 4.15 0.0117 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales 0 4.14 0.0001 
Bacteria.Proteobacteria.Gammaproteobacteria.Enterobacteriales.En
terobacteriaceae 
5 4.14 0.0001 
Bacteria.Proteobacteria.Gammaproteobacteria.Enterobacteriales 5 4.14 0.0001 
Bacteria.Firmicutes.Bacilli.Bacillales.Staphylococcaceae.Jeotgalico
ccus 
0 4.12 0.0000 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.M
oraxellaceae.Acinetobacter.species3509 
0 4.11 0.0006 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae 0 4.10 0.0001 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Gallicol
a 
B1 4.09 0.0018 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Butyri
vibrio 
0 4.09 0.0002 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4168 
5 4.09 0.0015 
Bacteria.Tenericutes.Mollicutes.Mycoplasmatales.Mycoplasmatace
ae.Mycoplasma.species4779 
4 4.07 0.0001 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Gallicol
a.species4484 
B1 4.07 0.0048 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Rum
inococcus 
0 4.06 0.0002 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.Ps
eudomonadaceae 
0 4.06 0.0007 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Anae
rovorax 
4 4.05 0.0000 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Anae
rovorax.species3651 
4 4.05 0.0000 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family295.Genus295 4 4.04 0.0013 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family295.Genus295.s
pecies295 
4 4.04 0.0013 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family295 4 4.04 0.0013 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5697 
B2 4.02 0.0107 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.GW_34.
species4517 
B1 4.00 0.0011 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae 4 4.00 0.0069 
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Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4163 
0 3.98 0.0049 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.Ps
eudomonadaceae.Pseudomonas 
0 3.98 0.0009 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4433 
B1 3.97 0.0003 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
319 
A2 3.97 0.0024 
Bacteria.Firmicutes.Clostridia.Clostridiales.Peptostreptococcaceae.
Genus2318.species2318 
A2 3.96 0.0418 
Bacteria.Firmicutes.Clostridia.Clostridiales.Peptostreptococcaceae.
Genus2318 
A2 3.96 0.0418 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
319.species3319 
A2 3.95 0.0024 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas.species5032 
A1 3.94 0.0018 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4423 
B2 3.93 0.0012 
Bacteria.Firmicutes.Bacilli.Bacillales.Staphylococcaceae.Jeotgalico
ccus.species4589 
5 3.93 0.0006 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Rum
inococcus.species5322 
0 3.89 0.0002 
Bacteria.Proteobacteria.Alphaproteobacteria 0 3.89 0.0003 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas.species5039 
B1 3.87 0.0059 
Bacteria.Firmicutes.Clostridia.Clostridiales.Veillonellaceae.Anaero
vibrio.species3646 
3 3.86 0.0000 
Bacteria.Firmicutes.Clostridia.Clostridiales.Veillonellaceae.Anaero
vibrio 
3 3.86 0.0000 
Bacteria.Bacteroidetes.Flavobacteriia.Flavobacteriales 0 3.85 0.0003 
Bacteria.Bacteroidetes.Flavobacteriia 0 3.85 0.0003 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Comam
onadaceae 
0 3.85 0.0008 
Bacteria.Spirochaetes.Spirochaetes.Spirochaetales.Spirochaetaceae.
Treponema.species5711 
0 3.84 0.0042 
Bacteria.Firmicutes.Clostridia.Clostridiales.Veillonellaceae 3 3.83 0.0087 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
337 
B1 3.80 0.0087 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
337.species3337 
B1 3.80 0.0087 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.stationis 
5 3.78 0.0000 
Bacteria.Actinobacteria.Actinobacteria.Bifidobacteriales.Bifidobact
eriaceae.Bifidobacterium.species3769 
0 3.76 0.0021 
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Archaea 0 3.75 0.0002 
Archaea.Euryarchaeota 0 3.75 0.0002 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4443 
B1 3.75 0.0022 
Archaea.Euryarchaeota.Methanobacteria 0 3.74 0.0002 
Archaea.Euryarchaeota.Methanobacteria.Methanobacteriales 0 3.74 0.0002 
Archaea.Euryarchaeota.Methanobacteria.Methanobacteriales.Metha
nobacteriaceae 
0 3.74 0.0002 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4190 
B1 3.74 0.0144 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Bacteroidaceae.5_
7N15 
0 3.74 0.0015 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2577 
0 3.73 0.0001 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2577.species2577 
0 3.73 0.0001 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Actinomyc
etaceae 
B1 3.72 0.0218 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Alcalig
enaceae 
0 3.72 0.0010 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas.species5040 
A2 3.72 0.0020 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Peptoni
philus.species4960 
B1 3.71 0.0009 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
14.species1314 
0 3.71 0.0010 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
14 
0 3.71 0.0010 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.Ps
eudomonadaceae.Pseudomonas.species5143 
0 3.71 0.0008 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Peptoni
philus.species4959 
B2 3.71 0.0059 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Peptoni
philus.species4956 
B1 3.70 0.0473 
Bacteria.Proteobacteria.Epsilonproteobacteria.Campylobacterales.C
ampylobacteraceae.Campylobacter.species3877 
B1 3.70 0.0195 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
03.species1303 
0 3.70 0.0116 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Actinomyc
etaceae.Trueperella 
5 3.70 0.0256 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Porphyromonadac
eae.Porphyromonas.species5033 
B2 3.70 0.0429 
Bacteria.Proteobacteria.Gammaproteobacteria.Xanthomonadales 0 3.69 0.0120 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Enterococcaceae 5 3.68 0.0380 
112 
 
Archaea.Euryarchaeota.Methanobacteria.Methanobacteriales.Metha
nobacteriaceae.Methanobrevibacter 
0 3.68 0.0004 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
03 
0 3.68 0.0116 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Anaeroc
occus.species3615 
A2 3.67 0.0196 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Butyri
vibrio.species3858 
0 3.67 0.0001 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4191 
0 3.65 0.0002 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2770.species2770 
0 3.65 0.0025 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2770 
0 3.65 0.0025 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Alcalig
enaceae.Oligella 
0 3.65 0.0295 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2670.species2670 
0 3.64 0.0002 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2670 
0 3.63 0.0002 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Comam
onadaceae.Genus1412 
0 3.63 0.0021 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Comam
onadaceae.Genus1412.species1412 
0 3.63 0.0021 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus11
10 
B2 3.63 0.0206 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus11
10.species1110 
B2 3.63 0.0206 
Bacteria.Bacteroidetes.Flavobacteriia.Flavobacteriales.Weeksellace
ae 
0 3.62 0.0008 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
342.species3342 
B1 3.61 0.0004 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
342 
B1 3.61 0.0004 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Mogi
bacterium 
0 3.61 0.0002 
Bacteria.Firmicutes.Bacilli.Turicibacterales 0 3.60 0.0016 
Bacteria.Firmicutes.Bacilli.Turicibacterales.Turicibacteraceae.Turic
ibacter 
0 3.60 0.0016 
Bacteria.Firmicutes.Bacilli.Turicibacterales.Turicibacteraceae 0 3.60 0.0016 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Streptococcaceae.Strept
ococcus 
5 3.60 0.0074 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4208 
B1 3.59 0.0028 
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Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4424 
B1 3.59 0.0019 
Bacteria.Proteobacteria.Gammaproteobacteria.Aeromonadales.Succ
inivibrionaceae 
0 3.58 0.0038 
Bacteria.Proteobacteria.Gammaproteobacteria.Aeromonadales 0 3.58 0.0031 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Enterococcaceae.Entero
coccus 
5 3.58 0.0450 
Bacteria.Firmicutes.Bacilli.Bacillales.Bacillaceae 0 3.58 0.0003 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus10
86 
5 3.58 0.0165 
Bacteria.Actinobacteria.Actinobacteria.Bifidobacteriales.Bifidobact
eriaceae 
0 3.56 0.0006 
Bacteria.Actinobacteria.Actinobacteria.Bifidobacteriales 0 3.56 0.0006 
Bacteria.Actinobacteria.Actinobacteria.Bifidobacteriales.Bifidobact
eriaceae.Bifidobacterium 
0 3.55 0.0007 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Streptococcaceae 5 3.54 0.0006 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus10
86.species1086 
5 3.54 0.0165 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4426 
B1 3.54 0.0003 
Bacteria.Firmicutes.Bacilli.Turicibacterales.Turicibacteraceae.Turic
ibacter.species5627 
0 3.53 0.0017 
Bacteria.Firmicutes.Bacilli.Bacillales.Bacillaceae.Bacillus 0 3.52 0.0005 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Carnobacteriaceae 0 3.52 0.0015 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Clostridi
um 
0 3.52 0.0018 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Copro
coccus 
0 3.51 0.0006 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s3196.species3196 
0 3.51 0.0003 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s3196 
0 3.51 0.0003 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Alcalig
enaceae.Oligella.species4836 
5 3.50 0.0415 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.Ps
eudomonadaceae.Pseudomonas.species5130 
0 3.50 0.0331 
Bacteria.Proteobacteria.Gammaproteobacteria.Aeromonadales.Succ
inivibrionaceae.Ruminobacter 
0 3.49 0.0101 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Micrococc
aceae 
0 3.49 0.0001 
Bacteria.Proteobacteria.Gammaproteobacteria.Pseudomonadales.M
oraxellaceae.Acinetobacter.species3521 
0 3.49 0.0007 
Bacteria.Bacteroidetes.Flavobacteriia.Flavobacteriales.Flavobacteri
aceae 
0 3.48 0.0047 
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Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Helcoco
ccus.species4556 
5 3.48 0.0059 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
331 
A1 3.47 0.0140 
Bacteria.Verrucomicrobia 0 3.47 0.0010 
Bacteria.Firmicutes.Bacilli.Bacillales.Bacillaceae.Bacillus.species3
689 
0 3.47 0.0071 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Genus3
331.species3331 
A1 3.47 0.0140 
Bacteria.Proteobacteria.Gammaproteobacteria.Enterobacteriales.En
terobacteriaceae.Erwinia 
0 3.46 0.0002 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Carnobacteriaceae.Trich
ococcus 
0 3.46 0.0031 
Archaea.Euryarchaeota.Methanobacteria.Methanobacteriales.Metha
nobacteriaceae.Methanobrevibacter.species4717 
0 3.46 0.0007 
Bacteria.Proteobacteria.Betaproteobacteria.Rhodocyclales.Rhodocy
claceae 
0 3.46 0.0018 
Bacteria.Proteobacteria.Betaproteobacteria.Rhodocyclales 0 3.46 0.0018 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4441 
B2 3.46 0.0064 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Carnobacteriaceae.Trich
ococcus.species5616 
0 3.45 0.0150 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4422 
A1 3.45 0.0209 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Helcoco
ccus.species4559 
B1 3.42 0.0317 
Bacteria.Proteobacteria.Gammaproteobacteria.Xanthomonadales.Si
nobacteraceae.Hydrocarboniphaga 
0 3.39 0.0080 
Bacteria.Proteobacteria.Gammaproteobacteria.Xanthomonadales.Si
nobacteraceae.Hydrocarboniphaga.effusa 
0 3.39 0.0080 
Bacteria.Proteobacteria.Gammaproteobacteria.Xanthomonadales.Si
nobacteraceae 
0 3.39 0.0098 
Bacteria.Verrucomicrobia.Verrucomicrobiae.Verrucomicrobiales 0 3.39 0.0014 
Bacteria.Verrucomicrobia.Verrucomicrobiae 0 3.39 0.0014 
Bacteria.Verrucomicrobia.Verrucomicrobiae.Verrucomicrobiales.V
errucomicrobiaceae 
0 3.39 0.0014 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Bacteroidaceae.5_
7N15.species3436 
0 3.39 0.0103 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Butyri
vibrio.species3844 
0 3.39 0.0005 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Peptoni
philus.species4973 
A1 3.37 0.0291 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Dorea 0 3.37 0.0003 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Clostridi A1 3.37 0.0204 
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um.species3989 
Bacteria.Actinobacteria.Actinobacteria.Bifidobacteriales.Bifidobact
eriaceae.Bifidobacterium.pseudolongum 
0 3.36 0.0013 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus11
17 
B2 3.36 0.0204 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus11
17.species1117 
B2 3.36 0.0204 
Bacteria.Firmicutes.Clostridia.Clostridiales.Christensenellaceae 0 3.36 0.0333 
Bacteria.Proteobacteria.Gammaproteobacteria.Enterobacteriales.En
terobacteriaceae.Erwinia.species4396 
0 3.35 0.0013 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Helcoco
ccus.species4560 
0 3.35 0.0057 
Bacteria.Proteobacteria.Alphaproteobacteria.Sphingomonadales 0 3.34 0.0022 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Dorea.
species4321 
0 3.34 0.0057 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Paraprevotellacea
e 
0 3.34 0.0009 
Bacteria.Bacteroidetes.Flavobacteriia.Flavobacteriales.Weeksellace
ae.Cloacibacterium 
0 3.33 0.0046 
Bacteria.Bacteroidetes.Flavobacteriia.Flavobacteriales.Weeksellace
ae.Cloacibacterium.species3929 
0 3.33 0.0046 
Bacteria.Tenericutes.Mollicutes.RF39 0 3.32 0.0001 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Helcoco
ccus.species4553 
A2 3.32 0.0162 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Oxalob
acteraceae 
0 3.31 0.0007 
Bacteria.Proteobacteria.Alphaproteobacteria.Sphingomonadales.Sp
hingomonadaceae 
0 3.31 0.0015 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Butyri
vibrio.species3843 
0 3.31 0.0006 
Archaea.Euryarchaeota.Methanobacteria.Methanobacteriales.Metha
nobacteriaceae.Methanobrevibacter.species4714 
0 3.31 0.0003 
Bacteria.Proteobacteria.Alphaproteobacteria.Sphingomonadales.Sp
hingomonadaceae.Sphingobium 
0 3.28 0.0241 
Bacteria.Firmicutes.Bacilli.Bacillales.Planococcaceae.Solibacillus A1 3.28 0.0298 
Bacteria.Proteobacteria.Betaproteobacteria.Rhodocyclales.Rhodocy
claceae.Genus2523.species2523 
0 3.27 0.0035 
Bacteria.Proteobacteria.Betaproteobacteria.Rhodocyclales.Rhodocy
claceae.Genus2523 
0 3.27 0.0035 
Bacteria.Firmicutes.Clostridia.Clostridiales.Peptostreptococcaceae.
Genus2308 
0 3.27 0.0014 
Bacteria.Firmicutes.Clostridia.Clostridiales.Peptostreptococcaceae.
Genus2308.species2308 
0 3.26 0.0014 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac 5 3.26 0.0015 
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teriaceae.Corynebacterium.species4199 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1810 
0 3.26 0.0250 
Bacteria.Proteobacteria.Alphaproteobacteria.Rhizobiales 0 3.25 0.0112 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.GW_34.
species4514 
B1 3.25 0.0069 
Bacteria.Cyanobacteria 0 3.24 0.0006 
Bacteria.Bacteroidetes.Saprospirae.Saprospirales.Chitinophagaceae 0 3.24 0.0244 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Enterococcaceae.Entero
coccus.species4349 
0 3.24 0.0373 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1810.species1810 
0 3.24 0.0250 
Bacteria.Bacteroidetes.Saprospirae.Saprospirales 0 3.24 0.0181 
Bacteria.Bacteroidetes.Saprospirae 0 3.24 0.0181 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4136 
0 3.23 0.0019 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
70 
0 3.22 0.0070 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
70.species1370 
0 3.22 0.0070 
Bacteria.Bacteroidetes.Flavobacteriia.Flavobacteriales.Weeksellace
ae.Elizabethkingia.meningoseptica 
0 3.22 0.0090 
Bacteria.Bacteroidetes.Flavobacteriia.Flavobacteriales.Weeksellace
ae.Elizabethkingia 
0 3.22 0.0090 
Bacteria.Firmicutes.Bacilli.Bacillales.Staphylococcaceae.Staphyloc
occus 
0 3.22 0.0008 
Bacteria.Proteobacteria.Alphaproteobacteria.Rhodospirillales 0 3.22 0.0353 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2733.species2733 
0 3.21 0.0004 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2733 
0 3.21 0.0004 
Bacteria.Firmicutes.Clostridia.Clostridiales.Peptococcaceae 5 3.20 0.0097 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2814 
0 3.20 0.0002 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4429 
A2 3.20 0.0087 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2814.species2814 
0 3.20 0.0002 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Mogi
bacterium.species4755 
0 3.20 0.0006 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Oscil
lospira 
0 3.19 0.0005 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam B1 3.19 0.0007 
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ia.species4425 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4147 
0 3.19 0.0001 
Bacteria.Firmicutes.Clostridia.Clostridiales.Veillonellaceae.Phascol
arctobacterium 
0 3.18 0.0067 
Bacteria.Firmicutes.Clostridia.Clostridiales.Veillonellaceae.Phascol
arctobacterium.species4986 
0 3.17 0.0114 
Bacteria.Bacteroidetes.Sphingobacteriia 0 3.16 0.0031 
Bacteria.Bacteroidetes.Sphingobacteriia.Sphingobacteriales.Sphing
obacteriaceae 
0 3.16 0.0031 
Bacteria.Bacteroidetes.Sphingobacteriia.Sphingobacteriales 0 3.16 0.0031 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Dietziacea
e 
0 3.15 0.0007 
Bacteria.Firmicutes.Clostridia.Clostridiales.Peptostreptococcaceae.
Genus2324.species2324 
0 3.15 0.0264 
Bacteria.Firmicutes.Clostridia.Clostridiales.Peptostreptococcaceae.
Genus2324 
0 3.15 0.0264 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Dietziacea
e.Dietzia 
0 3.15 0.0006 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Bacteroidaceae.5_
7N15.species3426 
0 3.13 0.0079 
Bacteria.Cyanobacteria.4C0d_2 0 3.13 0.0004 
Bacteria.Proteobacteria.Betaproteobacteria.Rhodocyclales.Rhodocy
claceae.Zoogloea 
0 3.12 0.0016 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Comam
onadaceae.Comamonas 
0 3.12 0.0015 
Bacteria.Actinobacteria.Coriobacteriia 0 3.12 0.0005 
Bacteria.Actinobacteria.Coriobacteriia.Coriobacteriales 0 3.12 0.0005 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Butyri
vibrio.species3838 
0 3.12 0.0030 
Bacteria.Actinobacteria.Coriobacteriia.Coriobacteriales.Coriobacter
iaceae 
0 3.12 0.0005 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Rikenellaceae 0 3.10 0.0020 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Actinomyc
etaceae.Genus1082.species1082 
B1 3.10 0.0287 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Butyri
vibrio.species3856 
0 3.10 0.0010 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Actinomyc
etaceae.Genus1082 
B1 3.10 0.0287 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Comam
onadaceae.Alicycliphilus.species3591 
0 3.09 0.0038 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Actinomyc
etaceae.Trueperella.species5624 
B1 3.09 0.0446 
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Bacteria.Proteobacteria.Alphaproteobacteria.Rhodospirillales.Rhod
ospirillaceae 
0 3.09 0.0217 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Paraprevotellacea
e.CF231 
0 3.09 0.0023 
Bacteria.Proteobacteria.Betaproteobacteria.Burkholderiales.Comam
onadaceae.Alicycliphilus 
0 3.09 0.0033 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Anaeroc
occus.species3619 
B2 3.08 0.0133 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Paraprevotellacea
e.YRC22 
0 3.08 0.0172 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Paraprevotellacea
e.YRC22.species5677 
0 3.08 0.0172 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Mogi
bacterium.species4744 
0 3.07 0.0204 
Bacteria.Proteobacteria.Betaproteobacteria.Rhodocyclales.Rhodocy
claceae.Zoogloea.species5681 
0 3.06 0.0108 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.ph2.spe
cies4983 
B1 3.06 0.0202 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4155 
0 3.06 0.0312 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1774.species1774 
0 3.05 0.0028 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Dorea.
species4310 
0 3.05 0.0173 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1774 
0 3.05 0.0028 
Bacteria.Proteobacteria.Alphaproteobacteria.Rhodospirillales.Rhod
ospirillaceae.Genus2536.species2536 
0 3.05 0.0171 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family248.Genus248 0 3.05 0.0003 
Bacteria.Proteobacteria.Alphaproteobacteria.Rhodospirillales.Rhod
ospirillaceae.Genus2536 
0 3.05 0.0171 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.RF16 0 3.05 0.0008 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family555.Genus555 0 3.04 0.0188 
Bacteria.Firmicutes.Erysipelotrichi.Erysipelotrichales 0 3.04 0.0046 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Helcoco
ccus.species4561 
B2 3.04 0.0037 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family555 0 3.04 0.0188 
Bacteria.Firmicutes.Erysipelotrichi 0 3.04 0.0046 
Bacteria.Firmicutes.Erysipelotrichi.Erysipelotrichales.Erysipelotric
haceae 
0 3.04 0.0046 
Bacteria.Verrucomicrobia.Verrucomicrobiae.Verrucomicrobiales.V
errucomicrobiaceae.Akkermansia 
0 3.04 0.0100 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family555.Genus555.s
pecies555 
0 3.03 0.0188 
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Bacteria.Cyanobacteria.4C0d_2.YS2 0 3.02 0.0004 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family248 0 3.02 0.0003 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2896.species2896 
0 3.02 0.0115 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family248.Genus248.s
pecies248 
0 3.02 0.0003 
Archaea.Euryarchaeota.Methanobacteria.Methanobacteriales.Metha
nobacteriaceae.Methanosphaera 
0 3.02 0.0183 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2896 
0 3.02 0.0115 
Archaea.Euryarchaeota.Methanobacteria.Methanobacteriales.Metha
nobacteriaceae.Methanosphaera.species4720 
0 3.01 0.0134 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
55.species1355 
0 3.01 0.0008 
Bacteria.Firmicutes.Clostridia.Clostridiales.Clostridiaceae.Genus13
55 
0 3.01 0.0008 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family304.Genus304.s
pecies304 
0 3.00 0.0182 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family304 0 3.00 0.0182 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family304.Genus304 0 3.00 0.0182 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2900.species2900 
0 2.99 0.0045 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2900 
0 2.99 0.0045 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4418 
B1 2.99 0.0058 
Bacteria.Firmicutes.Erysipelotrichi.Erysipelotrichales.Erysipelotric
haceae.Erysipelothrix 
5 2.98 0.0194 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4430 
0 2.98 0.0060 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family702.Genus702.s
pecies702 
0 2.98 0.0297 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family702.Genus702 0 2.98 0.0297 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family702 0 2.98 0.0297 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family619 0 2.98 0.0013 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family619.Genus619 0 2.98 0.0013 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family619.Genus619.s
pecies619 
0 2.98 0.0013 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Copro
coccus.species4080 
0 2.97 0.0109 
Bacteria.Proteobacteria.Alphaproteobacteria.Rhodobacterales.Rhod
obacteraceae 
0 2.97 0.0024 
Bacteria.Proteobacteria.Gammaproteobacteria.Xanthomonadales.X 0 2.97 0.0103 
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anthomonadaceae.Stenotrophomonas 
Bacteria.Proteobacteria.Alphaproteobacteria.Rhodobacterales 0 2.97 0.0024 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1753.species1753 
0 2.96 0.0041 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s3094 
0 2.96 0.0284 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Anaeroc
occus.species3613 
B1 2.95 0.0163 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s3094.species3094 
0 2.95 0.0284 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Facklam
ia.species4439 
0 2.95 0.0077 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family639.Genus639 0 2.95 0.0025 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1753 
0 2.95 0.0041 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family639 0 2.94 0.0025 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family639.Genus639.s
pecies639 
0 2.94 0.0025 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Blauti
a 
0 2.93 0.0006 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.RF16.Genus2471.
species2471 
0 2.93 0.0022 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.S24_7 0 2.91 0.0275 
Bacteria.Proteobacteria.Betaproteobacteria.Methylophilales 0 2.90 0.0053 
Bacteria.Proteobacteria.Betaproteobacteria.Methylophilales.Methyl
ophilaceae 
0 2.90 0.0053 
Bacteria.Firmicutes.Bacilli.Turicibacterales.Turicibacteraceae.Turic
ibacter.species5626 
0 2.90 0.0347 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Bacteroidaceae.Ba
cteroides.species3745 
B2 2.90 0.0113 
Bacteria.Actinobacteria.Actinobacteria.Bifidobacteriales.Bifidobact
eriaceae.Bifidobacterium.species3772 
0 2.90 0.0026 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Helcoco
ccus.species4554 
A2 2.90 0.0120 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.RF16.Genus2471 0 2.90 0.0022 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Micrococc
aceae.Arthrobacter 
0 2.89 0.0296 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family751 0 2.88 0.0056 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family751.Genus751.s
pecies751 
0 2.88 0.0056 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family751.Genus751 0 2.88 0.0056 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family484.Genus484 0 2.88 0.0028 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family484.Genus484.s 0 2.88 0.0028 
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pecies484 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family484 0 2.88 0.0028 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Mogi
bacterium.species4756 
0 2.87 0.0484 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Dermabact
eraceae.Brachybacterium 
0 2.87 0.0364 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Dermabact
eraceae 
0 2.86 0.0364 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family263.Genus263 B2 2.86 0.0071 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2940 
0 2.86 0.0176 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Peptoni
philus.species4969 
B1 2.86 0.0256 
Bacteria.Firmicutes.Clostridia.Clostridiales.Tissierellaceae.Anaeroc
occus.species3614 
A2 2.85 0.0115 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2940.species2940 
0 2.84 0.0176 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2832 
0 2.84 0.0005 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2832.species2832 
0 2.84 0.0005 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus11
06.species1106 
B1 2.84 0.0101 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1995.species1995 
0 2.83 0.0107 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Bacteroidaceae.5_
7N15.species3430 
0 2.83 0.0414 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1995 
0 2.83 0.0107 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family263 B2 2.83 0.0071 
Bacteria.Firmicutes.Bacilli.Lactobacillales.Aerococcaceae.Genus11
06 
B1 2.83 0.0101 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family263.Genus263.s
pecies263 
B2 2.83 0.0071 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Dorea.
species4324 
0 2.82 0.0277 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1944.species1944 
0 2.80 0.0448 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Genus
1944 
0 2.80 0.0448 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Corynebac
teriaceae.Corynebacterium.species4176 
0 2.80 0.0024 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family590.Genus590.s
pecies590 
0 2.80 0.0190 
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Bacteria.Firmicutes.Clostridia.Clostridiales.Family590 0 2.79 0.0190 
Bacteria.Firmicutes.Clostridia.Clostridiales.Family590.Genus590 0 2.79 0.0190 
Bacteria.Proteobacteria.Gammaproteobacteria.Enterobacteriales.En
terobacteriaceae.Genus1604.species1604 
0 2.79 0.0073 
Bacteria.Proteobacteria.Gammaproteobacteria.Enterobacteriales.En
terobacteriaceae.Genus1604 
0 2.79 0.0073 
Bacteria.Actinobacteria.Actinobacteria.Actinomycetales.Dermabact
eraceae.Brachybacterium.species3807 
0 2.78 0.0368 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Paraprevotellacea
e.Prevotella 
0 2.78 0.0096 
Bacteria.Proteobacteria.Gammaproteobacteria.Aeromonadales.Succ
inivibrionaceae.Ruminobacter.species5232 
0 2.76 0.0262 
Bacteria.Firmicutes.Clostridia.Clostridiales.Lachnospiraceae.Butyri
vibrio.species3839 
0 2.75 0.0233 
Bacteria.Bacteroidetes.Bacteroidia.Bacteroidales.Paraprevotellacea
e.Prevotella.species5044 
0 2.74 0.0053 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Rum
inococcus.species5275 
B2 2.72 0.0270 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Genu
s2163 
0 2.64 0.0156 
Bacteria.Firmicutes.Clostridia.Clostridiales.Mogibacteriaceae.Genu
s2163.species2163 
0 2.63 0.0156 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2615.species2615 
0 2.61 0.0197 
Bacteria.Firmicutes.Clostridia.Clostridiales.Ruminococcaceae.Genu
s2615 
0 2.58 0.0197 
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Abstract 
Bovine Digital Dermatitis (DD) is a leading cause of lameness in dairy cattle. DD is 
reportedly increasing in prevalence in beef cattle feedlots of the US. The exact etiologic agent(s) 
responsible for the disease have yet to be determined. Multiple studies have demonstrated the 
presence of a variety of Treponema spp. within lesions. Attempts to reproduce clinically relevant 
disease using pure cultures of these organisms has failed to result in lesions that mirror the 
morphology and severity of naturally occurring lesions. This manuscript details the systematic 
development of an experimental protocol that reliably induces digital dermatitis lesions on a 
large enough scale to allow experimental evaluation of treatment and prevention measures. In 
total, 21 protocols from five experiments were evaluated on their effectiveness in inducing DD 
lesions in 126 Holstein calves (504 feet). The protocols varied in the type and concentration of 
inoculum, frequency of inoculation, duration the feet were wrapped, and type of experimental 
controls need to validate a successful induction. Knowledge gained in the first four experiments 
resulted in a final protocol capable of inducing DD lesions in 42 of 44 (95%) feet over a 28 day 
period. All induced lesions were macroscopically and microscopically identified as clinical DD 
lesions by individuals blinded to protocols. Lesions were also located at the site of inoculation in 
the palmer aspect of the interdigital space, and induced clinically measurable lameness in a 
significant portion of the calves. Collectively these results validate the model and provide a rapid 
and reliable means of inducing DD in large groups of calves.  
 
Background 
Bovine Digital Dermatitis (DD) is a leading cause of lameness in dairy cattle in the 
United States (1) and is beginning to have an increased prevalence in beef cattle feedlots (2). DD 
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accounted for 61.8% of the lameness in bred heifers and 49.1% of the lameness in cows in the 
most recent National Animal Health Monitoring System survey of US dairy farms (1). Despite 
over 40 years of research, the identification and cultivation of etiological agent(s) with the ability 
to consistently recreate clinical disease have largely failed. The initial description of DD as an 
ulcerative disease of the bovine coronary band occurred at the 8th International Meeting on 
Diseases of Cattle in Milan, Italy (3). Some of the first reports describing potential etiologic 
agents associated with DD were published in 1992, followed by a report describing the isolation 
and identification of an anaerobic spirochete, believed to be a Treponema spp. (4, 5). A number 
of additional papers have been published demonstrating the association of the lesions with 
additional bacteria including Bacteroides spp. (6-10) and Porphyromonas spp. (9-11), 
Campylobacter spp. (12-16), and Dichelobacter nodosus (17-22). A positive clinical response to 
topical antimicrobial therapy (23-27) and the lack of viral or fungal DNA from shotgun 
metagenomics (28) suggests the disease process is bacterial in nature. More recent literature 
using culture-independent technology suggests the disease process is likely poly-bacterial in 
nature with multiple Treponema spp. involved at various stages of lesion development (6, 28, 
29). This hypothesis is supported by the fact that while several Treponema phylotypes are 
consistently identified in DD lesions (6, 30-34), attempts to induce disease using pure cultures of 
cultivable Treponema spp. have failed to induce significant DD lesions (35). Additionally, killed 
vaccines using cultivable spirochetes provide limited protection against DD development (36). 
The association of DD lesions with a variety of bacterial agents, the response of the lesions to 
antibiotics, and the failure to induce or protect from the disease using monovalent vaccines 
strongly suggests that DD is a polymicrobial disease process (34, 37-39). 
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Microscopic changes associated with the development of DD have been previously 
described (14, 17, 40-43). DD lesions are histopathologically characterized by acute, suppurative 
inflammation of the epidermis with superficial necrosis and hyperkeratosis (42), along with 
perivascular aggregations of lymphocytes and plasma cells (7). A consistent microscopic 
observation of spirochetes within lesions has been demonstrated by multiple researchers through 
the use of Hematoxylin and Eosin staining, Warthin–Starry silver staining (44), 
immunohistochemistry (33, 41), electron microscopy (33, 45), and fluorescence in situ 
hybridization (FISH) (17, 18, 20, 45-49). Recently a large set of naturally occurring lesions (193 
lesions) of various stages was evaluated for pathologic changes associated with developing DD 
lesions (28) and a histopathologic lesion grading system was developed. The grade 1 category 
encompassed all biopsies identified as normal bovine skin. Grade 2 lesions were described as 
hyperkeratosis, and acanthosis with surface hemorrhage and erythrocytic crusts. Grade 3 lesions 
were described as segmental localized necrotizing to necrosuppurative epidermitis with 
individual cell necrosis, ballooning degeneration of epithelial cells, necrotizing vasculitis, 
intralesional bacteria consisting of delicate spirochetes, bacilli, and coccobacilli. 
Despite the fact that DD is likely a poly-bacterial disease process, attempts to induce 
disease with a mixture of cultivable bacterial organisms isolated from natural DD lesions has yet 
to be attempted. There are two published reports of attempting to induce DD lesions by 
inoculation of pure growth bacterial cultures. Gomez et al. (35) attempted to induce DD with 
Treponema sp. in four yearling Holstein heifers. Only four feet of the four heifers in this 
induction trial,were utilized for attempting to induce with Treponema sp. Only one site was 
considered a successful induction with the lesion described histologically as being similar to a 
DD lesion, but with a “sparse bacterial mat, light invasion of spirochetes, minimal inflammation, 
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and no ulceration”. The only other attempt at inducing DD lesions with cultivable organisms was 
in a murine abscess model where multiple isolates of Treponema sp. isolated from DD lesions 
were able to induce abscess formation (50).  
Given the unclear etiology of DD, several attempts utilizing DD lesion homogenate as 
inoculum in an induction model have been undertaken. Gomez et al. (35) tested an experimental 
model on six feet from four Holstein yearlings utilizing a complex multi-layered foot wrap and a 
plastic boot., Four of the six feet were considered to have a lesions consistent with DD in the 63 
day protocol. However, the induced lesions were located adjacent to the dew claws and all 
attempts to induce lesions in the typical DD location (51) near the interdigital fold failed. Read 
and Walker described the successful induction of 6 calf feet using DD homogenate and a wrap in 
an abstract at the 47th annual meeting of the American College of Veterinary Pathologists (52). 
A full description of the model with morphologic and histologic descriptions of the induced 
lesions was never published. 
Based on the paucity of robust experimental models for DD induction present in the 
literature, there is a substantial need for the development of an consistent and predictable, 
experimental model that induces clinically relevant digital dermatitis lesions. Models are 
important tools for studying and confirming disease etiology, exploring the bacterial and host 
response to infection, and for conducting controlled infections to evaluate novel therapeutics or 
vaccine candidates. To the extent that this model could be used to study the protective effects of 
novel digital dermatitis vaccines, it needs to conform to the guidelines of the USDA APHIS 
Biologics Regulations and Guidance (53). The guidelines have several important implications for 
model design. First, the guidelines require that subjects should be immunologically naïve to the 
disease prior to enrollment of the study. Given the significant prevalence of DD reported in 
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Holsteins as early as breeding age heifers (54-56), and the lack of validated screening tools that 
can be used to exclude prior exposure, proving immunologic naïveté can be a challenge in 
mature cattle. One potential solution is to use young calves with a verifiable disease history. The 
USDA guidelines also require that efficacy studies include a placebo group in order to calculate 
the prevented fraction. This requires that a successful protocol have a high rate of success 
inducing lesions in treatment groups while not inducing disease in the negative control group. 
Finally, in order to reach statistical significance in an efficacy study, the disease model needs to 
be easily scaled up to include a large number of animals. 
The objective of this project was to develop and validate an induction model that would 
produce DD lesions in immunologically naïve calves. We hypothesized that inoculation of 
macerated DD lesion material, collected and handled in a manner to minimize oxidative stress, 
into a favorable environment of immunologically naive calves would result in consistent 
induction of clinical disease. Our approach relied on sequential testing of various combinations 
of inoculum, wrap duration and skin abrasion. As improvements in the methodology were made, 
we also evaluated the use of cocktails of cultivable DD associated organisms for their ability to 
induce disease. Through systematic evaluation of 21 different protocols we were able to develop 
a finalized consensus protocol that resulted in a 95% induction rate over a 28-day study.  
 
Materials and Methods 
Holstein dairy calves utilized for this study were approximately 200 pounds, 3 months of 
age, and weaned a minimum of 30 days. For inclusion in the study, calves needed to be 
vaccinated prior to arrival, BVD-PI negative and free of antibiotic residue at the start date of the 
trial. Calves were determined to be free of antibiotic residue as long as any systemic antibiotics 
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given prior to arrival had extended past each drugs slaughter withhold period. Throughout the 
course of the study, calves were fed a diet that consisted of free-choice hay and a whole corn / 
protein mix that did not contain antibiotics or ionophores. All calves were deemed to be in good 
health prior to onset of induction and any animals that required antibiotic treatment were 
removed from the study analysis. Calves experiencing lameness greater than locomotion score 4 
on a standardized 5 point locomotion scoring system (57) on these studies, were evaluated and 
treated by a veterinarian. All animal procedures and protocols were approved by the Institutional 
Animal Care and Use Committee of Iowa State University. Lesions were classified into three 
categories based on the physical exam performed by the veterinarian: 1) DD lesion associated 
lameness, 2) wrap associated lameness (i.e. wrap cutting into skin or inducing pain) and 3) 
lameness unrelated to DD.  
To assess pain and/or lameness associated with developing DD lesions on each individual 
foot, we developed an objective measure for each individual foot. Foot sensitivity was classified 
as one of five scores: 0) No signs of sensitivity, 1) Holds foot in air when standing still, 2) 
Favors when walking, 3) Reluctant to bear weight 4) Non-weight bearing. Scoring of foot 
sensitivity was done daily for the first three weeks of the trial and three times weekly thereafter. 
Any foot that was given a score of 3 was examined on the tilt table for signs of wrap associated 
lameness. If the lameness was due to a wrap issue, the wrap was removed and appropriate 
treatment was initiated. As lameness was one of our measurable outcomes for the induction of 
DD lesions, if lameness was not associated with a wrap, the wrap was left in place and anti-pain 
medication was administered (meloxicam 1mg/kg EOD). As long as the lameness was 
responsive to pain medication and the lameness did not reach the level of non-weight bearing, 
the DD lesions were allowed to remain untreated until the conclusion of the study. At the 
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conclusion of the study, each foot was determined if they experienced DD associated lameness 
while on study. Any animal that experience wrap associated lameness and those that received 
systemic antibiotics were excluded from analysis. We defined “DD associated lameness” as a 
foot that had a minimum of two observations of sensitivity in which at least one of them was a 
score of 2 or more. 
At the conclusion of the study, calves were treated with between one and six treatments 
of topical tetracycline until all evidence of visible lesions were healed. Four preliminary studies 
were conducted to optimize the induction conditions and exact methodologies that led to a final 
protocol. Table 1 is a summary of the protocols used in each of the experiments with the number 
of feet, wrap length, pen designations, and type of inoculum detailed for each protocol.  
A detailed materials and methods for the four preliminary experiments are presented as a 
Appendix B in this manuscript. As experiment 5 represents the final consensus protocol, the 
methodologies employed in this protocol will be described in detail below.  
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Table 1: A summary of each protocol evaluated during the five experiments. 
Experiment
Wrap 
Length
Protocol Inoculum Pen Protocol Description
# Feet 
Enrolled
Experiment 1 7 days 1 1 A No Abrasion with Macerated Lesion Material 20
7 days 2 1 A Foot Abrasion with Macerated Lesion Material 20
Experiment 2 25 days 1 1 B Controls - Segregated 12
25 days 2 1 A Controls - Within Pen 15
25 days 3 2 A Macerated Lesion Material + Treponema phagedenis 15
25 days 4 3 A Macerated Lesion Material + Dichelobacter nodosus 15
25 days 5 4 A Macerated Lesion Material 15
Experiment 3 14 days 1 1 B Controls - Segregated 16
14 days 2 1 A Controls - Within Pen 18
14 days 3 2 A Macerated Lesion Material 18
14 days 4 3 A
Pure Cultures of D. nodosus, Bacteroides spp., P. 
levii, and T. phagedenis
18
14 days 5 4 A Pure Cultures of T. phagedenis 18
Experiment 4 38 days 1 1 A Macerated Lesion Material 48
38 days 2 2 B
Pure Cultures of D. nodosus, Bacteroides spp., P. 
levii, T. phagedenis, and C. urealyticus
48
38 days 3 3 A Controls - Within Pen of Protocol 1 16
38 days 4 3 B Controls - Within Pen of Protocol 2 16
38 days 5 3 C Controls - Segregated 16
Experiment 5 28 days 1 1 A Macerated Lesion Material 48
28 days 2 2 B Macerated Lesion Material - frozen 24 hours 48
28 days 3 3 C Macerated Lesion Material - 10:1 dilution 32
28 days 4 4 D Controls - Segregated 32
Totals: 504  
Table 1: A summary of each protocol evaluated during the five experiments. The pen 
designations denote whether animals were housed within the same pen or separate pens and the 
letters may designate different pens across experiments. The types of inoculum utilized for each 
of the different protocols is outlined in the manuscript text. 
 
Each of the four preliminary experiments was designed to examine specific questions 
regarding protocol optimization, while experiment 5 was designed to validate the finalized 
consensus protocol. Experiment 5 utilized forty Holstein steer calves which were housed as ten 
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separate pens, each containing four calves. The location was Iowa State University Animal 
Research Station and the pens were located in 3-sided sheds with no access to areas without a 
roof. All four feet of each calf were enrolled and received the same inoculum. Negative controls 
for this study were isolated from all treatment groups with all four feet treated as controls. On 
day 0 of the trial, all feet were subjected to abrasion using a tungsten abrasion disk. A 5/8” 
diameter area of skin in the interdigital fold was abraded in a manner to remove the epidermis 
and approximately 50% of the thickness of the dermis. Following abrasion, a 4x4 gauze pad was 
soaked in Induction Broth which was a mixture of sterile growth media that contained 40% 
MTGE (Anaerobe Systems, Morgan Hill, CA), 30% Brain Heart Infusion Broth (BD and 
Company, Sparks, MD) 15% Trypticase Arginine Serine Broth (58), and 15% Mueller Hinton 
Broth (BD and Company, Sparks, MD). This gauze pad was placed over the abraded skin in the 
interdigital fold and wrapped with 2” Gorilla Tape, (Gorilla Glue Inc.), to minimize the transfer 
of moisture and debris into and out of the wrap. Calves were housed in their assigned pens and 
groups following the application of wraps and feet were monitored for side effects of the 
abrasion and wraps for 3 days.  
On day 3 of the trial, inocula were prepared and administered to each of the feet. The 
inocula were prepared using tissue lesion biopsies from 14 adult cows with naturally occurring 
stage A1, A2, B1, B2, 3, and 4 digital dermatitis lesions (as described in the Iowa Digital 
Dermatitis scoring system (28)). A total of 20 grams of lesion material was harvested and placed 
into Induction Broth with the addition of 20% Fetal Bovine Serum (Sigma-Aldrich, St. Louis, 
MO). The lesions were combined and macerated in an anaerobic chamber using two scalpel 
blades, and 1.5 ml of the supernatant was placed into each of 48 3 ml syringes for inoculum #1. 
A second set of 48 3 ml syringes was filled with 1.5 ml of the same inoculum and frozen at -
133 
 
80oC for 24 hours to serve as inoculum #2. A subset of the original inoculum was also diluted to 
10% of the original concentration with the use of additional Induction Broth. A third set of 32 3 
ml syringes was filled 1.5 ml of diluted inoculum and served as inoculum #3. A final set of 32 3 
ml syringes filled with 1.5 ml of Induction Broth to serve as a control for inoculum #4. A 1” 
sterile plastic teat cannula (Jorgenson Labs, Loveland, CO) was placed on all of the syringes and 
they were packaged into a sterile Whirl-Pak bag (one per calf) under anaerobic conditions. 
Inocula were then deposited behind the wraps in the exact location that all of the feet were 
abraded using the sterile plastic teat cannula. 
On days 11, 18, and 25 all wrapped feet were re-moistened by dispensing 1.5 ml of the 
Induction Broth behind each wrap in the location of abrasion using the same technique. On day 
28 all wraps were removed and feet were photographed. At this time, all feet were biopsied using 
a 3 mm biopsy punch and treated with topical tetracycline. 
Biopsies for histologic examination from all experiments were immediately placed in 
10% neutral buffered formalin and stained with hematoxylin and eosin (H&E) using the Gemini 
Autostainer with the H&E based staining protocol. Warthin-Starry staining was conducted using 
the Iowa State Veterinary Diagnostic laboratory standard operating procedure. A blinded 
pathologist evaluated the lesions and categorized them into one of three pathologic descriptions 
(Grades 1, 2, 3) as defined by Krull et al. (28). Any lesions having a unique pathologic 
description were grouped in the “other” category. The grade 1 category encompassed all biopsies 
identified as normal bovine skin or granulation tissue. Grade 2 lesions were described as 
hyperkeratosis, acanthosis with surface hemorrhage and erythrocytic crusts. Grade 3 lesions were 
described as segmental localized necrotizing to necrosuppurative epidermitis with individual cell 
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necrosis, ballooning degeneration of epithelial cells, necrotizing vasculitis, intralesional bacteria 
consisting of delicate spirochetes, bacilli, and coccobacilli. 
Since all induced lesions were considered stage 3 based on the Iowa DD lesion scoring 
system, a new lesion scoring system was necessary to better define the severity of the lesions and 
allow for group comparisons. The lesions from all 21 experiments were macroscopically scored 
using a novel induced lesion scoring system developed exclusively for these experiments. The 
scoring system (Table 2) is a sum of these three criteria (size, color and evidence of healing) with 
more weight being given to the size of the lesion than the other two observations since this 
measure allows for easily demonstrating a progressive lesion development. All photographs were 
blindly scored by a single observer (AK) with multiple photographs of each lesion examined in a 
random order. The correlation between the lesion scores and histologic changes consistent with 
digital dermatitis was highest when lesion scores were greater than or equal to 7 on the 10 point 
scale. For each individual foot to be designated as a successful induction, the macroscopic lesion 
score was required to be greater than or equal to 7. 
 To examine if difference existed between protocols within an experiment, a One-way 
ANOVA was conducted. To evaluate the differences between each of the groups, post-hoc t-tests 
were conducted assuming equal variances. As these comparisons involved multiple protocols per 
experiment, a Bonferoni correction was applied to each comparison. For the experiments in 
which microscopic and macroscopic scoring was done, a regression analysis was performed to 
evaluate the correlation between scores. 
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Table 2: Macroscopic Lesion Scoring System 
5 Expanding from initial abrasion area
3 No change is size
1 Lesion smaller than initial abrasion area
0 No lesion present
3 Bright red (hemorrhagic)
2 Pink (healing ulcer)
1 White (re-epitheliazation)
0 No lesion present
2 Non-descript edges
1 Well defined edges (2nd intention healing)
0 No lesion present
Observation 3: Edges of Lesion:
Observation 2: Color of Lesion:
DD Induction Lesion Scoring System:
*choose most accurate description from each of three 
observations and summarize                                                           
(10=most severe, 0=no lesion)
Observation 1: Size of Lesion:
 
Table 2: The macroscopic induced lesion scoring system utilized by blinded observer to score the 
degree of lesion development. The macroscopic scoring system had a high level of correlation 
with the histopathologic changes associated with digital dermatitis, r(30) = .48, p<.01. 
 
Results 
A summary of the results from all 5 experiments is shown in Table 3. Any calf that 
received antibiotics during the induction period of the trial or lost a wrap prior to the designated 
wrap removal date were not included in all statistical analyses or considered in the summary 
analysis.  
 
136 
 
Table 3: A summary of each protocol within the five experiments 
Experiment Protocol Pen Protocol Description
# Feet 
Qualified
Induction 
Rate
Average 
Lesion Score
SD
Experiment 1 1 A No Abrasion with Macerated Lesion Material 20 0% 0.00 0.00
2 A Foot Abrasion with Macerated Lesion Material 20 60% 6.65 2.32
Experiment 2 1 B Controls - Segregated 7 0% 2.14 2.85
2 A Controls - Within Pen 12 25% 5.00 2.69
3 A Macerated Lesion Material + Treponema phagedenis 7 71% 8.00 2.77
4 A Macerated Lesion Material + Dichelobacter nodosus 10 80% 8.70 1.70
5 A Macerated Lesion Material 9 89% 8.78 1.92
Experiment 3 1 B Controls - Segregated 12 25% 5.33 1.92
2 A Controls - Within Pen 16 75% 7.00 2.03
3 A Macerated Lesion Material 17 82% 8.35 1.80
4 A Mixed Pure Cultures 16 75% 6.75 1.61
5 A Pure Cultures of T. phagedenis 17 59% 7.18 1.55
Experiment 4 1 A Macerated Lesion Material 30 57% 6.10 3.92
2 B Mixed Pure Cultures 35 3% 2.46 2.39
3 A Controls - Within Pen of Protocol 1 15 33% 4.20 3.59
4 B Controls - Within Pen of Protocol 2 11 18% 2.00 3.61
5 C Controls - Segregated 14 14% 1.64 2.87
Experiment 5 1 A Macerated Lesion Material 44 95% 9.57 1.68
2 B Macerated Lesion Material - frozen 24 hours 48 85% 8.63 3.15
3 C Macerated Lesion Material - 10:1 dilution 28 89% 9.21 2.11
4 D Controls - Segregated 28 0% 0.00 0.00
Totals: 416
*
*
*
*
*
 
Table 3: The pen designations denote whether animals were housed within the same pen or 
separate pens and the letters may designate different pens across experiments. The number of 
feet qualified refers to the number of feet enrolled in each protocol that retained a wrap 
throughout the length of the study and did not receive topical or systemic antibiotics during the 
trial period. The induction rate is the percentage of feet that had a macroscopic lesion score of 7 
or greater. The brackets denote statistical significance between groups with alpha=.05 and a 
correction for multiple testing. 
 
Experiment 1 
Experiment 1 was designed to evaluate the necessity of skin abrasion in the induction 
protocol. Calves feet were randomized to treatment group (abraded or non-abraded). At the time 
of wrap removal (7 days post abrasion) in our initial pilot study, significant differences (p<.001) 
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were noted between the protocol in which feet were abraded prior to induction and the protocol 
in which feet were inoculated without abrasion. The abrasion protocol had an average lesion 
score of 6.65, whereas the non-abraded feet had an average lesion score of 0.0. Based on our 
macroscopic scoring system cutoff of lesion score greater than or equal to seven for 
determination of successful induction, 12 of the 20 abraded feet (60%) were designated as 
having successful induction. In contrast, none of the non-abraded feet had induced lesions. Based 
on the results of this experiment we concluded that abrasion significantly improved induction 
success and included abrasion as part of all further induction efforts. 
 
Experiment 2 
 This experiment was designed to test two key factors in model development. First, we 
wanted to determine if addition of culture grown Treponema phagedenis or Dichelobacter 
nodosus to the macerated inoculum improved induction success. Second we wanted to determine 
if within-calf control feet could be used as a negative control group for lesion induction. In order 
to test the this issue we randomly assigned one foot per calf to receive skin abrasion, wrap and 
inoculation with sterile media while the other feet were included in treatment groups. A second 
segregated control group (i.e. all feet in pen were skin abraded, wrapped and inoculated with 
sterile media) was housed in a separate pen. When comparing the use of macerated lesion 
material (protocol 5), as done in experiment 1, the average lesion score (8.78) was statistically 
different (p<.01) to the within calf controls (5.00) and the segregated controls (2.14). The 
addition of pure cultures of D. nodosus and T. phagedenis in protocols 3 and 4 did not increase 
or decrease (p>.5) the average lesion score when compared to the use of macerated lesion 
material only in protocol 5. The average lesion scores of both protocols 3 and 4 were statistically 
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different than the segregated controls (p<.01), although when compared to within calf controls, 
protocol 3 lesion scores (8.00) failed to reach statistical significance when compared to the lesion 
scores of this control group (5.00). The two control groups had noticeable differences between 
lesion scores with the within calf groups having an average lesion score of 5.00 and 25% of the 
feet having successful induction. In contrast the segregated controls had an average lesion score 
of 2.14 with 0% of the feet designated as successful induction. Despite these differences, the 
average lesion scores between the control groups did not reach statistical significance (p=.044) 
following a multiple comparison adjustment. Based on these results we made two important 
conclusions that influenced the development of the model. First, there was no evidence that the 
addition of culture grown Treponema phagedenis or Dichelobacter nodosus to the macerated 
inoculum improved induction success. Second we demonstrated that within-calf negative control 
feet (i.e. abraded, wrapped and sham inoculated with sterile media) had a 25% induction rate 
despite not being inoculated with bacteria and being continuously wrapped throughout the 
experiment. Two alternate hypotheses were developed based on this finding. Either the feet were 
becoming infected from within-pen environmental exposure penetrating the wrap, or the immune 
response of individual calves that developed in response to the challenged feet was resulting in 
lesion development in the control feet. 
 
Experiment 3 
 Experiment 3 was designed as a short duration pilot study (14 day wrap) to test the 
hypothesis that pure culture Treponema phagedenis alone or cocktails of pure growth DD 
associated bacterial consortiums could induce DD lesion development similar to that of 
macerated lesion material. Similar to experiment 2, both within-calf and segregated negative 
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control groups were utilized. Similar to experiment 2, the macerated lesion protocol (protocol 3) 
had the highest induction rate (82%), and the highest average lesion scores (8.35). The lesion 
scores in the macerated group were statistically higher than those of the segregated control pen 
(5.33). However, the within pen control lesion scores (7.00) were not significantly different from 
any of the other protocols tested with the exception of the segregated control group. Protocol 4, 
which utilized the cocktail of culture grown organisms isolated from DD lesions, had an 
induction rate of 75% however the lesion scores were not statistically different from either of the 
control groups. The lesion scores from the pure culture of T. phagedenis (protocol 5) were 
statistically higher than those of the segregated control even though the induction rate was lower 
(59%) than that of protocol 4 (75%). Despite the fact that protocol 3 had a higher rate of 
induction and higher lesion scores compared to the other two treatment protocols that utilized 
culture grown organisms (4 and 5), protocol 3 lesion scores were not found to be significantly 
different than protocol 4 (p=.011) or protocol 5 (p=.049) with adjustments for multiple 
comparisons. Similar to experiment 3, we found that the within pen control group had significant 
lesion induction (75%) despite not being directly induced. From this experiment we concluded 
that inoculation of feet with pure growth organisms resulted in good induction of DD lesions 
when housed in the same pen as macerated lesion groups. However, the continued high level of 
induction in the within pen negative control groups suggested that there was still significant 
potential for alternative mechanisms of lesion induction in these groups. 
 
Experiment 4 
 Given the concerns over the potential for cross-contamination between the macerated 
induction and pure growth cocktail groups due to co-housing the animals, experiment 4 was 
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designed to allow for segregation of the macerated lesion (protocol 1) group from the pure 
culture cocktail group (protocol 2). Similarly to the prior studies, a protocol utilizing macerated 
lesion material was tested as a means of comparing the induction success to the other 
experiments. In this experiment all 4 feet of each calf were inoculated with the same protocol 
and we dropped the within-calf negative control group. A within-pen negative control group in 
which all four feet were sham inoculum replaced it. Finally, we had a segregated negative 
control group as in the two previous experiments. This design allowed us to segregate the calves 
into different pens based on the protocol. A large and significant difference was observed 
between the two treatment groups (p<.0001) with the macerated lesion protocol (protocol 1) 
lesion scores averaging 6.10 and the pure culture protocol (protocol 2) averaging 2.46. An even 
larger difference was observed on the number of successful inductions where protocol 1 was at 
57% and protocol 2 was only 3%. Interestingly, protocol 1 was not statistically different (p=0.12) 
from the control group that was housed within the same pen (average lesion score of 4.20), 
however, protocol 1 did reach statistical significance (p<.01) when compared to segregated 
control and the controls housed in the pen with the protocol 2 induction calves. Collective 
analysis for the results of this experiment yielded several important findings. First, the finding of 
a very high rate of lesion induction in the within-pen negative control group suggests that 
significant within pen cross-contamination of lesions was the source of lesion induction. The 
alternative hypothesis discussed in experiment 2 (i.e. that immune response was leading to the 
within-calf negative control lesion induction) could be excluded in this experiment due to the 
sham inoculation of all 4 feet in this group. Based on this finding and the poor lesion induction 
observed in the segregated cocktail inoculum group (protocol 2) of this experiment, we 
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concluded that the success in previous experiments using pure growth cocktail for induction was 
likely due to cross-contamination from being housed in a contaminated environment.  
 The histological scoring of biopsies obtained at the time of wrap removal was analyzed 
for correlation to our macroscopic scoring system. There was a significant positive correlation 
between the macroscopic lesion score and the histologic grade designated, r(30) = .48, p<.01. A 
summary of histologic grades associated with each of the lesion scores is shown in Figure 1. As 
biopsies were only obtained from feet with any type of macroscopic lesion, the majority of the 
biopsies were from lesion scores 7-10. All lesion scores less than seven were lumped together for 
ease of presentation. For the lesion scores 7-10 the majority (19/23) were classified as histologic 
score Grade 3, whereas only three of the nine with scores less than seven were classified as 
Grade 3. 
 
Figure 1: Lesion Grades for each Macroscopic Lesion Score. Histopathology score summary 
from each of the macroscopic scores. As biopsies were only taken from feet with visible lesions, 
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the majority of the lesions scores were 6 or greater. Several lesion scores of 4 and 5 were 
included in the <6 category. The grade 1 (NDL) category encompassed all biopsies identified as 
normal bovine skin. Grade 2 (HASH) lesions were described as hyperkeratosisc, acanthosis with 
surface hemorrhage and erythrocytic crusts. Grade 3 (IPDD) lesions were described as segmental 
localized necrotizing to necrosuppurative epidermitis with individual cell necrosis, ballooning 
degeneration of epithelial cells, necrotizing vasculitis, intralesional bacteria consisting of delicate 
spirochetes, bacilli, and coccobacilli. 
 
Experiment 5 
 The final experiment was designed to validate the consensus induction protocol 
developed based on the outcomes of the first four experiments and to rule out a pen effect on 
induction. Since preparation of large volumes of macerated inoculum is time and labor intensive, 
we wanted to evaluate the induction success using frozen or diluted inoculum. As calves from 
each induction protocol were housed in separate pens, an accurate assessment of the true 
induction success as compared to the controls without the possibility of within-pen cross-
contamination was possible. At the conclusion of the trial, all three tested protocols (macerated-
1, frozen-2, and dilute-3) had decidedly higher (p<.0001) lesion scores than the segregated 
negative controls. All three protocols had greater than 85% induction with average lesion scores 
higher than 8.5. Of the 28 control feet, there was not a single foot that had had a lesion score 
greater than 0. Although lesion scores and percent induction were slightly higher in the typical 
macerated lesion protocol (1), there was no statistical difference between the other variations of 
macerated lesion material in protocols 2 and 3 indicating that a 90% dilution of inoculum or 
freezing of inoculum did not significantly decrease the effectiveness of the induction. Several 
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examples of induced lesions that were scored as 10 using the induced lesion scoring system are 
shown in Figure 2: 
 
Figure 2: Representative DD Lesions from Experiment 5. Digital Dermatitis lesions on day 28 
following wrap removal. Photos A and B represent control calves and photos C and D represent 
lesions that scored 10 using the induced lesion scoring system. 
 
Figure 3 shows the number of sensitive feet for each day of the trial. The number of sensitive 
feet remained very low for the first 12 days of the trial with only a couple sensitive feet the first 2 
days after abrasion. Approximately two weeks post abrasion the number of sensitive feet began 
to increase rapidly with an initial peak at day 19. This was followed by a period of time with 
lower numbers of sensitive feet until the end of the trial where the number of sensitive feet 
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peaked again at day 26. There was a statistical difference in DD associated lameness between the 
different protocols (p<.05), with control feet having a significantly lower number of lame feet 
compared to all induction protocols (Table 2). There was also no statistical difference in 
lameness between the three induction protocols. A high level of correlation was also observed 
between macroscopic score and foot sensitivity (r(147) = .23, p<.0001) with 21% of feet with 
DD lesions showing signs of sensitivity. 
 
Figure 3: The number of sensitive feet for each day on trial for experiment 5. Feet were wrapped 
and abraded on day 0, inoculated on day 3 and wraps were taken off on day 28. The minimum 
objective measure for a sensitive foot was that a calf held the foot off the ground while standing. 
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Table 2: The Number of Lame Feet for Each of Protocol 
Groups n Lame Average Std Err 
Control 28 0 0.0% 0.000 
Frozen 48 6 12.5%* 0.048 
Low Dose 27 7 25.9%* 0.086 
Treatment 44 11 25.0%* 0.066 
Table 2: Foot sensitivity was classified as one of five scores: 0) No signs of sensitivity, 1) Holds 
foot in air when standing still, 2) Favors when walking, 3) Reluctant to bear weight 4) Non-
weight bearing. Lameness was defined as a foot that had a minimum of two observations of 
sensitivity in which at least one of them was a score of 2 or more. *indicates statistical 
significance when compared to controls 
 
 The histological scoring of biopsies obtained at the time of wrap removal was analyzed 
for correlation to our macroscopic scoring system. Unlike experiment 4, all feet were biopsied 
regardless of macroscopic appearance of the skin. There was a much larger separation of lesion 
scores with the majority (140/147) of the scores either being 0 indicating normal skin or a lesion 
score of 9 or 10 indicating a large lesion. The lesion scores were highly correlated (r(145) = .87, 
p<.0001) to the histopathology scores with 98% of lesion scores 9 or 10 scored as grade 3 and 
92% of lesion score 0 scored as Grade 1. An example of the histopathologic changes observed in 
Grade 3 lesions is shown in Figure 4. 
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Figure 4: Grade 3 Digital Dermatitis Histopathologic Changes. Figure 4A shows the 
characteristic changes of a Grade 3 lesion with necrosis of surface epithelium inflammatory 
infiltration, and intra-lesional bacteria. Figure 4B shows more defined intra-lesional spirochetes 
within inflammatory loci when stained using W/S silver staining. 
 
Discussion 
 The experiments presented in this manuscript represent the largest and most successful 
induction of digital dermatitis lesions ever reported. Using 504 feet enrolled in 21 unique 
protocols and a systematic approach we were able to develop a clinically relevant induction 
model. The model consistently produces DD lesions in naïve calves in less than one month, does 
not result in significant induction of disease in negative control calves, and can logistically be 
accomplished on a large enough scale to produce statistical significance. Furthermore, the lesions 
produced are located in an anatomical location consistent with naturally occurring DD lesions, 
and are macroscopically and histopathologically indistinguishable from naturally occurring DD 
lesions. These collective attributes yield a model that can readily be applied to testing hypotheses 
4A 4B 
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regarding the pathophysiology of DD, evaluating vaccine efficacy and evaluating other treatment 
interventions of preventive therapies.  
The first four experiments were vitally important in optimizing the final protocols 
presented in experiment 5. In our initial pilot study, experiment 1, we concluded that skin 
abrasion aided in rapid development of clinical DD lesions. Interestingly, when we followed the 
calves for a period of time following wrap removal, several un-abraded calf feet that were 
normal at the time of wrap removal developed macroscopic changes (B1 lesions) associated with 
the onset of disease as described by Krull et al. (28). The continuous exposure to DD lesions on 
commingled infected feet made it impossible to determine if these new lesions were due to 
natural lesion development from environmental exposure or if a subclinical infection was 
initiated during the un-abraded induction., We elected to only use the lesion scores at the time of 
wrap removal in this and subsequent experiments for this reason. The macroscopic appearance of 
the feet at seven days post abrasion also made it difficult to determine the difference between 
naturally healing abraded skin and an effective induction. Based on this finding we elected to 
prolong the period of wrap in future experiments and to include an abraded negative control 
group. Finally, since the induced lesions were predominantly stage 3 lesions based on the Iowa 
DD lesion scoring system, we developed a more refined induced lesion scoring system (Table 2) 
to aid in further quantifying macroscopic differences in the induced lesions. Through future 
experiments, we were able to demonstrate that the induced lesion scoring system correlated very 
well with the histopathologic changes associated with digital dermatitis development. While 
experiment 1 showed a 60% induction rate, the lack of a negative control group makes 
interpretation of these results more difficult. 
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 Based on the outcomes of experiment 1, a number of changes were made to the induction 
protocols for the subsequent experiment. The wrap duration was increased from 7 days to 25 
days and two sets of controls were included in the experiment. For the within pen controls, a 
single foot from each calf was utilized as a negative control. That foot was abraded and wrapped 
in an identical manner to the treatment feet but was sham inoculated with sterile media. A 
segregated negative control group of calves was added to evaluate the potential role of 
environmental exposure to digital dermatitis organisms infecting our within-pen negative control 
feet. The increased duration of wrap length in this experiment resulted in a new set of issues. For 
the first nine days of the trial, all wraps remained on without causing any significant problems. 
However, starting at nine days a number of wraps started falling off or needing to be removed 
due to complications. We believe that in large part the issues were from extremely cold weather 
causing our water resistant tape to become very non-pliable. Any feet that lost wraps more than 
two days prior to the end of the study were excluded from our analysis which resulted in only 
63% of our initial feet enrolled eligible for evaluation at the study termination. Despite the large 
loss of feet eligible for evaluation, some important insights were obtained from this experiment. 
The inclusion of additional bacteria associated with DD to our macerated inoculum did not 
increase lesion development. Conversely, both induction success and average lesion scores were 
slightly lower with the addition of pure cultures; however these differences did not reach the 
level of statistical difference. Although there was not a statistical difference between the two 
negative control groups, there was a large difference in percent induction and average lesion 
score between them. As it was unknown if this was an effect of environmental exposure to DD 
pathogens from the other protocols or if this was a pen effect from a slightly different 
environment between pens, a similar experimental design was repeated in experiment 3. 
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 The major change in the design of experiment 2 was to shorten the wrap length to 14 
days in an attempt to minimize the wrap associated difficulties. As our induction success and 
lesion scores were only marginally different with the addition of pure cultures to our macerated 
lesion inoculum in experiment 2, an attempt to induce lesions with cocktails of bacterial cultures 
was tested in experiment 3. The shortened wrap length in this experiment did not allow sufficient 
time for our skin abrasions to heal enough to effectively differentiate a healing abrasion from a 
digital dermatitis lesion using our induced lesion scoring system. The differences between 
segregated controls from experiment 2 and 3 served as the best evidence to support this 
observation. The average segregated control lesion score in the 25 day protocol (exp. 2) was 
2.14, whereas the average segregated control lesion score in the 14 day protocol (exp. 3) was 
5.33. Despite the controls having higher lesion scores in experiment 3, the macerated lesion 
group and the pure cultures of T. phagedenis did reach statistical significance when compared to 
the segregated controls. However, similarly to experiment 2, the within calf controls were not 
statistically different from any of the other 3 protocols indicating some level of exposure to DD 
bacteria within the pen. The difference between the control groups was nearly significant 
(p=.018) as adjustments for multiple testing required significance to reach p<.01. As with the 
previous experiments, the macerated lesion protocol had the highest lesion scores (8.35) and 
percent induction (82%), which was easily significant when compared to segregated controls 
(p<.001) and nearly significant (p=.051) when compared to the within calf controls. 
 When developing the experimental design for experiment 4, we elected to make a 
fundamental change in our randomization protocol and study design. In an effort to control for 
animal level variability in the prior experiments we had randomized individual feet of a calf and 
utilized all treatment protocols in at least one foot of each calf. Based on the risk of cross-
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contamination observed in the within-calf negative control group we opted to modify the design 
with calf level randomization (i.e. all four feet of a given calf received the same inoculum). This 
change also allowed us to provide complete segregation of calves by treatment group. In order to 
further evaluate the role of cross-contamination we elected to place a group of within-pen 
negative controls (all four feet sham inoculated) in each of the pens in addition to a segregated 
negative control group. As experiment 3 determined that a 14 day wrap was too short for 
consistently differentiating residual skin abrasion from digital dermatitis, it was elected to extend 
the wrap length in this experiment to 35 days. We believed that this would allow for skin 
abrasions that were not developing into digital dermatitis lesions to fully heal prior to wrap 
removal. As a result, only true DD lesions would still be present at the conclusion of the study. 
Although there were issues with maintaining wraps for prolonged periods of time in experiment 
2, it was believed this was mostly due to the extreme cold during that trial. This experiment 
(experiment 4) was to be completed in July whereas experiment 2 was done in December. We 
also elected to drop down to a single injection of inoculum and follow up with additional sterile 
media to maintain wrap moisture throughout the prolonged length of the trial. In a modest 
improvement from experiment 2, 76% of the wraps remained intact until the end of the trial. 
Similarly to experiment 2, 100% of the wraps were intact on day 10, followed by a loss of 
approximately 5% of wraps per week until the end of the trial. It was noted that starting around 
day 28, many of the wraps were becoming constricting due to the growth of the calf and were 
starting to cut into the skin near the top of the wrap. Wraps noted to be cutting into the skin were 
removed and the affected foot was removed from final statistical analysis unless wrap removal 
was within 48 hours of the end of the study. The overall lesion scores across all groups were 
lower compared to the previous trials, but the macroscopic differentiation between skin abrasion 
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and digital dermatitis lesions was much more defined. Unlike in experiment 3 when a statistical 
difference could not be realized between macerated lesion material protocol (1) and the pure 
growth organisms protocol (2), a very large difference (57% vs 3%, p<.0001) was found between 
these two protocols in this experiment when the groups were housed in separate pens. The 
macerated lesion protocol (1) again had the highest induction rate (57%) and lesion scores (6.10) 
compared to all other protocols and was considered statistically different than all protocols with 
the notable exception of the control calves housed within the same pen. This finding, coupled 
with the results from experiments 2 and 3, demonstrated that any feet housed within the same 
pen as a protocol that included macerated lesion material consistently had an increase in lesion 
scores and induction rate. This information calls into question previous reports claiming to have 
created a DD lesion with Treponema spp. culture broth, since those calves were commingled 
with other animals inoculated with DD homogenate (35). 
 Looking at the results of the first four experiments, it is apparent that the only protocol 
that consistently produced lesion scores that were statistically higher than controls were 
protocols utilizing macerated lesion material. The use of pure cultures was abandoned in the final 
experiment in favor of testing variations of the macerated inoculum protocol in an effort to 
identify means of simplifying the logistics of the study while also allowing for direct comparison 
between studies. Prior to this point, our rule-of-thumb was to obtain approximately 1 gram of 
lesion material per 4 feet to be induced. As our trials increased in number, that amount of fresh 
lesion material became difficult to obtain within a short period of time. Since it was noticed in 
the other experiments that calves housed within groups inoculated with lesion material had an 
increase in lesion scores, it was hypothesized that an inoculum that was diluted 10:1 would be 
sufficient in inducing DD lesions. Likewise, the ability to freeze our inoculum would allow for 
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collection of inoculation material ahead of time, and would simplify inoculations by removing 
the 4-5 hours of preparation time necessary for making fresh macerate the same day as 
inoculation. Furthermore, the ability to freeze inoculum would allow the use of a large single 
inoculum preparation in multiple studies which would increase the consistency between 
experiments and allow for direct comparisons between experiments. The final wrap length for 
this trial was set at 28 days. This was based on the results the previous experiments indicating 
that 14 days was too short and 35 days was too long. Following successful induction using a 
single inoculation in experiment 4, it was elected to repeat the single injection with weekly 
follow up injections of sterile media. Finally, in order to allow for some assessment of pen level 
effects we elected to house animals in smaller pens (4 calves per pen) with multiple pens 
allocated per treatment group. 
The results of experiment 5 provided the best induction results of the five experiments 
due to the systematic evaluation and adoption of protocol improvements during the first 4 trials. 
The lesion scores of all three treatment protocols in experiment 5 were significantly higher 
(p<.0001) than the negative control calves. Protocol 1 (standard dose, fresh macerated DD 
lesion) had the highest lesion scores (9.57) and percent induction (95%) of any of the 21 
protocols reported here. There was a slight decrease in lesion scores with the frozen and 10% 
inoculum groups, although it was not found to be statistically significant than protocol 1. This 
indicates that the amount of inoculum needed to induce DD lesions was far less than originally 
anticipated. This may have been a contributing factor in the prior experiments where feet in the 
same pen as macerated lesion protocols were developing DD lesions from apparent 
environmental exposure. The wrap duration of 28 days utilized in this experiment provides the 
ideal balance between allowing the skin abrasions to fully heal (making it easier to identify true 
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DD lesions) and minimizing the complications associated with the long-term wraps. As a result, 
all 28 negative control feet had lesion scores of 0, further supporting our observations of possible 
environmental exposure resulting in cross contamination between protocols when commingled. 
The wrap integrity in this trial was far better than in prior long term protocols, with all wraps 
lasting the full 28 days of the experiment. Several factors were believed to play a role in the 
success of these wraps. From prior experiments, slight differences were observed in the way 
wraps were applied. Slight adjustments to how the feet were wrapped including wrapping further 
down on the claw and loosening the tops of the wraps made a large difference in not irritating the 
skin requiring wrap removal. Another factor that likely made a significant difference is the 
change in housing. The calves were kept in 10’ x 10’ pens that were completely covered. 
Whereas in prior experiments the calves were in pens 100’ x 20’ that had a covered area, but also 
had a dirt area. The mud and manure in the larger pens would cause many of the wraps to be 
pulled off when the calves would run in the pens. The smaller pens decreased the activity of the 
calves and the clean and controlled environment allowed for wraps to remain intact for the entire 
length of the trial. 
The inclusion of lameness as an objective measure for induction of DD lesions was 
important to provide a clinical measure of lesion induction. The use of locomotion score in 
natural DD lesions has been shown to be unreliable with only 26% of cows with slight lesions 
and 39% of cows with severe DD lesions (59) shown to have locomotion scores of 3 or greater 
on a five point scale (57). The use of locomotion score also eliminates our ability to assess each 
limb individually. Therefore, we felt that it was necessary to develop an objective measure for 
each foot subjected to induction. The results of this induction show a similar level of lameness 
compared to naturally developing lesions with 21% of the feet showing signs of sensitivity. This 
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is similar to the 26% of cows with DD lesions showing signs of lameness found by Frankena et 
al. (59). The spike of sensitive feet at day 19 of the study initiated our IACUC protocol which 
required calves with a locomotion score of 4 out of 5 to be treated with meloxicam. The use of an 
NSAID in these cases provided analgesia, but also decreased the amount of swelling in the foot. 
We believe that this decrease in swelling under the wrap decreased the sensitivity of the lesions 
due to less pressure being applied directly to the lesion surface. As seen in Figure 2, the number 
of sensitive feet decreased rapidly following administration of pain meds and remained constant 
until near the end of the study. The reason for the spike in foot sensitivity near the end of the 
study is likely 2-fold, 1) the DD lesions induced were becoming more severe and associated with 
increased lameness and 2) the growth of the feet during the trial was beginning to create 
increased pressure under the wrap. The results of our foot sensitivity measurements correlate 
well with macroscopic and histopathologic lesion scores and provide additional assurances to an 
induction of DD lesions similar to naturally developing lesions.  
 Valuable information and insights into DD induction were obtained from the first four 
experiments and integration of that knowledge into a final consensus protocol led to the highly 
successful induction described in experiment 5. We believe that several important premises have 
emerged from this work that are pertinent to induction of DD lesions. First, use of dairy calves 
provided consistent induction success and allows for known DD history on each animal in the 
study. This conforms to the guidelines of the USDA APHIS Biologics Regulations and Guidance 
for an ideal induction model utilizing immunologically naïve animals. Furthermore, dairy calves 
are more economical, easier to house and easier to restrain during induction trials, all of which 
allows for easier scale-up of induction trials. Most of our trials utilized 35-40 calves, however 
the ability to use a lower dose of frozen macerate allows for even further expansion of those 
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numbers if necessary. Second, experiment 1 clearly demonstrated that abrasion of skin prior 
wrapping feet was vitally important to the success of rapid lesion induction. Third, the duration 
that feet were wrapped was a very important factor in the success of each experiment with 
approximately 28 days being the ideal timeframe. Shorter wrap-length times did not allow the 
skin abrasions to fully heal, making macroscopic differentiation of these to true DD lesions 
difficult to assess. Longer durations than 28 days was associated with side effects due to 
constriction of the wrap associated with calf growth. Fourth, the highly infectious nature of the 
disease process was also demonstrated by the fact that commingling of calves within pens 
resulted in a high level of cross contamination. This is especially interesting given the fact that 
both the induced lesions and the negative control feet were wrapped for the entirety of the study. 
Therefore, this provides strong evidence that direct contact with lesions is not required for 
disease transmission, and that the infectious dose is small enough to leak out of one wrap and 
into another wrap with relatively high frequency. The low infectious dose is also supported by 
our success using a lower dose and frozen inoculum. Collectively these points confirm that it is 
important for all DD induction trials to have appropriate controls and segregation in place to 
assure that cross contamination does not confound interpretation of the results.  
 The use of cultivated organisms (alone or together) as inoculum for the induction of 
digital dermatitis in our experiments has yet to yield consistent results. In experiment 3, there 
was a statistical difference between our segregated controls and the use of T. phagedenis as an 
inoculum, but the fact that they were in the same pen as our macerated lesion group and they 
were not found to have different lesion scores than the controls within the pen suggests a 
significant risk of confounding. When pure cultures were used and the group segregated in a 
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separate pen, as in experiment 4, there were substantially fewer successful inductions (1 of 35) 
and the average lesion scores were similar to those of segregated negative control calves. 
 The DD induction model described has undergone significant refinement and provides 
substantial improvements to the previously described DD induction model. (35) First, the scale 
of experimental validation is considerably different with our experiments utilizing a total of 504 
feet from 126 three-month-old calves, compared to eight feet from four yearling heifers. Second, 
our protocol can rapidly induce a large number of lesions as evidenced by the final experiment 
inducing lesions on 108 of 120 (90%) feet within 28 days as compared to a 63-day protocol. 
Third, the DD lesions produced in this study more accurately mirror naturally occurring DD 
lesions in terms of anatomic location and severity whereas the previously described model was 
only able to induce lesions near the dew claws. 
Perhaps the most significant differences between the two protocols relate to the 
preparation and management of the feet and wraps prior to induction. We replaced the 
preliminary 18-day water maceration step with a skin abrasion step in our study. While both 
protocols induce an artificial manipulation of the foot that predisposes to lesion development in a 
manner quicker than natural disease, our model does this in 3 days versus 18 days. Our protocol 
also does this in a single time-point upon application of the wrap, whereas the previous model 
requires refilling the rubber boot on each foot with water every 12 hours for 18 days prior to 
induction. While one could develop a model that doesn’t manipulate the integrity of the skin, (as 
we did in experiment 1) lesion development is much slower with a lower induction rate at a 
significantly increased time and financial cost. The complexity of the wrap was also significantly 
different between the studies with our protocol involving a 4x4 and moisture resistant tape that 
was applied and remained on for the length of the study versus wraps that involved inoculation 
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chambers, cotton, seven layers of plastic wrap, a rubber boot and duct tape that was applied and 
removed up to 12 times during the study. We felt that creating a microaerophilic environment 
behind the wrap and maintaining that environment without removing the wraps was vital to the 
protocol. These simple and effective techniques utilized in our experiments greatly reduced the 
cost per calf, increased the number of animals that can be induced in a single study, and 
decreased the duration of housing for the calves on study allowing for the type of large scale 
trials necessary for treatment and prevention trials.  
 In conclusion, the protocol outlined in this study has the potential to be useful in a 
number of future research investigations. Research with novel vaccines against DD would be the 
most obvious use of the induction model. Alternate uses of this model could also include the 
testing of candidate pathogens isolated from DD lesions for their ability to reproduce disease. 
Having a validated model that predictably induces disease makes an ideal comparison when 
testing the ability of culture grown organisms’ ability to cause DD. The ability to rapidly produce 
a large number of DD lesions in young animals also makes the model ideal for testing new 
treatment strategies. The use of this model in treatment trials has several advantages. First, the 
use of young calves makes handling calves and feet much easier. Second, as these animals are 
not lactating and being moved daily to and from a parlor, it is easier to eliminate any 
environmental biases induced from a common exposure area. Third, there is a known level of 
chronicity within the induced lesions as well as a similar morphology that makes treatment 
outcomes easier to define and measure. Fourth, the use of induced lesions eliminates the time 
and cost associated with identifying natural lesions with a herd to use for a treatment trial. 
Finally, we feel that this model’s simplicity and consistency of induction gives it the ability to be 
scaled up to meet statistical significance for any number of the aforementioned research trials. 
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Appendix B: Preliminary Induction Trials Materials and Methods 
 
Experiment 1 
Ten Holstein steer calves were utilized for this study. The calves were housed in a single 
group at the Iowa State University Veterinary Medicine Research Institute in a 3-sided shed with 
an outdoor run. For this experiment, all four feet were utilized from each of the calves. For each 
calf, feet were randomly assigned as to have two feet per calf for each protocol either subjected 
to abrasion at the onset of the trial or to be wrapped without abrasion. As this was a comparison 
between two variables, no controls were utilized for this experiment. On day 0 of the trial, all 
feet were subjected to abrasion using a tungsten abrasion disk. A 5/8” diameter area of skin in 
the interdigital fold was abraded in a manner to remove the epidermis and approximately 50% of 
the thickness of the dermis. Following abrasion, a 4x4 gauze pad was soaked in Induction Broth 
which was a mixture of sterile growth media that contained 40% MTGE (Anaerobe Systems, 
Morgan Hill, CA), 30% Brain Heart Infusion (BHI) Broth (BD and Company, Sparks, MD) 15% 
Trypticase Arginine Serine (TAS) Broth (1), and 15% Mueller Hinton Broth (BD and Company, 
Sparks, MD). This gauze pad was placed over the abraded skin in the interdigital fold and 
wrapped with 2” Gorilla Tape, (Gorilla Glue Inc.), to minimize the transfer of moisture and 
debris into and out of the wrap. Calves were housed in their assigned pens and groups following 
the application of wraps and feet were monitored for side effects of the abrasion and wraps for 3 
days.  
On day 3 of the trial, an inoculum was prepared and administered to each foot wrapped 
on day 0. The inoculum was prepared using biopsies from four adult cows with stage 3 and 4 DD 
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lesions as described in the Iowa DD scoring system (2). Approximately five grams of lesion 
material was harvested and placed into MTGE Broth. The lesions were combined and macerated 
in an anaerobic chamber using two scalpel blades, and 1.5 ml of the supernatant was placed into 
each of 40 three ml syringes. A 1” sterile plastic teat cannula (Jorgenson Labs, Loveland, CO) 
was placed on the syringes and they were packaged into a sterile Whirl-Pak bag per calf under 
anaerobic conditions. The inocula were deposited behind the wraps in the exact location in which 
50% of the feet were abraded. On day 7 the wraps were removed and feet were photographed. 
Lesion progression was monitored via twice weekly photographs and locomotion scores until the 
conclusion of the study on day 32 
 
Experiment 2 
Eighteen Holstein steer calves were utilized for this study. The calves were housed in the 
same location as experiment 1. Three calves served as control calves and were placed in a 
completely separate pen from the rest of the calves. Similar to Experiment 1, all four feet were 
utilized from each of the calves. One foot from each of the induction calves served as a within 
calf control for this experiment. The other 3 feet from each calf were randomly assigned to one 
of three inocula. All feet in this experiment were abraded and wrapped on day 0 in an identical 
manner as that described in Experiment 1. Calves were allowed to commingle following the 
application of wraps and feet were monitored for side effects of the abrasion and wraps. 
On day 2 of the trial, inocula were prepared and administered to each of the feet wrapped 
on day 0. The inocula were prepared using biopsies from three adult cows with stage A2 and 
stage 4 DD lesions. Approximately five grams of lesion material was harvested and placed into 
MTGE Broth, macerated in an anaerobic chamber, and 1.5 ml of the remaining supernatant was 
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placed into 15 three ml syringes for inoculum #4. A separate set of 15 syringes was filled with 
0.75 ml of the macerated lesion inoculum and 0.75 ml of MTGE Broth containing log growth of 
3 isolates of Treponema phagedenis. The isolates of T. phagedenis were isolated in our 
laboratory from cases of digital dermatitis in adult Holstein dairy cows. Previous work in our lab 
showed log growth at approximately 72 hours with an estimated 10
7
 live cells per ml of MTGE 
Broth. This 50% mixture of macerated lesion and T. phagedenis organisms was used as inoculum 
#2. A third set of 15 syringes was filled with 0.75 ml of the macerated lesion inoculum and 0.75 
ml of MTGE Broth containing Dichelobacter nodosus (ATCC® 25549™). The D. nodosus was 
48 hour growth on BRU Agar (Anaerobe Systems, Morgan Hill, CA). Three plates of lawn 
growth were washed with TAS broth and added to the macerated lesion inoculum in a 50% 
mixture to make inoculum #3. Previous work in our lab showed this technique yielding 
approximately 109 live cells per ml of TAS broth. An additional set of 15 syringes were filled 
with 1.5 ml of MTGE Broth to serve as the within calf controls. A final set of 12 syringes were 
filled with 1.5 ml of MTGE Broth (inoculum #1) for all 4 feet of the three segregated control 
calves. A 1” plastic teat cannula was placed on all of the syringes and they were packaged into a 
sterile Whirl-Pak bag per calf under anaerobic conditions. The inocula were again deposited 
behind the wraps in the exact location that all of the feet were abraded. 
On day 4 of the trial, inocula were prepared in an identical manner to what was done on 
day 2 with approximately five grams of macerated lesions was collected from four adult dairy 
cows with stage A2, B2, 3, and 4 DD. The inocula were again deposited behind the wraps in the 
exact location in where all of the feet were abraded. Following induction, feet were re-moistened 
using MTGE Broth containing 33% Fetal Bovine Serum (Sigma-Aldrich, St. Louis, MO) on days 
10 and 18. On day 24 all wraps were removed and feet were photographed. Lesion progression 
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was monitored via twice weekly photographs and locomotion scores until the conclusion of the 
study on day 49. At the conclusion of the study, any remaining visible lesions were biopsied 
using a 3 mm biopsy punch and treated with topical tetracycline until no visible lesions 
remained. 
 
Experiment 3 
Twenty two Holstein steer calves were utilized for this study. The calves were housed in 
the same location as experiment 1. Four calves served as control calves and were placed in a 
completely separate pen from the rest of the induction calves. Similar to Experiments 1 and 2, all 
four feet were utilized from each of the calves. One foot from each of the induction calves served 
as a within calf control for this experiment. The other 3 feet from each calf were randomly 
assigned to one of three inocula. All feet in this experiment were abraded and wrapped on day 0 
in an identical manner as that described in Experiment 1. Calves were allowed to commingle 
following the application of wraps and feet were monitored for side effects of the abrasion and 
wraps. 
On day 3 of the trial, inocula were prepared and administered to each of the feet wrapped 
on day 0. The inocula were prepared using biopsies from three adult cows with stage A2 and 4 
digital dermatitis lesions. Approximately five grams of lesion material was harvested and placed 
into MTGE broth, macerated in an anaerobic chamber, and 1.5 ml of the remaining supernatant 
was placed into 18 three ml syringes for inoculum #2. A separate set of 18 syringes (inoculum 
#4) was filled with 1.5 ml of MTGE broth containing 72 hour log growth of the same 3 isolates 
of Treponema phagedenis utilized in Experiment 2. A third set of 18 syringes was filled with 1.5 
ml of mixed pure cultures isolated from DD lesions in adult Holstein dairy cattle. This mixture 
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contained Dichelobacter nodosus, Bacteroides spp., Porphyromonas levii, and Treponema 
phagedenis. The D. nodosus was prepared in an identical manner as described in Experiment 2 
and contributed to 15% of the inoculum. Four isolates of Bacteroides spp. and four isolates of P. 
levii were prepared from 48 hour growth on BRU Agar. These plates of lawn growth from each 
bacterium were washed with BHI Broth and each contributed to 15% of the inoculum. The final 
55% of the inoculum was from the 72 hour growth of the three isolates of T. phagedenis 
described in inoculum #2. This mixture of organisms isolated from DD lesions made up 
inoculum #3. Previous work in our lab showed this technique yielding approximately 109 live 
cells per ml of D. nodosus, Bacteroides, and P. levii. An additional set of 18 syringes were filled 
with 1.5 ml of Induction Broth which contained 30% BHI, 15% TAS, and 55% MTGE to serve 
as the within calf controls. A final set of 16 syringes were filled with 1.5 ml of Induction Broth 
for all 4 feet of the four segregated control calves. A 1” plastic teat cannula was placed on all of 
the syringes and they were packaged into a sterile Whirl-Pak bag per calf under anaerobic 
conditions. The inocula were again deposited behind the wraps in the exact location that all of 
the feet were abraded. 
On day 10 of the trial, inocula were prepared in an identical manner to what was done on 
day 3. Approximately five grams of macerated lesions was collected from seven adult dairy cows 
with stage A1, A2, B1, B2, 3, and 4 digital dermatitis lesions as described in the Iowa Digital 
Dermatitis scoring system to be utilized in the inocula. The inocula were again deposited behind 
the wraps in the exact location in where all of the feet were abraded. On day 24 all wraps were 
removed and feet were photographed. Lesion progression was monitored via twice weekly 
photographs and locomotion scores until the conclusion of the study on day 38. At the 
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conclusion of the study, any remaining visible lesions were biopsied using a 3 mm biopsy punch 
and treated with topical tetracycline until no visible lesions remained. 
 
Experiment 4 
Thirty six Holstein steer calves were utilized for this study. The calves were housed in 
three separate groups. The main treatment groups were housed in two separate pens each 
containing 16 calves at the Iowa State University Veterinary Medicine Research Institute in a 3-
sided shed with an outdoor run, whereas the four controls were moved to a completely naïve 
location within the Iowa State University Teaching Hospital. Similar to Experiments 1, 2, and 3, 
all four feet were utilized from each of the calves. For Experiment 4, all four feet of each calf 
would be treated with the same inoculum and there would not be a within calf control. A subset 
of 4 calves from each of the groups of 16 would serve as within pen controls. All feet in this 
experiment were abraded and wrapped on day 0 in an identical manner as that described in 
Experiment 1. Calves were allowed to commingle following the application of wraps and feet 
were monitored for side effects of the abrasion and wraps. 
On day 3 of the trial, inocula were prepared and administered to each of the feet wrapped 
on day 0. The inocula were prepared using biopsies from eight adult cows with stage A1, A2, 
B1, B2, and 4 DD lesions. Approximately 20 grams of lesion material was harvested and placed 
into Induction Broth containing 40% MTGE, 30% BHI, 15% TAS, and 15% Mueller Hinton 
Broth, macerated in an anaerobic chamber, and 1.5 ml of the remaining supernatant was placed 
into 48 three ml syringes for inoculum #1. A second set of 48 syringes was filled with 1.5 ml of 
mixed pure cultures isolated from DD lesions in adult Holstein dairy cattle. This mixture 
contained Dichelobacter nodosus, Bacteroides spp., Porphyromonas levii, Campylobacter 
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urealyticus, and Treponema phagedenis. The D. nodosus, Bacteroides spp., and P. levii, were all 
prepared in an identical manner as described in Experiment 3 and each contributed to 15% of the 
inoculum. An additional 40% of the inoculum was from the 72 hour growth of the three isolates 
of T. phagedenis described in Experiment 3. The final 15% of C. urealyticus was prepared from 
two isolates each plated on sheep blood agar and incubated under microaerophilic conditions for 
72 hours. The plates were washed with Mueller Hinton Broth and contributed to approximately 
15% of the final Induction Broth. Previous work in our lab showed log growth at approximately 
72 hours with an estimated 107 live cells per ml of BHI Broth. A final set of 48 syringes were 
filled with 1.5 ml of Induction Broth to serve as controls. Sixteen of the syringes were used on all 
4 feet of the four segregated control calves, 16 were used on all 4 feet of four control calves 
within the same pen as those receiving inoculum #1, and the final 16 were used on all 4 feet of 
four control calves within the same pen as those receiving inoculum #2. A 1” plastic teat cannula 
was placed on all of the syringes and they were packaged into a sterile Whirl-Pak bag per calf 
under anaerobic conditions. The inocula were again deposited behind the wraps in the exact 
location that all of the feet were abraded. 
On days 11, 17, and 25 all wrapped feet were re-moistened by dispensing 1.5 ml of the 
Induction Broth behind each wrap in the location of abrasion. On day 37 all wraps were removed 
and feet were photographed. At this time, any remaining visible lesions were biopsied using a 3 
mm biopsy punch and treated with topical tetracycline until no visible lesions remained. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE RESEARCH 
 
Summary and Conclusions 
 The epidemiology portion of this dissertation demonstrated that the novel scoring system 
developed during this study can be effectively utilized for the analysis of DD lesion development 
and served as an effective method to study lesion progression and regression. This scoring 
system had several significant advantages over previously described scoring systems and 
allowed for a more detailed evaluation of the development of early stage lesions by providing 
four distinct classifications. This scoring system provided a means of classifying DD lesions at 
their earliest stages and was the basis for investigating the etiology of disease through the use of 
next generation sequencing.  
From the results of the next generation sequencing, we conclude that the bacterial 
communities associated with DD biopsies change significantly as the lesions develop and that 
these bacterial communities are closely tied to the morphologic stage of lesion development. 
Each stage of the Iowa DD scoring system was statistically validated as containing a unique 
microbiota different from the prior or subsequent lesion stages. This conclusion is based on an 
extensive evaluation of more than 175 million sequences, evaluated with two different 
sequencing pipelines, encompassing 48 biopsies from all lesion stages as well as normal skin 
collected from our three year longitudinal study. In both 16S and shotgun sequencing, the 
amount of Treponema DNA isolated from each stage of development increased as the lesion 
score increased. This population of Treponema spp. also appears to have different constituents at 
each of the various stages of development, which may help explain the variability noted in the 
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Treponema spp. visualized from previous fluorescent in situ hybridization studies (1-3). The 
significance of these changes in Treponema spp. type and relative abundance in relation to the 
possible role of Treponema spp. in the etiology of DD remains unclear at the present time and 
warrants further investigation. It is clear that advanced lesions have a high percentage of 
Treponema spp. in relationship to other bacterial species, but it is still unknown if this is strictly 
an association or a true causation. 
 The Iowa DD scoring system provided useful information in a number of other areas as 
well. Utilizing the dichotomous categorization of pre-lesions in the Iowa DD scoring system, it 
was found that 1st lactation heifers had a higher rate of “B” type lesions, whereas “A” type 
lesions were more likely to be identified in multiparous animals. Given their age and the 
relatively low incidence of DD in heifers on this farm, this finding might suggest that DD naïve 
animals are more likely to develop this subtype of lesion during the first disease exposure. For 
clinical DD lesions that received topical treatment, scoring of the post-treatment lesions using the 
Iowa DD scoring system was found to be useful in prognosticating the risk of recrudescence and 
time until recrudescence. Significant differences were observed between lesions scores following 
treatment with lower lesion scores correlated with a lower rate of recrudescence and a longer 
time to recurrence. 
The knowledge gained from the preliminary induction trial experiments resulted in a final 
consensus protocol capable of inducing DD lesions in 42 of 44 (95%) feet over a 28 day period. 
All induced lesions were macroscopically and microscopically identified as clinical DD lesions 
by individuals blinded to protocols. Lesions were also located at the site of inoculation in the 
palmer aspect of the interdigital space, and induced clinically measurable lameness in a 
significant portion of the calves. This protocol has the potential to be useful in a number of future 
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research investigations including research with novel vaccines against DD, testing of candidate 
pathogens isolated from DD lesions for their ability to reproduce disease, and testing new 
treatment strategies. Finally, we feel that this model’s simplicity and consistency of induction 
gives it the ability to be scaled up to meet statistical significance for any number of research 
trials. 
 
Recommendations for Future Research 
  The research presented herein has generated many additional hypotheses to be tested in 
the future. In relation to the epidemiology of the disease, the first area of additional research 
would be determining the significance of “B” type lesions from “A” type lesions in 1st calf 
heifers. Although we speculated that the higher prevalence of “B” lesions could indicate that 
these lesions were associated with a first time exposure to DD pathogens, we were not able to 
prove this in our longitudinal study as many of the animals were either enrolled after their 1st 
lactation or they had existing lesions at the start of study. To address this question, one would 
have to enroll heifers at an earlier age and verify that the feet were clear of DD lesions prior to 
enrollment. The study would also have to be designed to minimize exposure to any footbaths, 
topical treatments, or systemic antibiotics. Frequent observations would need to be done to 
identify the first ever macroscopic changes to the skin at the onset of disease. This study design 
would allow one to compare the difference in “A” and “B” lesions without the confounders of 
unknown lesion history and exposure to prevention measures. 
 As the Iowa DD lesion scoring system was shown to be a valuable tool in measuring the 
outcome of DD intervention strategies, future research into whether more aggressive treatment as 
a means to return DD lesions back to normal skin would be beneficial in lowering the 
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recrudescence rate would be warranted. With the knowledge that a reduced lesion score 
following treatment was associated with a lower rate of recrudescence, a study designed to 
evaluate different treatment products or frequency of application would be beneficial as a means 
to lower the incidence of clinical lameness. To accomplish this goal, a herd would have to be 
identified that had a large number of clinical lesions and a randomized clinical control study 
could be performed with different products or protocols. An evaluation of each protocol’s ability 
to decrease lesion score could serve as a sufficient outcome based on our preliminary data, 
although to fully validate the observations, a long-term assessment of lesion recrudescence rate 
would be a better outcome measure. Similarly, further studies evaluating the economics of 
treating the more prevalent pre-lesions prior to developing into clinical DD lesions could be 
looked at to reduce lameness associated with clinical lesions. 
 Finally, utilizing the metagenomics data and the DD induction model, additional testing 
of individual organisms and combinations of organisms and their ability to induce DD lesions 
would be warranted. To this point, several pure culture organism combinations have been tested 
with minimal success. As many of the organisms identified in DD lesions have yet to be 
evaluated, there are an unlimited number of combinations of organisms that could be formally 
tested. With the final induction protocol having a large discrimination between successful 
induction and controls, the results of these studies would be simpler to interpret. Additionally, as 
novel vaccines are developed, the induction model would provide a way to study the protective 
effect of these vaccines in immunologically naïve calves. 
174 
 
 
References 
1. Klitgaard, K., et al., Targeting the Treponemal microbiome of digital dermatitis 
infections by high-resolution phylogenetic analyses and comparison with fluorescent in situ 
hybridization. Journal of clinical microbiology, 2013. 51(7): p. 2212-9. 
2. Knappe-Poindecker, M., et al., Interdigital dermatitis, heel horn erosion, and digital 
dermatitis in 14 Norwegian dairy herds. J Dairy Sci, 2013. 96(12): p. 7617-29. 
3. Rasmussen, M., et al., Bovine digital dermatitis: possible pathogenic consortium 
consisting of Dichelobacter nodosus and multiple Treponema species. Vet Microbiol, 2012. 
160(1-2): p. 151-61. 
 
